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4ABSTRACT
In this thesis, I explore the range of ethical problems that are seen in 
research generally, and in research involving individuals with compromised 
autonomy more specifically - that is, children, the elderly, and the mentally ill.
Chapter 1 deals with reasons why ethical issues surrounding research 
are becoming more important, and the focus society has on rights, autonomy, 
and consent. Problems with consent (definition, amount of information to 
disclose, communication difficulties, and risk-benefit analysis) are explored. 
The ethical implications of research versus experimentation, and clinical versus 
non-clinical research are analysed. Problems with clinical research (such as 
involvement of ill people and conflict or interest) are assessed, as are the 
problems of non-therapeutic research (use of well people, motivation to 
participate, and the role of patient consent). This forms the background for an 
analysis of research on those who have compromised autonomy - children, the 
elderly, and the mentally ill.
Chapter 2 relates to problems with research on children, assessing the 
role of parental consent and its advantages (preservation of family relationships 
and access to benefits of trial) and disadvantages (problems with parental 
understanding, and the idea that it represents necessarily the views and best 
interests of the child). The autonomy of the child is also assessed, and seen to be 
limited by balance of power, difficulties ensuring understanding and voluntary 
consent, and problems specific to adolescents. Psychosocial research is also 
analysed, as is the conflict of the doctor's involvement in paediatric research.
Chapter 3 relates to research involving the elderly and why this is 
important. Autonomy of the elderly may be compromised by a number of 
factors, such as ambiguity in terminology applied to the elderly, stereotype, 
extrinsic factors such as poverty and family relationships, and intrinsic factors, 
such as cognitive impairment, deafness, blindness, and so forth. Problems
5obtaining consent relate to the above factors, as well as institutionalisation and 
the pressures from family. However, research in this group is also important as 
they have problems which cannot be researched in other groups.
Chapter 4 assesses problems in performing research on the mentally ill, 
which are particularly highlighted through past exploitation of psychiatric 
patients. Autonomy in the mentally ill is threatened by a number of factors, 
such as the wide range of capabilities the mentally ill have; stigmatisation; 
communication, reasoning, and assessment problems; involuntary 
hospitalisation and treatment, and the use of psychotropic medications; and 
deranged interpersonal relationships. Children and the elderly who also have 
mental illness have extra problems and need careful handling for research. The 
doctor-patient relationship may also be jeopardised, which is even more 
significant in a group with fewer social supports.
In summary, there may be seen to be a number of factors which 
compromise the autonomy of children, the mentally ill, and the elderly. A 
recognition of these factors, coupled with practical measures to optimise 
consent and the acceptability of research, can help make such research more 
ethical. It is important to perform such research, in order to maximise the 
happiness and well-being of these individuals.
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There is, in recent times, an increasing focus on the ethical issues 
surrounding research. Much has been written on informed consent and the 
participation of autonomous individuals in research. There has also been some 
analysis of the problems of how to deal with people with no autonomous traits, 
such as those in a persistent vegetative state. Conversely, however, there has 
been comparatively little written about those potential research subjects who 
fall somewhere in between - those who have their autonomy compromised in 
some way, but who cannot be said to be either fully autonomous or fully non- 
autonomous. In this thesis, I aim to address some of the issues surrounding 
research on individuals with compromised autonomy.
In chapter 1 ,1 shall discuss a number of points which relate to research 
in general. Firstly, there has been an increasing awareness of research and its 
associated problems. Factors which contribute to this are: an increased respect 
for the rights of the individual and his or her autonomy; increased potential for 
the range of interventions we can provide; government legislature; the 
increasing role of the clinician in research; and poor treatment of research 
subjects, especially vulnerable ones, in the past.
Thus, there has been increasing focus on the rights, autonomy, and 
informed consent of the individual. However, there are a number of problems 
with consent, which I shall discuss. These include: difficulties in establishing 
what constitutes informed consent; difficulties assessing the amount of 
information that should be disclosed; communication problems; the impact on 
the doctor-patient relationship and trust; and risks and how they ought to be 
interpreted.
I shall also contrast experimentation and research, and explore the 
implications each of these have.
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Clinical and non-therapeutic research will also be analysed. Problems 
with clinical research include conflict of interest for the doctor; involvement of 
ill people and implications for autonomy; and difficulties about when to stop a 
trial once some results become apparent. Non-therapeutic research has its own 
difficulties, such as difficult risk-benefit analysis, the role of patient consent in 
such studies, the motivation of patients to consent, and the allocation of 
resources for this kind of research.
An awareness of these issues form a backdrop for an analysis of research 
involving individuals with compromised autonomy.
The first such group is children, whom I discuss in chapter 2. It is 
important to perform research on a group such as this, as children have many 
problems and disease which cannot be adequately assessed thorough research 
on adults, in order to optimise their well-being. Issues surrounding research on 
this group will be discussed.
The first main issue relating to research involving children is the role of 
parental consent. Problems with this include the fact that parental consent does 
not necessarily involve the best interests of the child or a substitute for their 
wishes. There are also problems with parental consent relating to lack of 
parental understanding and the way in which this impacts on parental consent. 
However, the consent of parents has the benefit of preserving family 
relationships and allowing children to access benefits.
The autonomy of children themselves needs also to be analysed. It forms 
a continuum between baby and adult, and problems include lack of 
understanding, unequal balance of power, parental preference, difficulty of 
ensuring voluntary consent, and problems specific to adolescents.
Psychosocial research on children causes debate on the subjects chosen, 
the involvement of well children and risk-benefit analysis, and the long-term 
outcomes.
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The doctor's involvement may also cause problems for research 
involving children, because it leads to conflict of interest, a change in 
relationship between parents and doctor, public pressure, and allocation of 
resources.
In chapter 3 ,1 shall examine issues relating to research involving elderly 
people. I shall explain why research in the elderly is necessary, and some of the 
associated problems.
The autonomy of the elderly can be compromised in a number of ways, 
which will be discussed, and which have obvious implications for research on 
tills group. The ways in which autonomy is affected include ambiguity of 
terminology applied to the elderly, stereotyping, external factors such as 
poverty and disturbed family relationships, and internal factors such as 
dementia, motor and sensory deficits. There are also problems obtaining 
consent in the elderly, due to factors such as institutionalisation and 
interactions with the relatives.
However, research may be more acceptable through benefit to the 
individual or group, satisfaction involved for the subject, previously expressed 
wishes, and a modification of the research process to optimise autonomy, 
consent, and ethical research process.
Finally, in chapter 4 I discuss some of the issues which relate to research 
involving psychiatric patients. I discuss the importance of such research, and 
reasons why there is increasing concern today (namely, through past 
exploitation of this group).
Factors affecting the autonomy of this group are also explored. These 
include: the continuum between normal and 'abnormal1, due to varying 
symptoms and degrees of treatment; stigmatisation; problems with
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communication, relationships and assessment of capabilities; involuntary 
treatment and hospitalisation; and the use of psychotropic medications.
Children and the elderly with mental illness are also discussed, as they 
face both the problems of having a mental illness, as well as age-related 
constraints of autonomy.
The doctor-patient relationship may also be affected by difficulties in 
interaction with the psychiatric patient, and conflict of interest and difficulties 
recognising these.
In summary, there can be seen to be a number of factors which 
complicate the autonomy of groups of potential research subjects, such as 
children, the elderly, and the mentally ill. It is important to develop an 
awareness of the kinds of factors which are likely to be affecting these potential 
research subjects, and by focussing on their capabilities, their autonomy may be 
optimised. It is in this way, coupled with techniques to modify the structure of 
research, that research involving these groups may be made more ethical and 
the lives of children, the elderly, and the mentally ill made happier and more 
healthy.
CHAPTER 1 - ETHICAL PROBLEMS IN RESEARCH
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1.1 - Introduction
In this chapter, I shall discuss some of the ethical issues which relate to 
research in general.
Firstly, I shall discuss factors which contribute to the increasing 
awareness of research and its associated ethical issues. These include: public 
concern for autonomy and the rights of the individual; more sophisticated 
technology; the role of the doctor in research; and the poor treatment 
historically of research subjects.
The consent of the research subject is usually thought to be of paramount 
importance for ethical research, and I shall also discuss difficulties relating to 
consent. Such problems include: defining informed consent; the amount of 
information to disclose; communication problems in the process of obtaining 
consent; and trust between doctor and patient.
Experimentation as opposed to research will be discussed, as well as the 
distinction between clinical and non-therapeutic research. Issues relating to 
non-therapeutic research also will be analysed. Such problems include: risk- 
benefit analysis; whether consent overrides risks to well patients; utilitarianism; 
the involvement of ill people; motivation to participate in such research; and 
allocation of resources.
Finally, ethical problems relating to the involvement of the clinician and 
of ill research subjects will also be assessed.
1.2 - The increasing importance of ethical issues relating to research, and factors 
which contribute to this
Issues surrounding research are becoming increasingly important for a 
number of reasons.
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1.2.1 - Factors which derive from the public and from government bodies
Factors which contribute to an increased awareness of ethical issues in 
research which derive from public and government bodies include the 
following: an increased belief in and concern for the rights of the individual; a 
reaction against paternalistic medicine; a rapidly increasing potential for 
intervention and techniques for doing this; and a significant increase in new 
treatments and government regulation of such practices1.
1.2.2 - Factors which are related to the involvement of clinicians in research
Other factors which contribute to an increased awareness of the ethical 
problems in research relate to the involvement of clinicians. These include 
increasing funding available for research; the need for clinicians in particular to 
demonstrate proficiency in research to advance in their careers; the 
development of research as a career - for example, clinical pharmacology; 
increasing emphasis the notion of preventative medicine, rather than on 
therapeutic treatment of individuals; and the greater capacity for good or harm 
possible with new treatments and investigations.2
1.2.3 - Historical factors
A third reason which has led to concern about research is poor and 
unethical treatment of research subjects in the past - particularly subjects whose 
autonomy was compromised in some way, including children, the mentally ill, 
and prisoners.
In the mid eighteenth century, it was common for orphans and 
'foundlings' to be conscripted for research, and children were used for
1 Mason, J.K. and McCall Smith, R.A. (1994), Law and Medical Ethics, Butterworths, London, p. 
349.
2Beecher, H.K., 'Ethics and Clinical Research1, in Kuhse, H. and Singer, P. (eds) (2000), Bioethics 
- An Anthology, Blackwell, Oxford, p. 422.
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autopsies and research on measles and smallpox3,4. The nineteenth century saw 
more experimentation on children (particularly those institutionalised) with a 
wide range of infectious diseases, such as syphilis5, scarlet fever, gonorrhoea, 
and vaccines for rabies and diphtheria6.
Despite analysis of the treatment of patients and research subjects from 
very early times historically (ranging from Hippocrates, through to Thomas 
Percival, William Beaumont, and Claude Bernard in the nineteenth century, 
and culminating in the Prussian directive and the Reich Circular in the early 
twentieth century, which give clear directives on ethical research process7,8) 
experiments on x-rays and metabolic diseases, among other things, were 
conducted on minors well into the twentieth century9.
Unfortunately, despite the existence of such guidelines and analyses, 
there continued to occur a range of unethical experiments. A notorious example 
occurred in Nazi Germany; the practices of Nazi physicians are well known 
and represent a notorious example of unethical research and inhumane 
treatment10.
Nazi doctors conducted a wide range of experiments, including finding 
antidotes to phosgene gas, limb and bone transplantation with no clinical 
indication, and injecting subjects' eyes with dye to try to change eye colour 
permanently11. Other experiments included investigating irregular menses in
3Lederer, S.E. and Grodin, M.A., 'Historical Overview: Pediatric Experimentation', in Grodin, 
M.A. and Glantz, L.H. (eds) (1994), Children as Research Subjects, OUP, NY and Oxford, p. 4-5.
4Grodin, M.A., 'Historical Origins of the Nuremberg Code', in Annas, G.J. and Grodin, M.A. 
(eds) (1992), The Nazi Doctors and the Nuremberg Code - Human Rights in Human 
Experimentation, OUP, NY and Oxford, p. 124.
5ibid, p. 127.
6Lederer and Grodin (1994), op. cit., p. 6-8.
7Grodin, M.A., 'Historical Origins of the Nuremberg Code', in Annas and Grodin (1992), op. cit., 
pp. 124-128,131.
8Perley, S., Fluss, S.S., Bankowski, Z. and Simon, F., 'The Nuremberg Code: An International 
Overview', in Annas and Grodin (1992), op. cit., pp. 150-151.
9Lederer and Grodin (1994), op. cit., p. 9-10.
10Zinner, S.E., 'The Elusive Goal of Informed Consent by Adolescents', Theoretical Medicine, 
1995; 16; 323-331.
11Proctor, R., 'Nazi Doctors, Racial Medicine, and Human Experimentation' in Annas and 
Grodin (1992), op. cit., p.26.
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women who learned of their impending executions12, and high altitude 
experiments, the effects of freezing on humans, deliberate infection with 
malaria and typhus, and poisoning with mustard gas13.
A more recent example of research abuse is a research project begun in 
1932 at Tuskegee, in which 400 black men with syphilis were denied treatment 
in order to study the natural history of the disease; this project was ceased only 
in 1972, after public outcry14. The individuals involved in this study had no 
idea that they were infected and that they were being denied treatment15. 
Another more recent example occurred at the Jewish Chronic Disease Hospital 
in 1963, where 22 chronically ill people were injected with live cancer cells 
without their knowledge16.
A combination of these factors has contributed to heightened concern 
about the ethics of research, particularly on subjects with compromised 
autonomy.
1.3 - Rights, autonomy and consent
As indicated in the preceding paragraphs, society is increasingly 
concerned with the rights and freedom of the individual. In terms of research, 
these central issues are embodied by the notions of autonomy and of consent. 
Much has been written about the issues of autonomous subjects and about 
those with no autonomy (for example, those in a coma or a persistent 
vegetative state).
However, less has been written about the difficulties posed by research 
on those individuals in whom autonomy may be more borderline. As research
12Pross, C., 'Nazi Doctors, German Medicine, and Historical Truth', in Annas and Grodin (1992), 
op. cit., p. 37.
13Taylor, T, 'Opening Statement of the Prosecution', Trials of War Criminals Before the 
Nuremberg Military Tribunals, quoted in Annas and Grodin (1992), op. cit., pp67-93.
14Macready, N., 'US to encourage more black people to join research trials', BMT, 1997; 314: 696.
15Katz, ]., 'The Consent Principle of the Nuremberg Code: Its significance Then and Now', in 
Annas and Grodin (1992), op. cit., p. 230.
16ibid.
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involving these subjects is likely to continue, a discussion of the particular 
problems they face is necessary.
In summary, problems with research on those w ith compromised 
autonomy include: problems in establishing what constitutes informed consent; 
compromised patient/ subject autonomy and associated difficulties with 
obtaining informed consent; proxy consent for potential research subjects with 
compromised autonomy; the extent to which the wishes of the individual with 
compromised autonomy should be taken into account; problems with 
communicating and understanding information about the research; and risks 
and benefits, and how much risk is justifiable. These problems will be discussed 
individually in the following sections.
1.4 - Consent
The exploitation of research subjects, particularly vulnerable ones such 
as children, led to the establishment of the Nuremberg Code, which states that 
'the voluntary consent of the human subject is absolutely essential' in 
research17; research needs 'informed consent' because this reflects the autonomy 
of the subject, and that they have chosen to participate in the research with 
understanding of the nature of the project, and possible consequences (risks 
and benefits).
Given the potential for exploitation of research subjects - particularly 
those with compromised autonomy - a focus on fully-informed, voluntary 
consent is understandable. However, there are a number of problems with the 
notion of consent.
1.4.1 - Difficulties in defining 'informed consent'
17Zinner (1995), op. cit., p. 324.
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The first problem is that the idea of 'informed consent' is too vague and 
poorly-defined. In a U.S. legal case (Salgo 18) it was stated that the doctor in 
question 'should give enough information to form the basis of intelligent 
consent'; the term 'intelligent consent' was later adapted and used more 
commonly as 'informed consent'. It has been noted that this is problematic 
because 'informed consent' is no more than a broad principle and gives no 
guide to practical aspects (i.e. how much information and what kind of 
information should be passed on), yet this phrase has become very widely 
used19.
1.4.2 - Patient versus professional standard of information disclosure
Further, it is unclear whether the information given to patients/potential 
research subjects should be 'complete' by the standards of the patient, or 
whether the doctor or researcher should be allowed to modify and limit the 
information passed on based on his or her professional judgement.
Thus, a 'patient standard' or a 'professional standard' may be taken as 
the basis for information disclosure20. The patient standard involves disclosure 
of information to a level determined by the patient, whereas the professional 
standard is a modified version which leaves scope for clinical judgement - the 
extent and detail of the information provided is determined by the professional. 
Most individuals would probably say that they would prefer the patient 
standard, but there are a number of difficulties with this.
1.4.3 - Problems with the patient standard of information disclosure
Firstly, the information provided to obtain informed consent for therapy 
or research is generally taken to be the level of information which would be
18 Salgo v Leland Stanford Junior U niversity Board o f Trustees, 317 P 2d 170 (Cal, 1957).
19Mason and McCall Smith (1994), op. cit., p. 238.
20ibid, p. 239.
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required by a 'reasonable patient', but it is difficult to establish just what this 
would be. Consent statutes are in use in the U.S., but these serve more to 
protect the doctor rather than provide adequate guidelines for information 
disclosure21.
Further, it is evident that various patients or research subjects want 
an d /o r need a very wide range of information in their contact with medicine, 
or indeed with research. In addition, it is difficult to define the notion of 'fully 
informed' and the amount of information which should be deemed necessary. 
As for the term 'reasonable patient', to be 'fully informed' means different 
things to different people, and it is difficult to ascertain how much an 
individual patient wants to know, far less be able to establish general principles 
for information disclosure.
However, there is a trend to interpret a patient standard ('fully 
informed1) to mean a ll information. And although many people would claim 
that they would want to be given complete information, it is questionable 
whether many would truly desire this. In fact, a patient in the U.S. sued for 
damages recently because she felt she had been given too much information.
It may be that when patients or research subjects say they want complete 
information, in reality they want some kind of guarantee against adverse or 
unexpected events. It is also often the case that individuals claim that they 
wanted to know more about what they went through, though when questioned 
prior to a procedure 'only want to know so much'22 - that is, it is after a 
particular procedure or investigation has been gone through that a person feels 
able to deal with more information.
1.4.4 - Impact on trust in the doctor-patient relationship
21ibid, p. 360.
■^Radley, A., 'The critical moment: time, information and medical expertise in the experience of 
patients receiving coronary bypass surgery', in Williams, S.J. and Calnan, M. (1996), Modern 
Medicine - Lay perspectives and experiences, UCL Press, London, p. 130.
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Another disadvantage of the 'patient standard' for disclosure of 
information in obtaining is that the focus on patient autonomy - not just 
instances of medical negligence - has contributed to the lack of trust between 
patient and physician, and the decreased role this now plays in a clinical 
setting. Although this may appear to be less of a problem in research, it is 
relevant in two ways.
Firstly, the physician often plays a part in research - particularly clinical 
research - if only as an intermediary between investigator and research subject.
Secondly, the idea of informed consent and its related problems, 
although important in clinical practice, also has a secondary impact on 
research, insofar as consent is also an issue in research of all kinds. This focus 
on patient autonomy has also led to an expectation of disclosure of 'complete' 
information in all situations, even when it is not appropriate for various 
reasons.
1.4.5 - Advantages of the professional standard of information disclosure
These kinds of difficulties mean that a 'professional standard' for 
disclosure of information may be more appropriate. There are a number of 
points in favour of this model.
Firstly, it may function to decrease the stress of research subjects, 
particularly those who are unwell, by allowing the physician or scientist some 
flexibility in the amount and type of information they give to the subject. 'Too 
much' information can be distressing and unhelpful to some individuals, 
particularly at the time of an illness or procedure; it is in retrospect that more 
information is usually desired, though the need and want for this is denied at 
the time23.
23Radley, A., in Williams and Calnan (1996), op. cit., p. 130.
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Secondly, it allows a physician or scientist to formulate an explanation, 
suited to the individual, which maximises that individual's chances of 
understanding the information to be conveyed.
Thirdly, it also helps to avoid the danger that research subjects may 
unreasonably misinterpret the information with which they are presented - 
perhaps in a way which is out of proportion to the 'real' risk.
For example, hormone replacement therapy (HRT) is generally thought 
to decrease the risk of fractures secondary to decreased bone density by 20% 
but to increase the risk of breast cancer by 20%. Patients often interpret this 
information differently from medical personnel - many tend to think that the 
two (as they both involve a change of 20%) cancel each other out, or that 
fractures are of minimal significance, or fail to realise that fractures are far more 
common than breast cancer, and that they are a significant cause of morbidity 
and mortality. So the risks are interpreted in such a way that the patient may be 
deterred from trying HRT when its use may be considered acceptable if they 
actually understood the information more accurately. (Though of course it is 
difficult to assess when someone 'really' understands something; and it is 
arguable that they should still be allowed to refuse, even if it does not seem 
'reasonable' - particularly when research, rather than treatment, is the issue.)
1.4.6 - Problems with the professional standard of information disclosure
However, there are a number of problems with using the 'professional 
standard1 for information disclosure.
Firstly, although it has been concluded (with respect to therapeutic 
intervention) that 'a doctor is not negligent if he acts in accordance with a 
practice accepted at the time as proper by a respectable body of medical 
opinion', it is also evident that as choice calls for a decision by the patient on 
information known to the patient but not to the doctor, it would seem illogical
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to hold that the amount of information to be provided by the doctor can be 
determined from the perspective of the doctor (or medical profession) alone24.
Secondly, the physician or researcher may be taking into account only 
medical or scientific aspects of the problem. The patient, or the person giving 
consent by proxy (for example, a parent) may have a different set of priorities 
which may affect their decision - for instance, the attending physician may 
recommend tablets because they are the cheapest, but parents may still want a 
liquid form of the drug, because (for them) it is worth the extra expense in 
terms of time and effort saved25. More complex factors likely to affect decision­
making (in both clinical and research scenarios) include family, social, religious, 
financial, and even cosmetic considerations, depending on what is involved. 
The investigator or attending physician may not be privy to such factors, which 
is another reason why the 'professional standard1 may be inappropriate.
A third problem with the professional standard of information 
disclosure is the risk that the physician or researcher may communicate only 
that which they believe to be correct, but that they turn out to be incorrect in 
this belief. This may mean that the patient/ research subject is exposed to an 
ineffective or harmful option which they would not have consented to at the 
time had they been given more complete information at the time of consent. An 
example of this is a senior New Zealand doctor, who believed that carcinoma in  
situ  of the cervix would not spread and was best left untreated. His patients 
were denied treatment over 15 -20  years without being told that they were, in 
effect, participating in a therapeutic experiment26. Thus, the fallibility of 
investigators is one argument against the professional standard of information 
disclosure.
Other problems with the professional standard of information disclosure 
include the possibility that too much information is withheld from the subject -
24Mason and McCall Smith (1994), op. cit., p. 245.
25Forman and Ekman Ladd (1991), op. cit., p. 8.
26Mason and McCall Smith (1994), op. cit., p. 361.
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or even that an inappropriately large amount of information is given to a 
particular subject - because the information disclosed to them is dependent on 
the subjective opinion as to what is 'appropriate information' of the investigator 
or physician.
The professional may also tend to withhold information because it is less 
complicated - and less effort - than going through the process of giving a lot of 
information.
There is also the risk that the process of consent may be altogether 
bypassed, if the physician or researcher believes that the individual's 
involvement in the procedure or trial will be to his or her benefit.
A further problem is that an investigator may limit the information he or 
she gives to a potential participant in order to recruit a sufficiently large 
number of research subjects.
1.4.7 - Problems in communicating information to a patient or research subject
Even if 'complete' information was desirable, it seems difficult to 
imagine how this might be communicated in a comprehensible form which still 
manages to retain a high degree of accuracy.
Complete information often involves a good deal of technical and 
specialised language which the patient (even when fully mature and 
competent) may well not understand. Yet even in modifying fairly 
straightforward information for a lay listener, it is likely that at least some of 
the accuracy and 'truth' of the information may be sacrificed; it is arguable that 
in modifying medical and technical language for the benefit of the layperson, a 
degree of subtlety of meaning is lost.
The physician or researcher has undergone years of study and his or her 
knowledge has developed to a high level through multiple learning experiences 
of different kinds, and it is difficult to see how this knowledge can be readily
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translated into a neat, concise package accessible to others lacking similar 
training.
Understanding frequently requires multiple interviews and ways of 
describing, as well as feedback and questions27. It is unlikely that this kind of 
approach can be used for many areas of research, if only because of time 
constraints; this kind of information acquisition is seen more often in patients 
with chronic illness.
Of course, this is not to say that all patients would be unable to 
understand complex information, nor that no information should be given. 
However, it is difficult to see how 'all' information relating to a particular 
procedure or research protocol can be communicated to a patient or research 
subject, even if this were desirable and something that all research participants 
truly wanted.
1.4.8 - Misunderstanding in communication between researcher and research 
subject
The situation is further complicated by the fact that patients and 
potential research subjects have the capacity to misunderstand and misinterpret 
the information with which they are presented, regardless of how complete it is 
from the giver's point of view.
Even in fully autonomous, adult patients, there are often marked 
problems with understanding. Even after supposedly informed consent, one 
study found that half the adult subjects receiving placebo in a nonblind, 
nonrandomised placebo trial still believed they were definitely receiving active 
medication28. Clinical trial subjects have a tendency to believe that investigators
27Forman, E.N. and Ekman Ladd, R. (1991), Ethical Dilemmas in Paediatrics - A Case Study 
Approach, Springer-Verlag, New York, p. 28.
28Park, L.L. and Covi, L. 'Nonblind Placebo Trial: An Exploration of Neurotic Patients' 
Responses to Placebo When Its Inert Contents is Disclosed, Arch.Gen.Psychiatrv & Psychology, 
1965; 12; 336, cited in Spece, R.G., Shimm, D.S. and Buchanan, A.E. (1996), Conflicts of Interest 
in Clinical Practice and Research, Oxford University Press, New York and Oxford, p. 362.
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are treating them in accordance with Marquis' 'therapeutic obligation'29, when 
the nature of the study often precludes this. Another study found that 69% of 
research participants failed to understand that allocation was random  and 40% 
stated explicitly that they would be allocated to groups depending on their 
therapeutic need30, and a third reports that most respondents believe that it is 
'the responsible doctor' who allocates them to their group, even when it is 
explicitly stated that allocation is by chance31.
In the case of clinical research, patients are often less able to comprehend 
fully because they are unwell and are suffering associated stress32. Although 
this does not apply to the case in which a proxy consents on behalf of a non- 
autonomous patient, it is arguable that proxy consent may not overcome this 
problem, as the stress of seeing the subject ill may compromise the proxy's 
ability to understand.
Finally, ought one to assume the patient is medically naive, or tell them 
of 'last chances', or expect them to understand an issue when medicine is itself 
divided on the issue?33
1.4.9 - Risks involved
A final issue relating to consent is the risk to which a research subject is 
exposed. A large proportion of the function of consent is to allow the patient to 
assess the probable benefits and risks to which they will be exposed if they 
participate in the study.
Risk is usually assessed as less than minimal (e.g. giving a urine sample); 
minimal (e.g. mild side effects such as headache or malaise, or a small risk of a
29Marquis, D. 'Leaving therapy to chance', Hastings Cent. Rep., 1983; 13; 40, cited in Spece, 
Shimm and Buchanan (1996), ibid.
30Zinner (1995), op. cit., p. 326.
31Bj0rn, E., Rossel, P. and Holm, S., 'Can the written information to research subjects be 
improved? - an empirical study', T.Med.Eth., 1999; 25: 265.
32Forman, E.N. and Ekman-Ladd, R. (1991), Ethical Dilemmas in Paediatrics - A Case Study 
Approach, Springer-Verlag, New York, p.28.
33Mason and McCall Smith (1994), op. cit., p. 360.
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more severe adverse reaction); moderate; or severe. Severe risks are only 
considered acceptable if: the risk is small compared with the risk from the 
disease; the disease is serious; there is no other method open to obtain the 
results; and the patient consents34. But one could argue that it is unlikely that 
the actuality is as straightforward; surely the point of research is that little is 
known about the compound or procedure in question.
With respect to severe risks, some patients who are particularly unwell 
may wish to take part in a trial even if it is considered too 'risky' , and it is 
difficult to decide whether such individuals should be permitted to participate. 
On one hand, it is arguable that their autonomy should be respected and that 
they should be able to participate if they so choose. On the other hand, such 
individuals are at risk of making ill-judged decisions under the stress of being 
unwell, and may be pressured to participate or exploited in other ways.
With healthy volunteers, it is also debatable whether they should they be 
prevented from participating in high-(or any) risk studies. Again, it may be that 
their decision should be respected in order to preserve their autonomy. 
However, they may have difficulties in understanding the information given as 
part of the process of consenting. An added complication in this group is that 
the likelihood of risks is likely to increase when there is inducement (e.g. 
financial) to participate in a study35 - but this group do not stand to gain other 
benefits, such as an improvement in health.
A final point about risks is that it is often difficult to assess both the 






So the issue of informed consent is central in both therapeutic 
intervention and research, but it can be seen that what constitutes 'informed 
consent' is not clearly defined, even for mature, competent adult humans. There 
are a number of difficulties with both the 'professional' and 'patient' standards. 
The importance that informed consent is generally believed to hold, and the 
difficulties with implementing it, makes research on individuals with less than 
complete autonomy - for example, children, the elderly, and less borderline 
cases such as comatose individuals - even more problematic.
1.5 - Experimentation and research
1.5.1 - Experimentation
There are a number of different areas in science and research and the 
distinction between these areas can have moral significance. One such 
distinction is the idea of experimentation, compared w ith the process of 
research.
Experimentation may be seen as more a d  hoc and speculative36, and 
therefore not always of obvious immediate benefit to the patient/subject. This 
may make experimentation more unethical because there is not necessarily an 
obvious benefit in sight which will justify the risks involved in the experiment.
This lack of obvious benefit and the 'see what we get' approach of 
experimentation also indicates that research subjects are more likely to be used 
as means, rather than ends, thereby undermining the entrenched idea that 
people have intrinsic value, and opening up the possibility of exploitation. 
(This is particularly the case with non-autonomous subjects.)
However, experimentation gives more scope to modify the conditions of 





Research, on the other hand, involves a more clearly defined endpoint 
and course of action38. The parameters of the study are clearer than in the case 
of experimentation, and the nature of the study, the potential risks and benefits, 
and other relevant information can be more easily communicated to the 
research subject. Research, p e r se, seems therefore to be more ethical than 
experimentation. However, research gives less scope for taking into account the 
response of the individual, and has a range of other difficulties.
1.6 - Clinical versus non-therapeutic research
Research may be categorised as clinical (or therapeutic), or non-clinical 
(non-therapeutic). These categories raise different issues.
1.6.1 - Clinical research
Clinical research involves two main consideration which are less an issue 
in non-clinical research. The first is that the doctor/ clinician is more frequently 
involved in therapeutic or clinical research. The second is that ill patients tend 
to be involved more often (for obvious reasons) in therapeutic research. The 
involvement of sick patients raises issues of: exploitation of the patient; 
compromised ability to consent to high-risk procedures; inappropriate pressure 
on researchers and compromise of the integrity of the study; and when to cease 
a study once beneficial or harmful effects become apparent.
1.6.2 - The dilemma of the involvement of the clinician in research
Clinical or therapeutic research raises issues of the involvement of 
clinicians in research. This is obviously more an issue than in non-clinical or 
non-therapeutic research as the clinical or treatment setting is much more likely
38ibid, p. 351.
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to involve the treating doctor, or another clinician. This raises several issues 
about the role and duties of a doctor.
Therapeutic research is aimed at improving the treatment of a patient, or 
group of patients39. This is more in keeping with the traditional 
(caring/healing) role of the doctor; this form of research may seem to pose less 
of a dilemma for the attending doctor - who is bound to put the care of his or 
her patient first - in that the aim is to improve patient care, and at least some of 
the unwell subjects are being treated.
/o r
On the other hand, involvement of one's patients in a trial mean that not 
all can receive the best therapy; some may receive a placebo or standard 
therapy, while others gain the advantages of the new treatment. Or there is the 
risk that the therapy on trial may be less effective than the standard therapy 
currently available, so that the treatment group receiving the new therapy may 
suffer ineffective treatment or adverse reactions, while the control group do 
better. Even if there is no difference between the placebo group and the control 
group, this could mean that all the subjects in the study may be worse off than 
non-participants on standard therapy. So - almost by definition - not all patients 
can be said to be receiving the best therapy at any given time. This is 
particularly an issue when the research subject has compromised autonomy 
and their consent in the trial depends on the consent or permission of a proxy.
Hence, there may be problems involving the doctor in research because 
on one hand they need to be able to say 'the health of my patient is my first 
consideration' and the structure of research means that the patient may not be 
receiving treatment which is known to be best. On the other hand, it has been 
noted40 that doctors need to be involved at some stage of the proceedings 
because they still need to care for their patient on a day-to-day basis, their 




point of contact between the study group and the patient, and they usually 
enjoy a special and privileged relationship with the patient (which conceivably 
may be compromised by participation in the study).
1.7 - The involvement of ill individuals in research
1.7.1 - The ill person and consent
1.7.1.1 - The sick role and decreased autonomy
Another problem with therapeutic research relates to the fact that this 
sort of research necessarily involves subjects who are ill an d /o r diseased. 
People who are ill tend to assume a 'sick role', which is difficult to avoid, and of 
course may represent an important and necessary part of being ill and 
recuperating.
The difficulty is that while adopting the sick role, such individuals may 
not function with the same degree of autonomy and assertiveness, and may 
consent to participate in research which involves conditions the individual 
might not normally consent to. Even if this is not the case for some ill people, 
the problem remains, as it would appear difficult to ascertain which individuals 
are giving their 'real' consent and which are influenced by illness.
1.7.1.2 - The ill person and coercion
There is also the risk that consent may not be wholly valid insofar as 
subjects in clinical trials are already unwell, particularly if hospitalised, because 
such individuals may be coerced or pressured (unintentionally or otherwise) 
into giving their consent to participate in the research.
1.7.1.3 - The ill person and decreased cognitive abilities
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Another aspect is that illness may tend to decrease one's cognitive 
abilities, thereby increasing the risk that the potential research subject will not 
understand the information they are given. And in the case of proxy consent, 
although this does not apply directly to the person giving proxy consent for a 
patient with compromised autonomy, it may be that the proxy, by virtue of 
their relationship with the patient, is sufficiently distressed that their own 
decision-making capacity is impaired. An example of this might be the parents 
of an ill child who are approached to consent to their child participating in a 
therapeutic trial.
1.7.1.4 - The effect on those consenting by proxy
Issues such as these are in one sense less of a problem for those with 
compromised autonomy, as it is usually the case that a proxy consents on their 
behalf. However, one could argue that the difficulty of interpreting the 
individual's 'real' wishes and thoughts remain, and are merely complicated 
further by being overridden in favour of the consent of a proxy. (This is 
particularly the case for children, who - unlike some other groups with 
compromised autonomy - have not had a chance to specify what they would 
want done in a particular situation.)
1.7.2 - Very ill individuals and clinical research
1.7.2.1 - Potential for exploitation of patients
Clinical research also creates ethical problems because it can involve 
very ill patients. Individuals who are seriously ill with a terminal, incurable 
condition may be open to exploitation in research because they may be 
sufficiently desperate to consent to high-risk or unethical procedures. An
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unethical researcher may also take advantage of this attitude in order to recruit 
subjects for research.
1.7.2.2 - The right of the seriously ill individual to consent to hieh risk procedures
It is arguable, of course, that involvement in trials for incurable diseases 
may be justified because they are likely to benefit future patients - and that such 
patients should have the right to consent to research if they feel that that is 
what they wish to do. This is less an issue in autonomous adults (possible 
illness-induced changes in competence aside) but is a problem for those with 
compromised autonomy in a number of ways.
Firstly, and most obviously, potential research subjects with 
compromised autonomy may not be capable of understanding the intricacies of 
such a situation. That is, they may not be able to comprehend the potential 
problems of consenting to a high-risk experimental procedure, thereby 
increasing the risk of exploitation.
Secondly, and conversely, mature minors or elderly people in the early 
stages of dementia, for example - that is, those who are borderline in terms of 
autonomy, and who may understand enough to give their consent - may wish 
to consent to this kind of treatment but have their decision overridden.
Thirdly, cases involving individuals with compromised autonomy may 
involve proxy consent, and so it may instead be the proxy who seeks desperate 
solutions, thereby exposing the patient to potential harm. One such example is 
the parents of a terminally ill child, who may consent to high-risk therapy on 
behalf of their child. There are a number of problems involved here. It may be 
unethical to expose the child to suffering when little gain may result from 
dangerous trials. Or the parents may be acting not out of concern for the child, 
but out of feelings of guilt, or selfishness, because they fear losing the child41.
41Downie/ R.S. and Randall, F., 'Parenting and the bests interests of minors', The Tournal of 
Medicine and Philosophy, 1997; 22; 227.
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1.7.2.3 - Problems with pressure from/exploitation by seriously ill patients
So on one hand, subjects of therapeutic research may be disempowered 
by their illness and by their need for the research into that disease42. This 
situation is further complicated by the lack of power and control enjoyed by 
those with compromised autonomy. But on the other hand, research subjects 
are capable of exerting a certain amount of power.
This derives partly from the fact that they are hum an beings with 
problems which justify research. This is particularly the case when individuals 
with compromised autonomy are involved. For example, patients with 
psychiatric problems, or ill children, may be deemed to be particularly 
deserving of research, for although other groups in the community also have 
health problems, those with decreased autonomy may be less able to defend 
their own interests, and so may require outside intervention to have their 
interests protected. The power research subjects may have may also be 
exacerbated by the need researchers have to defend what they do43 (both 
morally and in practical terms).
This power may manifest itself as pressure exerted on researchers and 
doctors by patients and their families if the study is known about, particularly 
if the disease is serious and there is no known cure.
As an example, researchers at Oxford were heavily pressured by the 
families of patients with ALS (amyotrophic lateral sclerosis) to make available a 
potential treatment before it was properly trialed, even to the extent that the 
researchers were harassed at their homes. Eventually, the treatment was 
released prematurely - and turned out to be ineffective.
A similar situation has been seen with research on HIV/AIDS, where 
patient lobbying and pressure can so powerful that it can affect decisions
42Little, M., 'Research, ethics and conflicts of interest', T.Med.Eth., 1999; 25; 259-262.
43ibid.
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against the judgement and advice of scientists44,45. Many individuals with AIDS 
believe they should breach trial protocols because they feel they are not 'true' 
volunteers; a common way in which the trial is compromised is through the 
treatment group sharing their treatment with those in the placebo group46.
Thus, pressure from patients or their proxies may jeopardise the entire 
process of research; if a study is poorly designed, or not followed according to 
plan, there is the risk that the data obtained will be meaningless, thereby 
making the study fundamentally unethical. This is of particular importance 
when the research subjects are individuals with compromised autonomy, as 
they are not the ones who make the choice to push for premature release of a 
treatment, despite the fact that this may well expose them to risks. In addition, 
when the proxies are parents of desperately ill children, for example, the 
pressure they put on researchers and physicians may well exceed the level of 
pressure the patient himself would try to exert.
1.8 - When to stop a trial once effects begin to become apparent
Another problem with clinical research arises once a trial is underway. 
This occurs in a controlled trial because the patients in the treatment group may 
receive a treatment which, as the trial progresses, shows signs of being 
beneficial, while the control group are denied this. Conversely, the subjects in 
the treatment group may receive a treatment which begins to show evidence of 
being ineffective or more harmful than the control group, and it may appear to 
be unethical to persist with this course of action.
Thus, it is an issue when to stop the trial when either beneficial or 
adverse effects become evident. Obviously, it is undesirable that a research 
subject should have to endure adverse effects for longer than necessary (or at
^ibid, p. 261.
45Mariner, W., 'AIDS Research an the Nuremberg Code', in Annas and Grodin (1992), op. cit., p 
286-303.
46Schiiklenk, U. and Hogan, C., 'Patient Access to Experimental Drugs and AIDS Clinical Trial 
Designs: Ethical Issues', in Kuhse and Singer (2000), op. cit., p441.
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all), nor should the placebo group be denied a treatment which appears to be 
effective. So there is the issue of when 'enough' good or harm has been 
demonstrated.
It is clear that this is more likely to be an issue in clinical or therapeutic 
research as this involves ill people in a trial which offers potential cure or 
palliation of symptoms. Non-therapeutic or non-clinical research is unlikely to 
have the same direct effect on ill individuals.
1.8.1 - Neural tube defects: an example
An example is the study which investigated whether folic acid decreased 
the incidence of neural tube defects (NTDs) in infants47. After a time, there was 
an apparent benefit, but one insufficient to establish with statistical significance 
that folic acid was actually making a difference. But while waiting for 
confirmatory data, a number of women (the control group) were denied folic 
acid - should the control group have been given folic acid immediately?48 In the 
case of folic acid and NTDs, the folic acid must be given prior to and in the very 
early stages of pregnancy to exert its effect - by the fourth week49, usually 
before the pregnancy is recognised - and so it is arguable that switching the 
control group onto therapy would have no effect by that stage. However, this is 
not the answer for the majority of other situations which involve a similar 
dilemma.
Firstly, it is arguable that it is not know n that the results which are seen 
early in a trial are 'true' u n til statistically significant results are obtained; a 
study needs to last for a certain length of time in order for the results to be 
statistically significant50. That is, it should be noted that it would not be justified
47The MRC Vitamin Study Group, 'Prevention of neural tube defects: Results of the Medical 
Research Council Vitamin Study', Lancet, 1991; 238; 131-137.
48Mason and McCall Smith (1994), op. cit., p. 358.
49Department of Health, Scottish Office Home and Health Department, Welsh Office, 
Department of Health and Social Services (Northern Ireland) (1992), Folic Acid and the 
Prevention of Neural Tube Defects, Health Publications Unit, Heywood, Lancashire, p. 8.
50Mason and Me Call Smith (1994), op. cit., p. 354.
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to switch over the control group to receive active treatment until one could be 
certain that it really was beneficial. However, to be certain of a beneficial effect, 
it is necessary to continue until the end of the trial, because it is a statistically 
significant difference which indicates a true benefit - that is the point of doing 
such studies - to ensure that preliminary findings really are a true or useful 
result. (Having said that, however, the idea of statistical significance raises the 
problem of the use and misuse of different statistical systems. It is a 
comparatively simple matter to manipulate data so that it appears significant 
(or not), depending on the particular statistical analysis used.)
Secondly, prematurely ending a trial would, in effect, undo the 'good' 
done by those women who had already participated in the trial - and they 
would have been exposed to any risks involved in the trial, without any 
associated gain. In this sense, there is a duty to those women who successfully 
completed the early stages of the trial, to continue with it in its original format.
Thirdly, it may be that withholding treatment from the control group 
until a statistically significant result is obtained, is justifiable in that it will 
provide benefit for all future mothers. However, it could be said that this still 
impinges on the rights of the control group subjects. Even research subjects 
who are fully autonomous are problematic in that such an eventuality is 
unlikely to be the kind of outcome they would consent to.
Fourthly, certain diseases and problems (such as NTD) represent a vast 
drain on the health care funding and other resources of society, and it could be 
argued that in a situation such as this, the interests and resources of the 
community must be considered.
Fifthly, the subjects in the study gave their consent to participate in this 
kind of trial, knowing the possibility that they might not receive treatment; it is 
hard to see why this is unethical if the subject is adult, mature and autonomous. 
However, it must be said that recall rates of information given, and probably 
levels of understanding at the time of consent, are notoriously poor, even in
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those we would call 'autonomous'. In one study involving adults in research, 
69% of participants failed to understand that assignment to treatment groups 
was random - in fact, 40% stated explicitly that they would be allocated to 
different groups based on their therapeutic need51. There is also an obvious 
difficulty with this defence when one considers the case of those with 
compromised autonomy who require consent by proxy, such as children, the 
mentally ill and incapacitated, and so forth.
And finally, continuation of a trial despite preliminary findings might be 
justifiable in the sense that were the study never embarked upon, the controls 
who had babies with NTD (as well as the treatment group) would have had 
that outcome anyway. However, this kind of objection does not work well for 
trials for a treatment where a reasonably effective, standard treatment already 
exists, unless the standard therapy is being used for the control group.
1.9 - Non-therapeutic research
There are a number of problems with non-therapeutic research.
1.9.1 - Risk-benefit problem in non-therapeutic research
The first problem to do with non-therapeutic research relates to risk- 
benefit analysis, which is relevant to a wide range of situations, both clinical 
and non-clinical research, as well as treatment.
The risk-benefit problem may be argued to be even more significant in 
the case of non-therapeutic research, as it is more likely to involve well or 
healthy individuals. If healthy volunteers are used, they are unlikely to have 
obvious or direct benefits - compared with ill research subjects in clinical 
research, who may benefit directly.
51Gray, B.H. (1975) 'Human Subjects in Medical Experimentation', Wiley, New York, cited in 
Zinner (1995), op. cit., p. 326.
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Thus, it is questionable whether the research can be said to be justified in 
risk-benefit terms; the research subject does not have an obviously direct 
benefit which offsets the potential risks to which he or she is exposed.
1.9.2 - Degree of risk involved in research may influence its acceptability
However, this argument may depend on the particular research being 
carried out; a trial with minimal risk may mean that the potential benefits to the 
entire group to which the subject belongs outweigh the risk, even though no 
direct benefit is expected for the individual. In addition, some studies may 
involve less than minimal risk (for example, giving a urine sample) and again, 
in cases such as these, objections on risk-benefit grounds would not appear 
warranted.
1.9.3 - A utilitarian defence of the involvement of healthy people in research, 
and problems with such a defence
Another way in which the lack of obvious direct benefit to the subjects 
may be justified is on utilitarian grounds - it can be argued that research such as 
this is justified because, overall, it leads to potential benefits to future 
individuals.
One problem with this is that it is difficult to ascertain how this degree of 
goodness should be assessed. Should the 'greater good' be in terms of the 
absolute number of people who will benefit? or the number of autonom ous 
people benefiting? and how should the suffering of some be compared with 
benefit to others? and so forth. However, having said this, it is arguable that 
realistically the needs of and cost to the community sometimes need to be 
factored into the equation. If a particular problem has a significant impact on 
society and could be reduced by research, then this may help justify the risks 
research subjects are exposed to.
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A second problem with a utilitarian analysis of the situation is that it 
compromises the idea of the rights and value of the individual.
1.9.4 - The role of patient consent in non-therapeutic research
Therefore, even if strong rights theorists do not accept utilitarianism as a 
defence for involving people in research, the possible compromise of the rights 
of the individual in non-therapeutic research may still be defended on the 
grounds that the research subjects have given their consent to participate. If a 
study involves risk of harm to participants, it could be argued that their 
autonomy should be respected and that they should be allowed to participate 
in the study if they so choose. This, however, raises at least three further issues.
Firstly, this does not hold for cases in which consent or permission is 
given by a proxy on behalf of an individual with no or compromised 
autonomy.
Secondly, even in autonomous beings, the notion of consent raises 
problems, some of which were discussed earlier - learning new information is 
often a complicated process, and the extent to which someone has understood 
information is difficult to ascertain with certainty. Although understanding is 
less likely to be complicated by illness, as in the case of therapeutic research, 
this lack of illness makes it even more important to ensure that consent is 
informed, given the lack of therapeutic benefit likely to be experienced by the 
subject.
And thirdly, a significant proportion of people we would consider 
autonomous may not understand the intricacies of a number of situations, and 
it is debatable whether their consent is meaningful when we know it to be less 
than fully informed. That is, merely having someone agree to participate does 
not absolve us of our responsibility to ensure they do not endanger themselves.
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1.9.5 - The involvement of ill people in non-therapeutic research
With respect to the problem of risks and benefits in non-therapeutic 
research, it has been argued that it is not justified to use healthy subjects, and 
that ill patients should be used instead, as they stand to gain something from 
the study to offset the risks involved.
However, one could argue that it is no less unethical to use ill patients as 
research subjects, because the potential benefit of the study may not be benefit 
which relates to their illness; their illness may make them more likely to suffer 
from the risks involved in the study; they are already ill and to ask them to 
participate in research which may have nothing to do w ith helping their 
condition might be to further increase their suffering; and there is the potential 
that involvement in the study might make these individuals more unwell as 
they have fewer reserves than healthy individuals.
Further, it seems evident that there are is a wide range of potential 
research subjects which do not relate directly to illness. Topics such as social 
factors, economic and occupational aspects of health and living, preventative 
medicine, and psychological problems are examples of such subjects. Thus, it is 
not feasible to use only ill people in research.
1.9.6 - Assessment of probable benefits in research
The issues discussed so far relate to the fact that non-therapeutic 
research poses an ethical dilemma because it tends to do poorly from a risk- 
benefit viewpoint. This implies that only research with a clearly defined and 
probable benefit should be considered ethical.
However, if the outcome (including risks and benefits) of a study could 
be accurately predicted, there would seem little point in undertaking it. It 
should also be said that many of the significant scientific discoveries to date
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have occurred through chance, which makes it difficult to limit research on the 
grounds that it is only justified if it is likely to have a benefit.
The issue of serendipity may be less important now in that knowledge in 
many areas of science and medicine has reached a sufficiently sophisticated 
level to mean that research is used primarily to refine knowledge, and as a 
result, the role of chance may play a lesser role and it may be easier to predict 
whether a study is likely to have a beneficial outcome. However, there are still 
many burgeoning areas of science and medicine; because so little is known 
about these topics, it is difficult to predict which studies are likely to benefit the 
subjects.
But it seems neither possible nor especially desirable to limit research on 
these grounds (though of course the study needs to be designed carefully in 
order to minimise the likelihood of problems occurring). In addition, much 
research may end up proving that the anticipated result does not occur (that is, 
the null hypothesis); this may still be useful and just as important as positive 
findings, even though it might be argued that such a study exposes its subjects 
to risks without direct benefit.
Further, it is arguable that the benefits which result from non-therapeutic 
research are not so much non-existent as merely less obvious and less direct; 
clinical, therapeutic research is not the only means of obtaining useful 
information. In addition, this kind of research is often necessary to develop 
enough information about a subject for therapeutic research to be possible; 
therapeutic research is but one end of the range of data which needs to be 
known about a particular subject. This range includes knowledge about normal, 
as well as diseased, states. The fact that this kind of research is just as necessary 
as clinical research counteracts the idea that only research with direct benefit to 
the subject is justifiable.
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1.9.7 - Motivation to participate in research
Another potential problem with non-therapeutic research relates to 
motivation to participate. Non-therapeutic research is more likely to involve 
healthy volunteers, for whom material inducements are likely to be important52 
- more so than for unwell patients participating in therapeutic research. The 
chance of beneficial therapy or cure is more likely to be a stronger motivating 
factor in this latter group.
Although it would seem that subjects (particularly healthy volunteers) 
should be compensated for time spent participating in the study, too large a 
sum  of money on offer, or too great a need on the part of the subject for the 
money on offer, could mean that subjects might ignore excessive risk or have 
their decision affected in some other respect. This is particularly an issue when 
the potential research subject has compromised autonomy, and there is the risk 
that the person giving permission or consent on their behalf may be influenced 
by financial or other inducements, thereby exposing the potential subject to a 
possibly dangerous or otherwise undesirable situation.
1.9.8 - Research subjects in non-therapeutic research
Further, healthy volunteers may not represent a randomised sample 
because they are a specific subset of the population who chooses to participate 
in an activity such as this. On the other side of the coin are specific populations 
who may be targeted for participation because of their availability or 
predisposition to respond to material inducements.
An example of such a group is a tertiary student population53,54. 
Students are usually healthy, intelligent, available in large numbers, and 
financially less well off than many other groups in society. The potential for
52Mason and McCall Smith (1994), op. cit., pp. 352,356.
53ibid, p. 357.
54See also Harling, R., 'Organophosphate pesticides are being tested on students', BMT, 15 Aug 
1998; 317: 430.
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exploitation of this group is reflected in the University College London 
recommendations to students that they should satisfy themselves that any 
project they engage in is approved by an independent ethics committee and 
that they are legally covered in case of mishap55. Another group is prisoners; 
the obvious risk for this group is coercion to participate in a study56.
However, with both these 'at risk' groups, it is arguable that they should 
be allowed to participate in research if that is their choice. The difficulty is 
assessing the extent to which they are truly free in their consent. A similar sort 
of problem applies to potential research subjects who belong to 'borderline' 
autonomous groups, such as children and the elderly.
1.9.9 - Allocation of resources to non-therapeutic research
It should also be noted that it may not be justifiable to spend resources 
on research which has no obvious direct benefit. Much research is done which 
is not unethical in the sense that it is approved by an ethics committee, but the 
results have little or no use, and it is difficult to see how this justifies the risk to 
patients, the time spent both by researchers and by research subjects, and the 
use of funding.
However, as I have noted above, likely benefits in a research project are 
difficult to predict, particularly in a new field of study; difficulty in perceiving 
benefits doesn't mean that no benefits exist; unexpected benefits often result 
from research and although that is not to say that any research should 
necessarily be permitted, it would seem disadvantageous to restrict the scope of 
research to include only studies which have a very obvious, predictable benefit 
as outcome. Even if one considers that therapeutic research is more justifiable, it 
should be pointed out that therapeutic research is not the only source of 
important knowledge, and in fact a certain amount of non-therapeutic research
55Quoted in Royal College of Physicians of London (1990), Guidelines on the practice of ethics 
committees in medical research involving human subjects, p. 25.
56Mason and McCall Smith (1994), op. cit., p. 357..
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needs to be done to accumulate enough knowledge to permit therapeutic 
research.
1.10 - Conclusion
To conclude, in this chapter I have discussed a number of issues relating 
to research in general.
Firstly, I discussed factors which contribute to the increased awareness 
of ethical issues relating to research. These factors include: increasing focus on 
the rights of the individual; increasing capacity for intervention in health and 
illness; influence from government bodies; the dual role of doctor as researcher; 
and historical examples of the mistreatment of research subjects.
Secondly, I discussed the increasing focus on rights, autonomy and 
consent, and outlined a number of problems which pertain to consent. Such 
problems include: difficulty in defining what constitutes 'informed consent1; 
different standards of information disclosure, such as professional and patient 
standards; difficulties in communicating; risks involved; and the role of doctor- 
patient trust.
Thirdly, I differentiated between experimentation and research, and 
explained why both have some advantages and disadvantages.
Clinical research and non-therapeutic research were also contrasted. 
Some of the problems with clinical research include the involvement of the 
clinician and conflict of interest; the involvement of ill individuals, and the way 
in which this may cause ethical problems; and the issue of when to stop a trial 
once benefits become evident. Non-therapeutic research has problems with 
risk-benefit analysis, the role of consent, involvement of ill people, motivation 
to participate, and allocation of resources.
These factors set the scene for an analysis of research problems involving 
sub-groups of the research population with compromised autonomy, namely, 
children, the elderly, and the mentally ill.
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CHAPTER 2 - RESEARCH INVOLVING CHILDREN
51
2.1 - Introduction
In this chapter, I shall discuss a number of aspects of the role of children 
in research. Firstly, I shall describe why research on the paediatric 
subpopulation is important. Secondly, I shall also discuss the notion of parental 
consent, and arguments in favour of this as well as against it. Thirdly, the 
autonomy of the child will be described, and their ability to consent for 
themselves analysed. Fourthly, the special case of adolescents will be 
mentioned, and various aspects which set them apart from other children will 
be discussed. Fifthly, psychological and social research will be assessed in terms 
of the way in which they apply to children. Finally, the role of the doctor in 
research involving children will be examined. These analyses are important to 
maximise the possibility of ethical research in children.
2.2 - Research involving children
2.2.1 - The need for research in the paediatric subpopulation
Clearly research on children is necessary, at least to a certain extent. 
Some medical problems exist only in children (such as retinopathy related to 
prematurity, neuroblastoma, Wilms tumours, and congenital heart disease, and 
metabolic disorders which need treatment in childhood to avoid irreversible 
damage) and mean that other age groups cannot be used for research into these 
conditions57. Children are anatomically and physiologically different from 
adults58, and respond differently to drugs and various other therapies that are 
used for diseases common to both children and adults. Drug handling and side
57Kauffman, R.E., 'Scientific Issues in Biomedical Research with Children', in Grodin, M.A. and 
Glantz, L.H. (eds) (1994), Children as Research Subjects, OUP, NY and Oxford, pp. 35, 37.
58ibid p. 29-30.
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effects are also often different in children59, either quantitatively or 
qualitatively. These factors also explain the need for research involving 
children.
2.2.2 - Lack of research leads to inadequate treatment and increased risks
As a result of the factors listed in the preceding section, a lack of 
properly conducted trials (particularly for medicines) in the paediatric 
subpopulation means that safe and effective therapy for children is often not 
known. Although there is no clear evidence of children having been harmed 
through lack of 'child specific' testing, this cannot be known for certain60. The 
lack of research involving children means that current practice often involves 
extrapolation from adult data, and treatment on a case-by-case basis. This 
exposes children to an increased risk of adverse reactions or suboptimal 
therapy61,62.
Thus, it would seem unethical n o t to  do research on children63, provided 
that care is taken. The National Committee for the Protection of Human 
Subjects specifies that research on children should only be permitted if the 
experiment investigates a significant problem, it is a good design, the results 
are likely to be useable, it could not otherwise be done on adults, and there has 
been previous testing on animals, adults and older children64,65. However, such 
guidelines represent an ideal situation and are not always practicable, and they 
do not eliminate a number of ethical problems that arise when children are
59ibid, p. 38-40.
60Warden, J., 'Loophole exposed in testing of child medicines', BML 1997; 314: 698.
61U.S. Food and Drug Administration, Regulations Requiring Manufacturers to Assess the 
Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients, pages 
66631-66672 [FR Doc. 98-31902] OC 98142, Docket No. 97N-0165.
62Rutter, T., 'Drugs must be tested for use in children', BMT, 1997; 315: 445.
63Forman, E.N. and Ekman Ladd, R. (1991), Ethical Dilemmas in Paediatrics - A Case Study 
Approach, Springer-Verlag, New York, p. 69.
^ibid, p. 70.
65See also British Medical Association (1984), The Handbook of Medical Ethics, BMA, London, 
pp. 31-32.
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used as research subjects, particularly in the context of non-therapeutic 
research.
2.2.3 - Issues raised by the involvement of children in research
Research involving the use of children as research subjects raises a 
number of issues which I shall discuss. These include difficulties with parental 
rights and their limits, parental consent on behalf of the child, the consent of the 
child himself, psychological and social research, and the involvement of the 
doctor in research.
2.3 - The issue of parental consent
The first such issue surrounding research involving children is whether 
parents should be able to consent on behalf of their child.
2.3.1 - Historical basis of parental consent
This revolves around the notion of parental rights and their limits. The 
rights of parents exist today partly through historical precedent (from 
antiquity, children were considered property of parent or state66) but may also 
be considered to be socially bestowed, as parents have genetic ties to the child, 
presumably know him or her best, care about the child, and are usually most 
directly affected by decisions involving their child67,68. In addition, children 
often w ant their parents to choose, and to interfere in this process may disrupt 
the structure of the family and may reflect negatively on parents, implying 
neglect or abuse69.
66Lederer, S.E. and Grodin, M.A., 'Historical Overview: Pediatric Experimentation1, in Grodin 
and Glantz (1994), op. cit., p. 8.
67Forman and Ekman Ladd (1991), op. cit., p. 9.
68Brock, D.W., 'Ethical Issues in Exposing Children to Risks in Research', in Grodin and Glantz 
(1994), op. cit., p.94.
69ibid, pp 95,100.
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2.3.2 - Shift away from complete control of a child by their parents
However, there appears to be a shift away from complete control of a 
child by his or her parents, even allowing for the fact that ideal parenting seems 
difficult to define and impossible to achieve. Certain things are already 
compulsory - even if they conflict with parents' wishes - such as schooling, life- 
saving treatment, and vaccinations (at least in the U.S.70). Society is increasingly 
prepared to intervene to protect the child, particularly when it seems clear that 
parents are putting the child in danger (either unintentionally, or through 
abuse or neglect), or that they do not have the child's best interests at heart. 
Lord Fraser, in the case of G illick, stated that '[pjarental rights to control a child 
exist not for the benefit of the parent but for the child'71, an echo of an earlier 
statement by Lord Denning, who said that '[pjarental rights start with the right 
of control and end with little more than advice'72.
Thus, over the past few decades, there has been an emerging trend in 
which the judgement of the child is given increasing weight73, and although 
parents continue to be involved and to be able to consent before a child is 
considered capable of doing so, evidently there are now limits to parental 
rights over a child. This factor is particularly an issue when it comes to research 
involving children; as consent is considered of fundamental importance in the 
process of ethical research, decisions about who is the right person to give 
consent when a child is involved is a key issue. A shift away from complete 
parental control implies that parents ought not to have an absolute right to 
consent on behalf of their child, but on the other hand, a middle ground 
appears difficult to determine, both legally and morally.
70Bradley, P., 'Should childhood immunisation be compulsory?', I.Med.Eth., 1999; 25: 330-334.
71Gillick v West Norfolk and Wisbech Area Health Authority, 1985.
72Hewer v Bryant, 1970, quoted in Mason and McCall Smith (1994), op. cit., p. 223.
73Weithorn, L. and Scherer, D.G., 'Children's Involvement in Research Participation Decisions: 
Psychological Considerations', in Grodin and Glantz (1994), op. cit., p 133.
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Research on children in the past has been restricted partly owing to 
doubt about the legality involved74. Legally, children under 18 are considered 
minors, though those aged between 16 and 18 may consent to therapeutic 
intervention' according to the Family Law Reform Act of 196975. The case of 
younger minors was less clear until the case of G illick, which found that 
parental right to choose treatment for the minor 'terminates if and when the 
child achieves a significant understanding and intelligence to enable him or her 
to understand fully what is proposed'76. Thus, although the issue of consent of 
minors to therapeutic procedures is fairly clear (at least legally), the situation is 
less certain when research is involved.
It is generally held that parents may 'volunteer' their child for research 
when the research is therapeutic and the benefits are obtainable only in the 
context of the research in question77. However, it is not clear that the situation is 
always so admirably straightforward, and so justification of parental consent 
on these grounds does not seem valid. However, the Age of Legal Capacity 
(Scotland) Act 199178 states that young people aged between 16 and 18 have the 
capacity to consent to treatment or a procedure on their own behalf, but also 
that children under 16 are also capable of giving valid legal consent to a 
treatment or procedure, including research, provided he or she is judged to 
understand the nature and consequences of the procedure. This applies even 
when the treatment is not directly for the benefit of the child.
However, one of the main issues remains essentially unchanged, and 
that is ensuring that the minor does truly understand the implications of their
74The Royal College of Physicians of London (1990), Research Involving Patients, RCP, London, 
p. 19.
75The Royal College of Physicians of London (1990), Guidelines on the practice of ethics 
committees in medical research involving human subjects, RCP, London, p. 27.
76Gillick v West Norfolk and Wisbech Health Authority, 1985, quoted in Mason, J.K. and 
McCall Smith, R.A. (1994), Law and Medical Ethics, Butterworths, London and Edinburgh, p. 
224.
77Forman and Ekman Ladd (1991), op. cit., p. 70.
78Quoted in: The Scottish Office - Home and Health Department, Local Research Ethics 
Committees, Scotland, Dd 0011213 CIO 8/92 Ed(203704), p. 13.
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consent. Making something legal does not automatically mean it is morally 
right; as has been noted, 'competency' is often interpreted in the legal sense, 
with those under the age of eighteen being considered incompetent79.
2.3.3 - Arguments against parental consent
2.3.3.1 - Parental consent as a substitute for a child's own judgement
Clearly, there are a number of problems with parental consent and 
whether it can be said to be justified. One way of looking at the situation is to 
see parental consent as a substitute for the child's own judgement that cannot 
yet be expressed - that the parents are expressing what the child would want to 
say, had he or she the ability to do so80.
This seems an inadequate justification, whether the argument be for 
therapy or for research. It is clear that children often have an opinion that is at 
variance with that of their parents, whether we consider that opinion 
reasonable or not. And if a child genuinely could not express his or her opinion, 
thereby requiring someone to speak on their behalf, it would seem unclear that 
anyone could know what that opinion was and be able to conclude that the 
parents were representing this accurately. Adults may express views on the 
way in which they would like to be treated in certain circumstances that can be 
taken into account should those circumstances arise and the patient is unable to 
speak for themselves. But this seems distinct from the case of children in two 
ways.
Firstly, the view outlined above implies that the child has not yet 
reached the stage at which they are able to communicate their judgement; if one 
allows this, then the child would never have expressed his or her judgement at 
any stage previously.
79Brock, in Grodin and Glantz (1994), op. cit., p. 81.
80Forman and Ekman Ladd (1991), op. cit, p. 370.
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Alternatively, and perhaps more realistically, the child may have the 
capacity for judgement, but is unlikely to have thoughts previously about what 
they would do in response to many (or all) medical interventions or research 
proposals. In either case, the child is unlikely to have given an indication in 
advance of their wishes. However, it seems unreasonable to conclude that the 
child (particularly if older) can have no judgement when presented with a 
choice and the relevant information.
2.3.3.2 - Parental consent in the 'best interests1 of the child
It is also often argued that parental consent is justified because it is 'in 
the child's best interests'. This implies that the child does not know what is in 
his or her best interests, and that the parents do know.
However, evidently some children, particularly older ones, do  know 
what is in their interests, or can at least have a point of view that is reasonable, 
as I have stated above. Further, it is not clear that parental consent is justifiable 
on the grounds that they alone know what is in the child's best interests - they 
may not know, or if they do, the situation may be complicated by duties to 
other family members, to their jobs, and so forth81.
And although it is generally assumed that the child's parents will feel 
strong and unselfish love for the child which will lead them to decide in the 
best interests of the child82, it is however arguable that a feeling of love does not 
necessarily translate into an automatic knowledge of the course of action which 
is in the child's best interests (although it may be some kind of protection 
against deliberate harm). Nor is such a love guaranteed, as may be seen by the 
many cases of child abuse and neglect. In addition, it may be that others (such




as the attending doctor) know equally well, or better, what is in the child's best 
interests83, particularly in a medical context.
Another point is that the 'best interests' of the child may not be 
particularly clear. The situation is further complicated by the fact that the 
interpretation of what represents the child's 'best interests' may be biased, 
depending on who is doing the interpreting. For example, the child's 'best 
interests' according to his or her parents may be quite different from the 'best 
interests' according to the child's doctor. Although it is to be hoped that this 
kind of complication does not arise often, it is unclear whether the problem is 
readily soluble; there may be no 'formula' for assessing a child's best interests, 
thereby making any decision on this point somewhat arbitrary. Thus, on these 
grounds, it is not clear why parents should automatically be the ones to make 
decisions about consenting for a child.
2.3.3.3 - The problem of lack of parental understanding
Another problem with parental consent is that the parents may not fully 
understand the trial to which they are consenting on behalf of their child, 
perhaps exposing the child to a situation or to risks they or the child would not 
want to be involved in, were their understanding more comprehensive.
It is arguable that although parents may be in a good position to give 
their permission for many things in a child's life, it is less ethical for them to 
consent to research on behalf of their child because they may not fully 
understand the medical information relevant to the study. This lack of 
comprehension may be exacerbated by stress if their child is already unwell84.
Although the signature of the parents on a consent form satisfies legal 
requirements, it is less clear that this is morally adequate, given that
83Downie, R.S. and Randall, F., 'Parenting and the best interests of minors', The Tournal of 
Medicine and Philosophy, 1997: 22; 219-231.
84Forman and Ekman Ladd (1991), op. cit., p. 28.
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understanding at the time of signing is often suboptimal85, and the level of 
recall even more inadequate86. It is difficult to assess the extent to which the 
parent has understood, particularly if consent is being sought during the 
limited time of a consultation.
Further, it may be seen that understanding often develops through 
multiple interviews and various methods of describing, as well as through 
feedback and asking questions. This is seen, for example, in parents who have 
chronically ill children87, but it is reasonable to assume that this would also 
apply to information about research, particularly if complicated. However, the 
time and multiple sessions that may be needed are unlikely to be available, 
thereby jeopardising parents' understanding.
Thus, lack of understanding is a problem for parental consent because it 
may lead parents to consent when they would not do so were they to 
comprehend fully. It may also lead them to refuse their consent even when the 
trial is in the best interests of the child, and in a situation where they would 
give their consent, were they to understand the trial more fully. They may be 
confronted with an outcome which, although a reasonable or expected part of 
the trial, is not so for them because they had not understood the situation fully. 
And finally, the child may be harmed if parents consent to a dangerous trial 
they have not fully understood, though it is to be hoped that researchers and 
ethics committees would help prevent this eventuality.
It may be seen, therefore, that the researcher has a responsibility to help 
parents understand the need for research, as children are different from other 
potential research groups. For example, we can avoid involving prisoners and 
developmentally-delayed adults in much research, as other, autonomous adults 
may be used as research subjects instead88. This, however, applies less to
85Bj0rn, E., Rossel, P. and Holm, S., 'Can the written information to patients be improved? - an 
empirical study', T.Med.Eth., 1999; 25: 263-267. (p.266)
86Forman and Ekman Ladd (1991), op. cit., p. 28.
87ibid.
88Brock, in Grodin and Glantz (1994), op. cit., p. 90.
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children; in the majority of cases, there is no alternative group who can be used 
instead. Researchers need also to help parents to evaluate the risks and benefits 
involved, both social and medical/scientific89.
2.3.3.4 - Problems with the amount of information to disclose to parents
These difficulties in parental understanding have been outlined on the 
assumption that although complete disclosure may be difficult to achieve, it is 
desirable. However, this may not be the case. 'Informed consent' is a 
problematic idea because many people take it to mean that the patient or 
research subject should be given a ll information, which is not necessarily the 
same as enough to make a reasoned, balanced decision in the circumstances; 
the amount of information to give is difficult to gauge. Giving 'all'
information is problematic for a number of reasons. Firstly, it would be too 
time-consuming in many cases. In addition, it is arguable that much 
information is changed, not just in form but in content, when it is adapted for a 
non-medical audience. Thirdly, 'complete' information is difficult to define and 
may mean quite different things for different people. Fourthly, complete 
information may not be necessary for an individual to make a reasonable and 
intelligent decision; and fifthly, a lack of background knowledge may 
predispose the listener to misinterpret the information and focus 
disproportionately on benefits or harms - even more so in the case of worried 
parents of a sick child.
2.3.3.5 - Risks to the child's health resulting from parental consent
A further difficulty with parental consent is that parents can endanger 
their child by giving their consent to a procedure or drug that is not yet - or 
never will be - at the stage of being trialed formally.
89ibid, p. 87.
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An anecdotal example is the case of a Sydney mother with an autistic 
boy who remained non-responsive to the range of medications used for the 
treatment of this condition. The boy was becoming increasingly difficult to 
control and physically too powerful for his mother. She approached a number 
of Sydney doctors and requested that they try a new treatment on her son - the 
use of the gastrointestinal hormone secretin, which is not approved for any use 
in Australia - which she had heard about on a current affairs show. There was 
no scientific evidence to support these claims - merely two anecdotal cases. 
Despite this, a gastroenterologist eventually agreed to administer the 
medication, at the request of the mother, despite the risks this untested and 
unlikely treatment poses to the child.
While it is largely uncontested that a physician ought not to force 
treatment onto a patient when they do not want it, it is rather less clear what 
responsibilities the doctor has when a particular treatment is requested90, 
especially when the treatment is of doubtful efficacy, or when it is being 
requested for a third party, such as a child. It may be argued that doctors have 
a duty to co-operate with reasonable requests, but perhaps only those requests 
that are obviously reasonable as one has an obligation to 'do no harm', and 
perhaps not if there are other factors that override the request91 (e.g. other 
'more reasonable' requests). Similarly, parental consent poses problems because 
it means that a child's wishes can be overridden, even when it seems they are in 
full possession of the facts, and understand that which they are consenting to, 
which would appear unethical.
2.3.4 - Arguments in favour of parental consent
There are a number of arguments for parental consent.
90Jackson, ]., 'Unproven treatment in childhood oncology - how far should paediatricians co­
operate?: Commentary', T.Med.Eth., 1994; 20: 77-79.
91 ibid.
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2.3.4.1 - Parental consent allows the child to access benefits of a trial
Objectively, participation in the trial may be to the child's advantage, 
more obviously in the case of therapeutic trials. However, non-therapeutic 
trials may still be advantageous to the child because such research may benefit 
overall the group to which the child belongs92, thereby making the research 
more justifiable by providing a benefit to balance potential risks involved. 
Parents may be seen as a socially approved proxy whose consent allows the 
child to access these benefits.
2.3.4.2 - Parental consent permits development of 'pro-social' traits in the child
Parental consent may also be considered justifiable if it is interpreted as 
parents fulfilling their duty to society by engaging the child in 'pro-social' 
activities. It may be argued that parents may not have the right to impose 
'selflessness' on their children in this way, but it may serve to breed a sense of 
altruism in the child which an older child at least may be capable of 
appreciating93.
2.3.4.3 - Difficulties in overriding parental consent
Further, even if we do not approve of the parents of a child giving their 
consent for the child to participate in a trial, it may be difficult to justify 
intervening to prevent this, as it is unlikely that the child's life is threatened 
through either choice or neglect94. This may be particularly true of involvement 
in research, rather than therapy, which is comparatively straightforward.
2.3.4.4 - Respecting parental consent allows preservation of family relationships




A further argument in favour of parental consent is that it contributes to 
the preservation of intimate family relationship95; it has been argued that a 
good family life is one of the greatest personal values96. Thus, one could argue 
that the parental rights that underlie and justify parental consent are not rights 
of 'ownership' of the child, or derived from knowing the child's best interests, 
but the right to have the family structure protected against interference from 
external bodies97. This is one reason why parents should be the ones to give 
proxy consent, rather than some other person, particularly in the case of very 
young children or infants, where it is more clear that proxy consent is truly 
needed. This is, of course, compatible with taking into account the views of 
both the child and the attending doctor98. This would appear to apply equally 
well to consent to research, as well as therapy. However, it should be noted that 
protection of the parent-child relationship may not be realistic if the parent 
makes a decision with which the child does not concur99.
2.4 - The consent of the child
Traditionally, parents had a great deal of control over children and were 
able to consent to medical intervention on behalf of their child until that child 
attained majority. As I have discussed above, there are a number of reasons that 
are often cited in support of parental consent. 'Parental' reasons for parental 
consent - most of which are not without problems - include notions of parental 
rights, the best interests of the child, parental consent as a substitute for the 
child's own views, and preservation of intimate family relationships. Focusing 
on the child, on the other hand, the main reason that may be used to justify 
parental (or other proxy) consent is the idea that children are non-autonomous.
95Downie and Randall (1997), op. cit., p. 219.
96Forman and Ekman Ladd (1991), op. cit., p. 9.
97Downie and Randall (1997), op. cit., p. 225.
"ibid, p. 226.
"Zinner, S.E., 'The Elusive Goal of Informed Consent by Adolescents', Theoretical Medicine, 
1995; 16: 323-331.
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2.4.1 - The autonomy of the child
However, it is questionable whether children are actually non- 
autonomous.
2.4.1.1 - Autonomy is partly dependent on age
Autonomy is partly dependent on age, and although it is certainly 
arguable that infants and small children lack the requisite features to be 
characterised as autonomous, as children get older, many do have the capacity 
to make reasonable judgements and decisions; the capacity to reason like an 
adult does not suddenly come into existence on the child's eighteenth 
birthday100. Most children have views on issues and situations they face, and 
although they may not fully understand some of the complexities of health 
issues, the same is true of some adults101.
2.4.1.2 - Children are capable of reasoning and decision-making
In any event, there is good reason to think that many do have a 
comprehensive understanding of quite sophisticated topics. Decision-making 
capacity increases through practice, as seen in children with (for example) 
chronic illness, who have a more mature and knowledgeable outlook102, but 
quite sophisticated understanding and decision-making is also seen in well 
children, to a greater extent as they get older.
Even young children recall things well (though it is more difficult to 
assess understanding)103 and it has been found that children aged nine to 
eleven demonstrated a sophisticated way of evaluating information and asking 
relevant questions when participating in a classroom discussion about
100Forman and Ekman Ladd (1991), op. cit., p. 12.
101Downie and Randall (1997), op. cit., p. 221.
102Forman and Ekman Ladd (1991), op. cit., p. 13.
103Zinner (1995), op. cit., p. 329.
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research104. Similarly, a comparison of 36 minors and 36 adults found that there 
was no difference in the frequency of agreement to participate in various sorts 
of studies105; generally children will make the same kinds of decisions as 
'autonomous' adults, though they may not be able to give such sophisticated 
reasons for their choices106. A further study found that 14-year-olds did not 
differ significantly from adults in their choices about hypothetical medical 
situations, and the majority of 9-year-olds in the same trial made the same 
decisions as adults107.
Thus, not only are children capable of having reasonable views on 
treatment and research options, but many - even very young children - make 
the same kinds of decisions that we would consider reasonable when made by 
adults, whom we consider autonomous.
2.4.1.3 - Continuum of capabilities and corresponding continuum of ability to consent
So it would seem that we cannot claim that children are non- 
autonomous, because they possess skills which we consider part of being an 
autonomous being. Certainly, not all children of all ages can be considered fully 
autonomous in all respects. But there seems to exist a continuum between a 
completely helpless and non-autonomous neonate, and a near-adult teenager108 
who appears fully capable of making intelligent decisions, which suggest that a 
corresponding 'sliding scale' of consent would be more appropriate.
Thus, there is a trend towards permitting minors to take increasing 
control of the decision-making process. This is reminiscent of Locke, who 
believes that although parents, to fulfil their duty to society, have the right to 
limit the liberty of their child in order to bring him or her up in a certain way, 
the goal of parental guardianship is to nurture the autonomous and rational
104ibid, p. 328.
105ibid.
106Forman and Ekman Ladd (1991), op. cit., p. 13.
107Zinner (1995), op. cit., p. 328.
I08weithorn and Scherer, in Grodin and Glantz (eds) (1994), op. cit., p. 133.
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powers of children, so that they can be free from the need for parental 
supervision at adulthood. This implies that there ought to be an inverse 
relationship between parental supervision and control, and the increasing 
maturity of the child. (The validity and usefulness of this of course depend on 
the age of the child, what is being asked' and the extent to which the child 
appears to understand the proposition.) However, there are a number of 
difficulties with this.
2.4.2 - Issues relating to the consent of a child
2.4.2.1 - The practical problem of children consenting
The first problem is that having a theoretical framework is one thing, but 
implementing it, making it feasible and fair, is more difficult. The very nature 
of the 'sliding scale' model of consent means that no absolute, clearly defined 
rules can be firmly implemented to enhance to freedom of children who can 
consent for themselves, and to protect those who cannot. Guidelines, while 
useful in the main, cannot cover every eventuality. And although it is to be 
hoped that guidelines are derived from a thorough analysis of the ethical 
problems involved, they do not form a substitute for the judgement required in 
a particular situation of a child giving his or her consent. In addition, guidelines 
are likely to represent the more common, straightforward situations, whereas it 
is the 'grey' areas that tend to be problematic.
2.4.2.2 - The validity of a child's consent - autonomy
There are also a number of other problems with children giving consent. 
One main problem is whether such consent can be considered valid at all. One 
reason why the consent of a child is argued to be invalid is because children are 
often thought of as non-autonomous.
However, as I have discussed above, this cannot be said to be true of 
many, let alone all, children. This is because many possess the characteristics
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we consider necessary for autonomy - namely, the ability to reason and to come 
to rational decisions in the same way adults (most of whom we consider 
autonomous) do.
Some might contend that children are, by definition, non-autonomous, 
but this seems inadequate and a way of merely avoiding the issue, given that 
many children have characteristics consistent with autonomy.
Certainly, not all children are fully autonomous in all situations. But it is 
arguable that a child, with the potential protection or doctor, parents and ethics 
committees, should be encouraged to make his or her own decisions, including 
the decision whether or not to participate in research, in order to learn 
responsible and thoughtful decision-making in a comparatively controlled and 
safe environment.
2A.2.3 - The validity of a child's consent - understanding
Secondly, it can be argued that children's consent is invalid because we 
cannot be sure they understand fully that which they are consenting to - 
particularly when research is involved, rather than therapy.
Again, as I argued above, there is good reason to believe that children 
can understand a good deal, simply based on the way they behave. Certainly, 
merely observing children for signs that they understand (or even conducting 
more formal research) is not a wholly infallible way of ensuring 
comprehension. However, to demand some other, more exact means of 
assessing understanding seems unjustified; the same degree of scepticism is not 
applied to other groups of potential research subjects109.
In any event, it is difficult to see exactly how  a child's knowledge could 
be assessed otherwise, and there seems no way of establishing 'rules', given the 
variety both of children and experimental scenarios. The potential problem is 
that researchers or the attending doctor may not take sufficient care to ensure
109ibid, p. 155.
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the child understands to a satisfactory level. An unethical or overenthusiastic 
researcher may also deliberately content him- or herself with what they know 
to be a sub-standard level of understanding in the child research subject, in 
order to progress with their research.
In any event, it is arguable that a research subject does not need to 
understand perfectly in order to be able to participate safely in research, and 
the majority of adult research subjects are unlikely to have in-depth knowledge 
of the research they are involved in. In categorising all minors as a single group 
unable to know enough to give valid consent, we may be making the level of 
understanding required unreasonably high. Indeed, although most people 
would say that they would want 'complete' information, it is questionable that 
this is either possible - or desirable.
The majority of patients and research subjects do not have the training 
and background knowledge to allow them the level of understanding 
researchers and clinicians have. This means that in conveying information to 
research subjects, the scientist or clinician is required to modify the information 
into a form that the subject is able to understand. I would argue that the fact a 
research subject has a lower level of knowledge, and lacks the requisite 
background knowledge to assimilate new information to the same level of 
complexity as the researcher, immediately invalidates the possibility of 
'complete' knowledge in many situations.
Similarly, the specific vocabulary used in medicine in particular has very 
precise meaning; modifying one's explanation to eliminate 'jargon' is not simply 
a case of presenting information differently, but often decreases the precision 
and changes the actual meaning of what is said.
So the capacity to give a potential research subject all the information 
pertaining to the research is certainly not always possible, even if it were 
desirable. This is one of a number of reasons why trust between physician and 
patient (or research subject) is of great importance; the physician has
69
knowledge that the patient does not, and the patient trusts the physician to do 
the best thing for the patient using the advantages of expertise. This is even 
more so the case when the research subject or patient is a child.
However, despite these difficulties with communication and 
understanding, it is still certainly possible for potential research subjects - 
including some children in some situations - to have su fficien t understanding 
to make their consent valid. The notion of informed consent creates problems 
because - despite its wide usage and acceptance - it is a general, non-specific 
principle110 that may be interpreted by some as implying that the individual 
should be told everything about their condition/treatm ent/ role in the trial. Yet 
as I have outlined above, this complete information is either difficult or 
impossible to communicate, even to adults, and it is unclear whether full 
information is desirable, from the point of view of both the physician or 
researcher, and the patient or subject. What should instead be focused on is the 
capacity to give in te llig e n t consent, which is a more meaningful and realistic 
goal, and certainly one within reach of many children.
2.4.2A - The validity of a child's consent - child versus parental consent
Apart from the issues of autonomy and understanding, and the extent to 
which children possess these, there are further difficulties with children giving 
consent and the validity of this.
One is that although there are reasons why even young children should 
sometimes be able to consent for themselves, realistically it is the child's parents 
who do give consent. This is particularly the case in cases which are 'grey 
areas'. Similarly, the researcher is likely to give more weighting to the wishes of 
the parents in trying to recruit a child for research, because the decisions
110Mason and McCall Smith (1994), op. cit., p. 238.
111See the U.S. case of Salgo, where the judge found that the attending doctor should give 
enough information to form the basis of in telligen t consent. Quoted in Mason and McCall Smith 
(1994), ibid.
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involved are more complicated compared with standard, 'proven' therapy 
(which renders the child's decision more straightforward for him or her).
The fact that parents do still have a good deal of power to consent on 
behalf of their child - particularly in research - raises the question of whether it 
is harmful to consult the child on the matter, and to try to get his or her 
permission, if the child's choice is then ignored in favour of the parent's 
decision112.
However, there are still good reasons for involving children in the 
decision-making process, even if they do not have the final word. These 
include: giving the child a sense of control, thereby decreasing levels of anxiety, 
depression and other psychopathology; allows practice of decision-making; 
improves compliance and commitment to the research project; and develops a 
sense of altruism and self-esteem113.
2A.2.5 - The validity of a child's consent - the difficulties of ensuring consent is voluntary
Another reason why the consent of children may be invalid is because it 
is hard to ensure that their consent is voluntary.
Physically, of course, children are weaker than adults and easily 
overpowered114; even if they were not physically forced to receive some kind of 
treatment, or to participate in a trial, the child would be aware that that kind of 
potential is there. Children are also psychologically more vulnerable in a 
number of respects; they have no power to impose their decisions and are 
aware of this, they may feel an absence of a perception of choice115, they tend to 
want to please, and they often fear abandonment116. All these factors 
complicate the consent given by a child, and should be taken into account. 
(However, it should also be noted that these factors are likely to be more
112Forman and Ekman Ladd (1991), op. cit., p. 12.
113Weithom and Scherer, in Grodin and Glantz (1994), op. cit., ppl35-136.
114Forman and Ekman Ladd (1991), op. cit., p. 13.
115Weithorn and Scherer, in Grodin and Glantz (1994), op. cit., p. 146.
116Forman and Ekman Ladd (1991), op. cit., p. 13.
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marked in younger children, when less weighting is given to their consent in 
any event.)
Finally, for consent to be valid, there must be the possibility of dissent117, 
and in the majority of clinical scenarios involving children, this is not possible - 
parents or the court can override the wishes of the child, if those wishes are not 
deemed appropriate. Thus, 'consent' obtained from the child, when it is 
unlikely that the child would be permitted to choose the alternative course of 
action, is less valid than consent when there is the possibility of dissent.
2.5 - Adolescents
The case of consent of, and research on, adolescents is in certain respects 
both simpler and more difficult than that involving younger children.
It is clearer that adolescents have an increasing capacity for all sorts of 
tasks, including making responsible and reasonable decisions about receiving 
medical treatment or participating in research. Most adolescents aged between 
sixteen and eighteen can already consent for themselves medically118. It is 
arguable that many teenagers should be able to consent for themselves in a 
wider range of situations than is currently permitted by law, including 
research, because many teenagers are clearly capable of reasoning and deciding 
in a mature way.
This is already partly recognised in that some adolescents who are still 
under the age of eighteen can consent independently to a number of 
procedures - for example, treatment of sexually transmitted diseases,
117ibid.
118The Family Law Reform Act 1969 states that consent to medical treatment of a minor who 
has attained the age of 16 years is as effective as it would be if he were of full age [i.e. 18 years] 
and it is, therefore, not essential to obtain consent from his parent or guardian. (Quoted in The 
Royal College of Physicians of London (1990), Research Involving Patients, RCP, London, p. 20.) 
The Age of Legal Capacity (Scotland) Act 1991 also provides that young people aged 16 and 
over have full capacity to consent to examination or treatment (including research) on their own 
behalf. (See The Scottish Office Home and Health Department, Local Research Ethics 
Committees, HMSO, Scotland, Dd 0011213 CIO 8/92 Ed (203704), p. 13.
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management of pregnancy, drug and alcohol problems119,120, and general 
medical treatment when the teenager is living independently of his or her 
parents and is taking responsibility for him or herself121,122. In some areas of the 
U.K., a child under the age of 16 is also capable of giving valid legal consent to 
a medical procedure or treatment, including research, provided that he or she 
is, in the opinion of the attending doctor, capable of understanding the nature 
and possible consequences of the proposed treatment or procedure123.
This reflects the perception that adolescents are more clearly competent 
than younger minors - for whom proxy consent may be more justifiable - and 
this competence increases closer and closer to an adult level as the adolescent 
approaches adulthood.
2.5.1 - The competency of adolescents to consent
2.5.1.1 - The capacity of adolescents to reason in a similar way to adults
The notion of competency of adolescents to consent is based primarily on 
the capacity for understanding that the individual possesses, and there is a 
good deal of evidence that adolescents are able to reason in the same way as 
adults and arrive at similar decisions. Although they may be influenced more 
by their peers124 than adults, and may lack familiarity with research context125 
and the idea of conflict of interest of the physician and researcher, they have an 
increased sense of individuation, a greater control over their environment126, 
and a greater capacity for reasoning than younger children.
119Munson, C.F., 'Toward a standard of informed consent by the adolescent in medical 
treatment decisions', Dickinson L. Rev., 1981; 85; 436, quoted in Zinner (1995), op. cit., p. 328.
120Brock, in Grodin and Glantz (1994), op. cit., p. 82.
121Zinner (1995), op. cit., p, 325.
122Brock, in Grodin and Glantz (1994), op. cit., p. 82.
123The Age of Legal Capacity (Scotland) Act 1991, quoted in The Scottish Office, Local Research 
Ethics Committees, op. cit., p. 13.




2.5.1.2 - Studies which indicate similar reasoning and decision-making to that seen in adults
One study found that in a comparison of individuals aged 9,14,18, and 
21, the fourteen-year-olds demonstrated understanding and competency levels 
comparable to that of adults127. Another study found no significant difference 
in decision-making ability between pregnant minors (aged 13-17) and older 
pregnant women (aged 18-25)128. A research team performing a meta-analysis 
of data on legal minors also concluded that 'at about the age of 14 years...a 
minor has achieved a level of competence in making decisions that differs from 
that of an adult only in terms of less experience and information and not in 
terms of ability to make a judgment'129. Similarly, it has been noted that 
evidence suggests that
[M]ost adolescents can be seen as capable of understanding research procedures when 
these are explained, using appropriate examples, and when the adolescents' queries 
are answered with attention to [their] levels of concrete and abstract thinking. [In 
consenting] to research...adolescents are not only 'adult-like'; they are adults.130 
Thus, there is evidence that the decision-making capacity of adolescents, 
particularly those aged about fourteen and above, is in many respects 
equivalent to that of adults.
It is also not clear why consent to research should be restricted when 
therapeutic consent is permitted; it has been observed that 'most mid- to late 
adolescents (ages fourteen and older) are probably competent to provide 
informed consent for research at a level commensurate with that observed in
127Weithorn, L. and Campbell, S.B., 'The competency of children and adolescents to make 
informed treatment decisions', Child Dev., 1982; 53:1589-1598.
128Lewis, C.C., 'A comparison of minors' and adults' pregnancy decisions', Am. I. 
Orthopsychiatry, 1980; 50: 446-453, quoted in Weir, R.F. and Horton, J.R., 'Genetics, adolescents, 
and consent', Theoretical Medicine, 1995; 16: 347-373.
129Nicholson, R.H. (ed) (1986), Medical Research with Children: Ethics, Law, and Practice, 
Oxford University Press, Oxford, p.149, in Weir and Horton(1995), op. cit., p. 354.
130Lynch, A. 'Research involving adolescents: are they ethically competent to consent/refuse on 
their own?' In Koren, G. (ed), Textbook of Ethics in Paediatric Research, Krieger Publishing 
Company, Malabar, 1993; 15:127-128.
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adults'131. In addition, research and treatment appear similar in terms of 
benefits, risks, side effects and alternatives132. It seems unreasonable, therefore, 
to prohibit minors from consenting for themselves on the grounds that their 
decision-making abilities are below that of adults.
2.5.1.3 - Placing unreasonable restrictions on adolescents that we would not apply to other 
groups
In any event, even adult patients or research subjects are notorious for 
misunderstanding or forgetting what they have been told133, and one could 
argue that it is unfair to discriminate against adolescents on the basis that they 
may lack understanding.
This is because in many respects their capacity for understanding is 
equal to that of adults, and also because adults are fallible when it comes to 
understanding and remembering information with which they are presented, 
though they are not restricted in their ability to choose for themselves on these 
grounds. However, it may be that this weakness in adults may mean that the 
case of minors consenting for themselves is even more doubtful.
Still, it would seem that many adolescents have a level of understanding 
and ability to reason similar to that of adults, whom we consider able to 
consent for themselves. Thus, it is arguable that many adolescents should be 
permitted to consent for themselves. However, there remain difficulties with 
this.
2.5.2 - The problem of age-specific values
One difficulty is that although adolescents - and even younger minors - 
seem able to understand information relating to research, and to make
131Weithorn, L.A. and Scherer, D.G., 'Children's involvement in research participation 
decisions; psychological considerations', quoted in Weir and Horton (1995), op. cit., p. 354,
132Weithorn and Scherer, in Grodin and Glantz (1994), op. cit., p. 147.
133Bj0rn, Rossel and Holm (1999), op. cit., p. 265; Gray, B.H. (1975), Human Subjects in Medical 
Experimentation, Wiley, New York, quoted in Zinner (1995), op. cit., p. 326.
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decisions about it which parallel adult decisions, in some respects adolescents 
differ from other age groups. For example, some decisions m ade by 14-year- 
olds differ from those made by 9-, 18- and 21-year-olds, such as refusing 
medical treatment because of the possibility of unwanted cosmetic side- 
effects134.
Thus, although adolescents have a more sophisticated capacity for 
reasoning and decision-making (compared with younger children, for whom 
proxy consent seems more clear-cut), it may be argued that adolescents should 
have their capacity for consent restricted because some of their decisions may 
not seem 'reasonable'. So although different individuals may have different 
attitudes and beliefs and choices, there are some values that are specific to 
certain age groups - such as adolescents - and these have been termed 'age- 
specific values'. It is probably the existence of these which prom pts many to say 
that the consent of adolescents should be restricted, rather than the suggestion 
of a lack of actual decision-making ability.
Age-specific values are seen in most members of a particular age-group, 
are characteristic of that age group and are not universal across groups, change 
over time, and fulfil developmental needs135. The difficulty is that age-specific 
values will change over time and this raises the problem of whether we should 
allow certain groups, such as teenagers, to make decisions based on these age- 
specific values, given that the adolescent's attitude is likely to change in the 
future. The adolescent may commit him or herself to a particular course of 
action now, the consequences of which may prove unacceptable at a later stage 
in his or her life. This is one reason why there is a tendency to discount the 
views of adolescents (and, indeed, younger minors).
134Weithorn and Campbell (1982), op. cit., quoted in Ekman Ladd, R. and Forman, E.N., 
'Adolescent decision-making: giving weight to age-specific values', Theoretical Medicine, 1995; 
16: 334.
135Ekman Ladd and Forman (1995), op. cit.,, p. 336.
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2.5.3 - 'Reasonable1 values
Another problem is the question of what sorts of values are considered 
'reasonable' and whether these attitudes are justified. On one hand, it does not 
seem entirely justified to impose some kind of external definition of 
'reasonableness', particularly when dealing with adolescents, who in many 
respects are mature and competent. On the other hand, however, to say simply 
that whatever seems reasonable, is reasonable, does not advance matters. 
Naturally, one's own beliefs and values do seem reasonable to oneself136, but 
there are plenty of cases in which people make unreasonable choices (though 
such decisions are presumably justified for them in some way). There are 
several ways in which the reasonableness of a value or choice can be assessed.
2.5.3.1 - 'Reasonable' as an objective measure
One way of defining 'reasonable' is from an objective point of view. 
'Reasonable' based on an objective standard is taken to mean what any 
reasonable, 'average' person would decide; this kind of approach is used when 
making decisions on behalf of infants and small children, severely mentally 
retarded people, and individuals whose personal preferences are not known to 
the proxy decision-maker137. That is, the objective standard is used for 
individuals whose preferences and views on a particular treatment or 
procedure are not known, and obviously it would seem inappropriate to apply 
this to adolescents, who clearly have opinions and values of their own. The 
objective standard is problematic because it ignores stated preferences, and also 
because it assumes that adult values are the 'right' ones138, i.e. the objective 






2.5.3.2 - 'Reasonable' as a subjective measure
The alternative is 'reasonable' according to a su bjective standard. This 
involves deciding for someone based on what the proxy thinks they would 
decide, were they able. This is also problematic because it implies that the 
individual in question has fixed values which will not change140, and this is not 
true of some values held by adolescents - particularly the values which are 
likely to cause others to want to intervene.
2.5.4 - 'Real' values
The fact that some adolescent values change over time is another 
argument against allowing adolescents to consent for themselves. The 
implication is that a value which changes over time is not 'real'. It makes sense 
to say that holding a value over a long period of time is evidence of 
commitment to that value, and the long-term nature of some values suggest 
their importance in an individual's total lifespan.
However, this viewpoint involves the risk of paternalism towards 
teenagers because their age-specific values are transient in nature and therefore 
not 'real'141. (In fact, paternalism is a risk for all age-groups, given that prime of 
life and old-age values are equally age-specific.) It also implies that adolescent 
age-specific values are not worthwhile or important because of their transient 
nature.
Another difficulty is that this attitude suggests that it is right to restrict 
the extent to which the individual acts on adolescent values and to impose 
adult values on them. This may not be justifiable, given that one cannot assume 
the universality of adult values. However, it is arguable that although the 
future values of a particular adolescent are not known with certainty, it is 




sense, it may be valid to assume that the adolescent will hold 'standard' adult 
values142. The difficulty with this is that sometimes the values an adolescent 
hold may seem to be age-specific, though these may prove to be more long­
standing for that individual.
2.5.5 - Ways in which permitting adolescents to consent may put unreasonable 
pressure on them
Another problem is that allowing all teenagers to consent for themselves 
may be putting too much pressure on them when they may still sometimes 
wish to act with the spontaneity and disregard for consequences which are 
characteristic of younger minors.
However, this perceived problem may simply reflect the attitude - 
previously prevalent and still extant - that adolescents tend to behave too 
'childishly' to allow them to consent on their own behalf, despite evidence to 
the contrary.
It should also be noted that even younger, pre-teen minors are capable of 
recognising the serious nature of medical intervention, and that it has the 
potential to impact significantly on them, even if they are unsure of the way in 
which this will be manifested. Thus, it would seem unlikely that they would 
behave in a particularly 'childish' way.
2.5.6 - The need to recognise that not all adolescents are capable of consenting 
for themselves
The view I have outlined above in favour of adolescents consenting for 
themselves is also problematic because it implies that all adolescents are 
capable of consenting for themselves, when (realistically) this is not the case. 
However, it is fairly evident that the majority of adolescents would be capable
142Forman and Ekman Ladd (1991), op. cit., pp. 15-16.
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of consenting for themselves in a wider range of situations than is currently 
permitted.
In fact, it is arguable that adolescent consent represents an important 
means of learning to behave responsibly, and to curb the independence of the 
adolescent is to hinder his or her satisfactory development. Some kind of 
continuum of responsibility may be appropriate, with each adolescent assessed 
on a case-by-case basis. This kind of analysis may pose risks because it involves 
a subjective judgement on the part of the physician or investigator - though this 
may still be more desirable than the inflexibility posed by guidelines.
Alternatively, a more appropriate course of action might be to allow the 
adolescent greater responsibility for him or herself, only overriding decisions 
when they pose a true threat to the adolescent. There are a number of 
arguments in favour of respecting an adolescent's values and choices in this 
way.
2.5.7 - Reasons for respecting adolescent values and choices
It is arguable that even if some adolescent values are age-specific, they 
are still important for the development of the teenager and should be respected 
whenever feasible. It is possible to look at adolescence as a series of 
psychological tasks which must be 'completed' in order to allow the teenager to 
develop emotionally and socially, and to move into adulthood. These include 
developing one's self-esteem and separate identity; establishing relationships; 
and gradually achieving independence from one's family143.
Early and mid-adolescents, for example, are particularly concerned with 
body image, which explains their tendency to refuse certain types of treatments 
and procedures because of the threat of change to their appearance144. Thus, it 
may be reasonable for adolescents to have 'adolescent' values, and to override
143ibid, p. 14; and Ekman Ladd and Forman (1995), op. cit., p. 342.
144Ekman Ladd and Forman (1995). op. cit., p. 342.
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choices made by adolescents based on these age-specific values may have an 
adverse effect on the development of that adolescent.
Illness also causes a good deal of stress to the individual, and to override 
the values and choices of the adolescent could contribute further to his or her 
distress. Additionally, in an adolescent, this stress may derive partly from the 
interruption of their emotional development145, which may be grounds for 
respecting the choices of the teenager. However, it must be noted that there will 
be some situations in which the adolescent's choices may need to be discounted.
2.5.8 - When it may be appropriate to override adolescent choices
2.5.8.1 - Restricting adolescent choice when it may lead to an adverse future outcome
The first, and most obvious, situation in which it may be appropriate to 
override the adolescent's choice is when that choice will seriou sly  affect his or 
her future health or welfare146. This would appear to be a situation in which it is 
justifiable to override the wishes of the adolescent, and instead act on the 
decisions of an appropriate proxy.
One problem with this is that it may in some situations be difficult to 
know with any certainty what will have an adverse effect on the adolescent.
Another problem is that it is easy to extrapolate from this and conclude 
that allowing an adolescent to consent for himself is always problematic 
because it involves a potential restriction of future choices.
2.5.8.2 - Restricting some future options is a normal part of development
However, it is difficult to justify overriding the decision-making of the 
adolescent on the grounds that they might restrict future opportunities, unless 




This is because all adolescents must and do restrict future opportunities 
to some extent - this is an integral part of shaping one's existence and preparing 
for a particular course in life. There are in fact many situations in which the 
adolescent is actively encouraged to pursue a course of action which entails 
closing off certain future choices - for example, when a young person shows 
signs of being particularly proficient at a musical instrument, a sport, or 
academic work, and they are encouraged to devote much of their time to the 
pursuit of this.
2.5.8.3 - Adolescent choice in a research context
Choosing to participate in research is likely to be perceived as a 
somewhat different situation - compared with choice in other areas of the 
adolescent's life - and as a result, it may be contended that these objections do 
not hold when considering the consent of adolescents.
Firstly, however, it is arguable that participating in research need not 
involve situations which affect the future welfare and choice of the adolescent.
Secondly, research has a greater number of safeguards in place to protect 
the welfare of the adolescent than many other situations in which adolescents 
make important choices. For example, encouragement (or pressure) to pursue a 
particular course in life (thereby potentially limiting future choices) may have a 
significant impact on the teenager, yet remains something that is not as 
objective as other areas of the adolescent's life. An example of this is parents 
who pressure their adolescent to achieve in a particular pursuit, such as sport 
or a certain academic course.
A third point about the participation of adolescents in research is that the 
existence of certain age-specific values may serve to protect, rather than harm, 
the adolescent. For example, the concern adolescents tend to have about their 
body image may make them more cautious than other age groups about 
consenting to research which may have physical and cosmetic side-effects.
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Similarly, the need many adolescents have to conform to expectations of their 
peers may make them less likely to do anything perceived as 'different', such as 
participating in research. The tendency teenagers have to establish their own 
identity by 'breaking away' from authority figures such as parents may also 
make them disinclined to go along with the suggestion of a doctor or scientist 
to participate in a study. These factors help indirectly to protect the teenager.
2.5.8.4 - Restrictine adolescent choice in order to preserve family relationships
Protection of the parent-child relationship is a further reason it may be 
appropriate sometimes to restrict the choices of the adolescent.
If the parents' preference for their child is overridden in favour of the 
child's preference, the relationship of the parents with both the child, and the 
doctor or researcher, may be adversely affected. This may be seen to have a 
negative impact on the child, as the family usually forms the basis of the child's 
social support network.
2.6 - Psychological and social research involving children
There are several issues relating to psychological and other 'non-medical' 
research involving children.
2.6.1 - Risk taking in psychological research
The first such problem is that children, particularly those who are well 
and are more likely to be used in psychosocial and educational research, rather 
than those children who are unwell, are readily available as research subjects, 
compared with potential research subjects of other ages. This tends to decrease 
the logistical complications, which may lead to increased risk taking on the part 
of the researchers147.
147Koocher, G.P. and Keith-Spiegel,' Scientific Issues in Psychosocial and Educational Research 
with Children' in Grodin and Glantz (1994), op. cit., p.48.
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2.6.2 - Subjective element of psychosocial research may affect the outcome
Some aspects of this type of research may rely on more subjective 
assessments by the researchers in interpreting their findings, compared with 
more 'scientific' or 'medical' research. Thus, investigators' theoretical 
perspectives may affect the outcome (for example, the mother may be 
perceived as the 'root of all evil') or the risk assessment (e.g., believing children 
to be more strong or capable than they really are)148. Such factors have obvious 
implications for the wellbeing of the child involved in research.
2.6.3 - Difficulties with longer studies
Social experiments tend often to be of even longer duration than some 
clinical trials. This leads to problems both in recruiting research subjects and 
also in retaining them during the course of the trial. This kind of study raises 
issues in that a research subject leaving the trial can be seen to have a more 
significantly negative impact on the study. This is of particular relevance when 
children are involved in the study because children can tend to be somewhat 
fickle in their decision-making, opting out of decisions with perhaps less 
thought than one might see in older individuals. This also puts them at risk of 
'heavy-handedness' to ensure they do not exit the trial without a 'good' 
reason149.
2.6.4 - Results from psychological or social studies
In addition, having completed the study, it can be difficult to know what 
should be done with the information obtained- that is, how to act on one's 





where a medical problem is investigated and an answer is found about 
pathogenesis and often the most effective treatment available.
The findings of this kind of research may also have significant impact on 
the social circle of the child, given that psychosocial circumstances are 
interpreted in a different way from 'medical' problems in the following ways.
The child's involvement in a study which looks at the behaviour and 
development of children may attract unfavourable attention from other 
children, leading to teasing and bullying.
The child's parents, on the other hand, may also be affected by the child's 
involvement in the study. They may feel that an invitation to participate 
implies their child has 'something wrong with him or her'. They may make 
certain judgements, or receive certain feedback, during the trial which leads 
them to judge their child in a certain way which may impact negatively on 
family dynamics. More straightforwardly 'medical' problems do not attract 
negative value judgements in the same way.
2.6.5 - Non-therapeutic research
It is also arguable that the kind of research discussed in the preceding 
paragraphs is more obviously non-therapeutic, which raises the issue again of 
whether the parents' proxy consent to non-therapeutic research can be said to 
be valid151.
The need for parental consent also leads to parents frequently requesting 
feedback on their child's 'performance' during a study152; they seem to believe 
that they are 'owed' this in return for their cooperation. If children are asked 
their permission for this kind of disclosure and they refuse, it can also be 




2.7 - Issues when the doctor is involved in research on the child
2.7.1 - The conflict between research and the duty to care for the child
Research on children is again problematic when the doctor who cares for 
the child is involved in the project. The first and most obvious difficulty is that - 
as stated in the Declaration of Geneva - the health of the patient must be the 
doctor's first consideration153,154.
However, this is not clearly the case in a research setting. Ideally, if there 
was an equal chance of either method benefiting the patient, the role of the 
doctor to put the care of his or her patient first would not be compromised. 
Unfortunately, however, this is not often the case; the doctor usually has a 
suspicion that one treatment will prove to be of superior efficacy, and indeed 
there would be little point embarking on a trial if there was no reason to believe 
one treatment to be better than the other.
With adult patients, this seems less of a problem in that it is more certain 
that the patient understands that they may not receive the most effective 
treatment. However, it is less clear that children may appreciate this, 
particularly younger ones. Still, it must be said that this objection may not 
apply to randomised control trials in which the attending physician is blinded 
to the treatment his or her patient is receiving, because he or she does not know  
a) whether the treatment being trialed is more or less effective than placebo, 
and b) which group his or her patient will be in.
Further, the care of the child may be compromised if the doctor urges 
participation in a particular study, or if the trial therapy is prematurely ceased 
because it does not appear to be effective155. In the hope of improving the care 
of the child and to gain more contact time with the physician, parents may feel
153Peclaration of Geneva (as amended at Sydney, 1968), reproduced in Mason and McCall 
Smith (1994), op. cit., p. 430.
154Kauffman, R.E., 'Scientific Issues in Biomedical Research with Children', in Grodin and 
Glantz (1994), op. cit., p.31.
155Forman and Ekman Ladd (1991), op. cit., p. 78.
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pressured to consent156. There is some evidence to suggest that patients believe 
that it is the attending doctor who determines the allocation of treatment, even 
if they have been given written information to the contrary157, and this may 
influence parents to consent for their child if they believe the doctor can 
determine which treatment their child will receive. Similarly, it is often thought 
that allocation to groups in a trial is based on therapeutic need, rather than by 
randomisation.
2.7.2 - The effect of the research on the relationship between doctor and parents 
This raises another difficulty - the effects on the relationship between the 
doctor and the parents when a doctor is involved in paediatric research. 
Although the doctor may try to assure parents that they are not compelled to 
participate in the study, if the doctor is viewed as an authority figure the 
parents may still feel obliged to give their consent.
Alternatively, parents may interpret the involvement of the doctor in the 
study as an unspoken recommendation, or they may believe that the doctor 
would not suggest they participate if it could be ineffective or harmful158.
The doctor-parent relationship may also be altered by the doctor feeling 
as though he or she owes the parents a favour because they have given one in 
consenting to the trial; on the other hand, though, the relationship may be 
affected positively by creating a sense of partnership and by educating parents 
about medicine and about the uncertainty involved in it159.
The relationship between the doctor and the parents may also be altered 
by the fact that the methodology of the study may require a certain number of 
research subjects to be recruited160. The potential anxiety of the parents may 
limit the possibility of them allowing their child to participate in the study,
156ibid.
157Bj0rn, Rossel and Holm (1999), op. cit., p. 265.
158Forman and Ekman Ladd (1991), op. cit., p. 78.
159ibid.
160Kauffman, in Grodin and Glantz (1994), op. cit., p31.
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which may impact negatively on their relationship with the doctor - 
particularly in the current clinical environment, where there is a good deal of 
pressure on clinicians to undertake research and publish.
The anxiety of the parents (and of the child) may be allayed by a number 
of methods - for example, by performing research using biological samples 
which have been obtained for another reason (such as CSF taken during a 
lumbar puncture with a clinical indication), by using smaller samples, or by 
using less invasive methods, such as MRI or PET scanning161 (though children 
can be afraid of the machinery used, and they are exposed to radiation and 
isotopes via these imaging techniques).
2.7.3 - The issue of high-risk or alternative trial therapies
Doctors caring for a terminally ill child may also be pressured by parents 
to use non-standard therapy of doubtful efficacy or possible harm. An example 
of this might be parents who wish to use, on a trial basis, untested anti-cancer 
medications which are not recognised by western medicine. The doctors caring 
for the child may believe that standard therapy will offer no cure for their 
patient, but be equally convinced that the alternative therapy has no evidence 
to support its use. This raises a number of ethical dilemmas if the co-operation 
of the doctor is needed for the implementation of this 'trial' treatment.
2.7.3.1 - Refusal to participate may compromise the care of the child
The first is that refusal to co-operate with the parents may leave the 
family in a worse position162; they may also be forced to 'shop around' for 
another doctor who may agree to the parents' wishes but who may jeopardise 
the care of the child. However, agreeing to co-operate with the parents may
161ibid, p 33.
162See: Yeoh, C., Kiely, E. and Davies, H. 'Unproven treatment in childhood oncology - how far 
should paediatricians co-operate?', I.Med.Eth., 1994; 20: 75-76.
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lead to difficulties in the doctor-parent relationship, and may compromise 
clinical freedom and professional standards.
2.7.3.2 - Difficulty in assessing possible risk in untested therapies
A second problem: if such a decision were patently not in the interests of 
the child, the doctor would be obliged n o t to co-operate163, as it is generally 
held that the care of the child ought to be his or her primary concern. If, on the 
other hand, co-operation in such a project involved no possibility of harm to the 
child, but the possibility of some benefit - even if unlikely - then there may be 
nothing wrong in complying with the parents' wishes164.
However, it is unlikely that one could reliably exclude the risk of harm 
when very little is known about the treatment at all. And even some of the 
relatively straight-forward procedures that might be required - such as 
insertion of a central line - may pose some risk. It may also be argued that this 
irregular means of trialing a new therapy is unethical in terms of its risk-benefit 
analysis.
Thus, by agreeing to use experimental kinds of treatment, the doctor 
may be party to a form of child abuse, insofar as parents do not always know 
what is best for their child, and their decisions, if automatically acted on, can 
put the child in danger.
2.7.3.3 - Public pressure on doctors to be involved in trial treatments
A third problem in this kind of scenario is that public opinion may lead 
the doctor to give his permission and assistance to parents wishing their child 
to participate in a trial treatment, even though in different situations (e.g. if the 
patient were an adult) the use of such a treatment would not be embarked 
upon.
163Jackson (1994), op. cit., p. 77.
164Yeoh et al (1994), op. cit., p 76.
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The public and media generate a highly emotional atmosphere when it 
comes to children and their health - and may generate much support for 
interventions that have very little success165. Disproportionate representation of 
the situation means a doctor who refuses to participate in unlikely and 
unproven trial treatments for children is likely to be branded as unfeeling166; it 
is often easier for the doctor simply to acquiesce.
2.7.3 A - Difficulties with allocation of resources in trial therapies
A fourth - related - difficulty is that involvement in untried, unreliable 
and (usually) expensive 'alternative' therapies would appear unequal in terms 
of allocation of health care resources, particularly if it is not part of a properly 
conducted trial to assess the efficacy of the treatment.
However, it should be considered why the treatment has little evidence 
to support it - it may not be reasonable to use it if it is fundamentally 
implausible, but there may be some justification in trying it if other factors are 
operating167 (e.g. expense, poor recruitment rates to the trial).
It could be argued that the disproportionate allocation of resources is 
justified in the sense that the treatment of a child is more likely to be successful 
medically168, though this would, of course, depend on the procedure involved. 
If the trial treatment really is unfeasible, the child is unlikely to benefit, thereby 
invalidating this particular defence of the allocation of resources in favour of 
children.
Another way in which this sort of allocation of resources may be 
defended is in terms of utility; there is likely to be a greater benefit when young 
are treated preferentially169. This may appear to outweigh the notion that the 
elderly should have equal rights to health care but (the morality of this aside) it
165Downie and Randall (1997), op. cit., p. 227.
166ibid.
167Jackson (1994), op. cit., p. 78.
168Downie and Randall (1997), op. cit., p. 227.
169ibid.
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is arguable that allocation of health care resources to the elderly should be 
increased; the proportion of the population who is aged is increasing at a rapid 
rate, and poor health in the elderly is likely to become increasingly costly to 
society.
Hence, the lack of clear reasons why child health care should have 
unlimited access to resources means it is unclear that parents should be able to 
consent to trial treatments of doubtful benefit on behalf of their child.
2.7.4 - The issue of limited parental understanding and the role of the doctor
The involvement of the child's doctor in research is again a problem in 
that lack of parental understanding raises the question of the extent to which 
one should intervene in such cases - bringing up the issue of medical 
authoritarianism, the view that 'the doctor knows best' and should be the one to 
make medical decisions. Parents may refuse to consent to their child 
participating in research for a number of reasons, but it would seem that it is 
only ethical to respect the wishes of parents when such wishes are in the best 
interests of the child170.
This creates a dilemma for the attending physician when he or she has 
reason to believe that participation in the trial will benefit the child, particularly 
if the parents' refusal derives from a lack of understanding. Clinicians and 
researchers have often spent years learning about a disease while many parents 
are unlikely to be trained to the same level and it is obviously difficult for them 
to develop the same depth of knowledge, particularly in a short period. When 
this difference in knowledge impacts negatively on the care of the child, there is 
a case for overriding the wishes of the parents, and certainly this does occur in 
cases where the child has a life-threatening condition.
Medical authoritarianism is problematic in that it may lead to difficulties 
such as the breakdown of the relationship between doctor and patient, and the
170Forman and Ekman Ladd (1991), op. cit., p. 31.
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risk that the doctor may be wrong. Another problem is that it assumes that only 
medical factors are relevant in the decision-making process171. Parents may 
have other, quite valid, reasons for their decision, in which case it would not 
seem justifiable to override their wishes.
2.8 - Conclusion
In conclusion, research involving children may be seen to be important 
in order to maximise the health and well-being of children.
Despite historical precedent, there is a shift away from complete control 
of the child by the parents. Problems with parental consent include the 
mistaken notion that parental consent necessarily represents the child's own 
judgement, or that it is automatically in the best interests of the child. Other 
problems include limited parental understanding and risks to the child from ill- 
judged or misinformed parental consent.
On the other hand, parental consent does have some benefits, including 
preservation of family relationships and a socially approved way for the child 
to access benefits.
The child on the other hand, may be seen to have a good deal of capacity 
for autonomous action. Evidence suggests an ability to reason like an adult, and 
a continuum of capabilities is suggested. However, there are problems with a 
child's consent, including limited understanding, unequal balance of power, 
parental preference, and the difficulty of ensuring voluntary consent. 
Adolescents have particular problems, such as age-specific values which need 
to be recognised.
Psychosocial research raises different problems, such as the subjective 
element of the assessment, the use of normally well children, difficulties with 
long-term studies, and the difficulty with what to do with the results.
171 ibid, p. 8.
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The involvement of the doctor may also complicate research on children 
because of conflict of interest, changes in the relationship between doctor and 
parents, public pressure and allocation of resources.
An awareness of these factors is important to try to ensure research 
involving children is as ethical as possible.
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CHAPTER 3 - RESEARCH INVOLVING ELDERLY PEOPLE
3.1 - Introduction
In this chapter, I shall discuss aspects of the issue of performing research 
on elderly individuals.
These factors include the ways in which autonomy in the elderly may be 
compromised, difficulties obtaining consent, institutionalisation, community 
care and the role of relatives.
A defence of research involving the elderly will also be put forward, 
emphasising the importance of research in this group, benefit to the individual, 
methodological modification which may make the research more acceptable, 
the involvement of autonomous elderly, and economic benefit to the 
community.
3.2 - Research involving the elderly - an overview
Research involving elderly people raises a number of difficulties. These 
problems derive not so much from old age itself, but rather from certain factors 
which tend to be associated with members of this age group, or which are seen 
more commonly in the elderly than in individuals of other ages.
Some of these problems lead to compromise in autonomy. These include: 
difficulty in defining who is 'elderly' in an increasingly heterogeneous group; a 
stereotypic perception of the health and competence of older individuals; an 
actual decrease in mental capacity due to mental, physical, social and 
environmental factors; greater dependence on others for care; and increased 
vulnerability172. These factors contribute to decreased competence and 
compromised autonomy (perceived or actual), and this raises difficulties for 
research on elderly individuals affected in this way.
172Oppenheimer, C., 'Ethics and Psychogeriatrics', in Bloch, S. and Chodoff, P. (eds) (1991), 
Psychiatric Ethics, Oxford University Press, Oxford, p. 365.
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Despite the multiple difficulties associated with elderly research subjects, 
there are a number of reasons why such research is important. The elderly have 
specific medical and social problems which do not exist in other age groups; 
many elderly are autonomous and should not be ignored; and the health and 
well-being of older individuals have a significant impact on economics and 
resources.
There are a number of factors which may make research on the elderly 
more acceptable. These include: benefit to individual, group of individuals, 
family, and society generally; the type of research; and satisfaction for those 
involved.
3.3 - Ways in which the autonomy of older persons may be compromised
3.3.1 - Ambiguity in terminology applied to older persons
Some basic terminology (for example, 'old age' and 'elderly') and 
definitions (such as the definition of old age as over sixty-five) give rise to a 
number of difficulties which are relevant to elderly research subjects. There are 
at least three such problems. These are: the arbitrary and inappropriate nature 
of the definition of old age as sixty-five years and over; the use of terms such as 
'old age' and 'elderly' to refer to people with an increasingly wide range of ages 
and capabilities; and the risk that such definitions lead society to see any older 
person over a certain age as a generic 'old person', rather than as an individual.
3.3.1.1 - Arbitrary classification of 'elderly1
As I have mentioned, the first difficulty with the terminology associated 
with older persons is that the cut-off point defining 'old age' (usually over sixty- 
five years) is somewhat arbitrary and may be inappropriate, particularly now 
that increased longevity, expectation of longevity, and health are enjoyed by a
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greater proportion of older individuals173. The use of age sixty-five to signify 
the transition to old age may have been more appropriate in earlier times, when 
life expectancy was lower, and morbidity more usual from an earlier age. 
However, an increasingly large number of people are living to ever-greater 
ages, often with 'compressed morbidity' (that is, fewer years of disability and 
ill-health). This would indicate that the use of a specific age, such as sixty-five 
years, as a cut-off point has become a somewhat arbitrary means of defining old 
age, given that the many people who fit into such a group do not have the 
characteristic morbidity and short life expectancy one tends to associate with 
the term 'old age'.
3.3.1.2 - Heterogeneous nature of 'elderly1 as a group and the way in which this complicates 
research
The second problem with classifying 'old age' as any age over an 
arbitrary point such as sixty-five years, is that the range of ages covered by this 
blanket term is becoming increasingly broad. Various sub-groups within this 
category may be quite different from others, making the >65 cut-off often 
meaningless for treatment of, and research on, the elderly174. For example, 
individuals aged over 85 tend to have many more of the problems traditionally 
associated with old age (such as physical illness and dementia) than people 
aged 65-75, for example. And it has been noted that the difference between a 
65-year-old and a 95-year-old may be as great as the differences between a 55- 
year-old and a 25-year-old175. Therefore, age stratification terms such as '>65' 
would be more meaningfully replaced by classification by decade, at least to 
age eighty-five176, as grouping together all individuals aged over sixty-five
173Mason, J.K. and McCall Smith, R.A. (1994), Law and Medical Ethics, Butterworths, London, 
p. 267.
174Avorn, J., 'Including elderly people in clinical trials', BMT, 1997; 315:1033.
175Oppenheimer (1991), op. cit., p. 365.
176Avorn (1997), op. cit., p. 1033.
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tends to give a misrepresentative impression of the health and capabilities of 
this group. This complicates research in at least three ways.
Firstly, a misrepresentative impression of the characteristics of this age 
group may lead to misunderstanding and incorrect application of research 
results. This may adversely affect the way in which the health problems of the 
elderly are dealt with.
Secondly, the diversity now seen within the group classified as the 
'elderly' means that research projects may not differentiate between the 
different sub-groups within the elderly population. More research subjects may 
be required to retain the same power in the face of such diversity, making 
research more complicated, time-consuming, and costly. This adverse effect on 
the process of research may also lead researchers to exclude the elderly.
And thirdly, certain subgroups (such as the 'old old') may be excluded 
because they have complicated physiology and comorbidity, which may make 
the research process difficult and the results unfavourable. Specifying 
subgroups (such as those aged sixty-five to seventy-five, and so forth) would 
make research results more meaningful because it would be clear which of the 
wide range of elderly are included in the research, and to whom the results 
should apply.
3.3.1.3 - Use of 'elderly1 terminology detracts from individuals being seen as such
The third problem with defining old age as over 65 years is that older 
people then risk being viewed simply as an 'old person', rather than as an 
individual. This is exacerbated in elderly people who are unable - through 
physical incapacity or mental decline - to communicate the various factors 
upon which we usually assess the nature of someone's individual personality 
and belief system. Relatives may also give inaccurate and conflicting 
interpretations of the elderly person's personality, beliefs and desires177; this
177Oppenheimer (1991), op. cit., p. 367.
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lack of clear information about the person as an individual thereby reinforces 
the tendency to view the elderly individual simply as an 'old person'.
3.3.1.4 - Summary of impact of terminology on elderly as a group
Thus, even the basic terminology (including terms such as 'old age' and 
'elderly') and concepts (for example, defining 'old age' as over 65 years) create 
problems in research on older individuals because the cut-off age seems no 
longer appropriate, and somewhat arbitrary; an increasingly broad range of 
ages and capacities are covered by the blanket term, 'old age'; and the older 
person risks being viewed simply as an 'old person', rather than being 
considered as an individual and assessed on his or her own merits. These 
factors contribute to the impression that all older individuals over a given age 
(for example, sixty-five years) are equally infirm, mentally incompetent and, 
therefore, lacking in autonomy.
3.3.2 - Stereotypic perceptions of the elderly
In the previous section, I outlined three ways in which terminology and 
definitions associated with research on the elderly may be problematic. A 
fourth, related, problem is that a stereotypic perception of the elderly may arise 
through the way in which definitions and terminology are used. As I 
mentioned, terms and definitions currently in use tend to create the impression 
that a ll older individuals are generic 'old people' who are physically ill and 
cognitively impaired and, therefore, lacking autonomy and unable to consent. 
Were this impression accurate, it would have obvious implications for research 
involving the elderly. Realistically, however, a large proportion of elderly 
individuals (particularly the 'young' old) are physically well and cognitively 
intact. The perpetuation of a stereotypic perception of the health and 
capabilities of this group may impact negatively on the elderly in a number of 
ways.
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3.3.2.1 - Wavs in which a stereotypic perception of the elderly is reinforced and perpetuated
Firstly, it was previously the case that many elderly persons would live 
for a shorter period of time, and suffer from more disease, than is true of 
elderly persons today. It may be that historical precedent distorts the way in 
which current reality is perceived, leading society to believe that the elderly 
suffer from the same degree physical and cognitive incapacity as the elderly of 
previous generations. This is the first factor which may contribute the 
stereotypic perception that the elderly are more ill, disabled, and cognitively 
impaired than is actually the case.
The second factor which may act to perpetuate the negative stereotype of 
elderly persons is the way in which most people believe that a decline in health 
is usual as a person ages. Thus, when we encounter an elderly person who is in 
good health, we tend to think that such a person is an exceptional case; whereas 
encountering an older person in poor health or mental decline is often seen as 
more 'normal', and to be expected. In this way, the impaired elderly are 
focussed on, while the proportion of the elderly who are healthy are 
underestimated. Therefore, a stereotypic perception of the elderly may 
continue to be perpetuated, despite the fact that many elderly are obviously 
well, self-sufficient and autonomous.
Thirdly, this stereotypic perception of the elderly may also be 
perpetuated inadvertently by health care professionals, who tend to see, treat 
and research the more infirm end of the spectrum of older people, and who 
may, as a result, tend to believe that the impaired individuals they see are 
representative of all elderly people.
Fourthly, old age may also be perceived as more of a problem than it 
actually is, and be generally misrepresented, because the majority of literature 
on the subject is written by younger individuals178. It may be that such authors
178Oppenheimer (1991), op. cit., p. 366.
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hold their own prejudices about the capabilities of the elderly and may lack 
insight.
Fifthly, another difficulty is that care for the elderly - from low-level, 
community-based care to high-level care in nursing homes - becomes a public 
issue insofar as such care is subsidised by public resources. This may lead to the 
unfair and inaccurate perception that all older people are a 'burden' on 
society179, because the stereotypic infirm, institutionalised elderly person is 
focussed on by the public eye.
3.3.2.2 - Wavs in which the stereotypic perception of the elderly may affect them adversely
Firstly, a stereotypic idea that the elderly are all incompetent may lead 
society to implement guidelines and laws which may impose restrictions on the 
autonomy of the elderly - for example, by limiting the extent to which they can 
participate in, or consent to, research. It is in this way that competent, 
autonomous elderly persons may be restricted, through stereotype, in their 
choice to participate freely in research.
Secondly, autonomy in competent older individuals may also be 
compromised in more subtle ways by stereotypic perceptions; if there is an 
expectation that an elderly person is likely to conform to the stereotypic image 
of an 'old person', it may be assumed that the individual in question is 
incompetent and unable to consent, without the likelihood of this being 
properly explored. As a result, the elderly may sometimes be denied needlessly 
the benefits of research on the assumption that they are a group from whom 
informed consent is difficult to obtain.
Thirdly, although relatives are legally unable to consent180 on behalf of 
adult patients or research subjects, an assumption that the elderly individual is 
likely to be incompetent may mean that the opinions and wishes of the relatives
179ibid., p. 368.
180Randall/ F. and Downie, R.S. (1999), Palliative Care Ethics, Oxford University Press, Oxford,
p. 61.
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may be given undue weighting when this is inappropriate. This is another way 
in which the autonomy of the elderly person may be compromised through the 
stereotypic perception of that age group.
Thus, it may be seen that the stereotypic perception of the health and 
ability of older individuals ignores the majority of elderly persons who are in 
fact in good health and cognitively intact, and has an adverse effect on their 
autonomy and ability to participate in research.
3.3.3 - Real factors which lead to compromised autonomy in older individuals 
Having pointed out that many older persons may be more healthy and 
competent than the stereotypic image of the elderly might suggest, it is still 
evident that there are a number of elderly individuals who clearly do have 
problems other than stereotype which can compromise autonomy.
3.3.3.1 - Endogenous and exogenous factors limiting autonomy
These problems may be 'exogenous' (externally-imposed) or 
'endogenous' (arising from within the elderly individual)181. Externally- 
imposed difficulties include poverty and dependence - financial or physical - on 
others for care, while internally-imposed factors include physical illness or 
weakness, and diminished mental capacity and cognitive function.
3.3.3.2 - Global impairment of autonomy in the elderly
Some of the afore-mentioned factors, such as compromised mental 
functioning, may lead to decreased autonomy because the capacities generally 
held to be a feature of an autonomous person - self-governance through 
features such as understanding, reasoning, deliberating, and independent 
choice182 - may be jeopardised. That is, some of the health problems typically
181Mason and McCall Smith (1994), op. cit., p. 268.
182Beauchamp, T.L. and Childress, J.F. (1994), Principles of Biomedical Ethics, Oxford 
University Press, Oxford, p. 121.
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associated with the elderly more than with members of other age groups (such 
as dementia, or coma arising at the end of a terminal illness) tend to decrease 
the autonomy of the elderly person in a much more global and extensive way 
than some other problems experienced by this age group.
3.3.3.3 - Limited impairment of autonomy in the elderly
Alternatively, however, some problems likely to affect elderly 
individuals may affect specific choices which are usually dependent on 
autonomy, rather than the fundamental, self-governing characteristics of an 
autonomous being. That is, even autonomous individuals may sometimes fail 
to be able to govern themselves in certain circumstances because of temporary 
constraints, such as illness, depression, ignorance of a given situation, coercion, 
or adverse circumstances183.
These are more subtle factors than some of the illnesses in, and problems 
of, the elderly, and their negative impact on an elderly individual may be 
underestimated. It is also arguable that these factors may affect elderly 
individuals more than other age groups, which is again an important reason for 
being aware of their existence and their likely impact on an individual's 
autonomy.
3.3.3.4 - Significance of range of limitation of autonomy for research
Thus, it may be seen that although the elderly may appear to have 
decreased autonomy through problems with stereotype and generalisation, 
there remain some who have real limitations to their autonomy, whether it be 
through internal or external factors.
The distinction between the two kinds of difficulties are not necessarily 
clear-cut and it may be difficult to assess the extent to which they contribute to 
compromised autonomy in the elderly. For example, it is difficult to be certain
183ibid.
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whether adverse external circumstances prevent the enacting of an autonomous 
decision, or whether it actually inhibits autonomy at a more fundamental level. 
However, an awareness that such factors may be operating for an elderly 
person may allow the compromised aspects of the individual's decision-making 
process to be minimised.
Thus, these 'real' limits on autonomy may be global or limited to certain 
situations, and this is important in that an elderly person's autonomy may still 
be maximised if one recognises that the limiting influences need not be 
universal in scope for that individual.
Therefore, the participation of the elderly in research may be maximised 
in an ethical way if one recognises that compromised autonomy in the elderly 
need not be global (that is, affecting all traits which we would normally 
associate with an autonomous individual), and if their ability to consent is 
maximised.
3.4 - Problems with research involving elderly subjects
3.4.1 - Difficulties obtaining consent
Obtaining consent is the first main problem encountered in research 
involving the elderly. As I have outlined in earlier paragraphs, consent may be 
problematic because the elderly person may have compromised autonomy, and 
there are many factors which act to compromise the autonomy of elderly 
people, such as poverty, dependence, vulnerability, frailty, as well as decreased 
physical and mental functioning. This restriction of autonomy may be 
specifically compromised in certain circumstances, such as short-term illness; 
or compromised autonomy may be more global, through a problem such as 
dementia.
3.4.1.1 - Diminished mental capacity and its impact on giving/obtaining consent
103
Diminished mental capacity is usually in the form of dementia and is a 
major contributing factor to decreased decision-making capacity in the elderly. 
It is likely to become an even greater problem in the future. It is estimated that 
the number of elderly individuals aged over 65 will increase by 60% in the next 
35 years, but that the increase in those with cognitive impairment will increase 
by about 90%. Although it is predicted that the change in the number of elderly 
individuals will then stabilise at about 50% more than 1996, the number of 
cognitively impaired will stay high, peaking at about twice as many in 50 years' 
time184.
Dementia poses problems because many of the factors necessary for 
autonomy are jeopardised by the disease, such as understanding, deliberating 
and reasoning. The loss of short-term memory, which is usually the first deficit 
seen, is problematic because the person is unable to retain information long 
enough to deliberate on it. Choices may also be affected because the dementing 
individual is unable to deal with the idea of long-term consequences and 
benefits. In this sense, the situation of the elderly demented person may 
resemble the compromised autonomy of the child, although it is arguable that 
many children have the capacity to reason which the dementing may not.
Similarly, dementia may generate problems which compromise 
autonomous choice, such as comorbidity (which is more common in the 
demented), depression, and lack of understanding of many situations. The 
demented elderly person is also more likely to be institutionalised, creating an 
increased likelihood of circumstances adverse to free decision-making, as well 
as creating an increased potential for coercion.
3.4.1.2 - Physical impairment and its impact on giving/obtaining consent
184Melzer, D., Ely, M. and Brayne, C., 'Cognitive impairment in elderly people: population 
based estimate of the future in England, Scotland, and Wales', BMT, 1997; 315: 462.
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Secondly, other factors, such as physical disability and impairment, may 
make the process of obtaining consent more difficult when dealing with elderly 
potential research subjects.
Problems with sensory impairment makes obtaining consent more 
difficult. For example, many older individuals suffer from varying degrees of 
deafness (44% of people aged over sixty-five were offered hearing aids in one 
study185), which has obvious implications for effective communication with this 
age group. And although 39% of women and 55% of men thought they had 
some degree of hearing loss, few (10% and 12% respectively) had sought advice 
or treatment for their problem186, a further contributing factor to impaired 
communication. Blindness in an elderly individual may similarly restrict the 
extent to which communication is effective, thereby compromising the process 
of obtaining consent.
Knowledge that an elderly individual has sensory impairment may also 
decrease the extent to which the person seeking consent makes an effort to 
communicate with the elderly subject. A stereotypic perception of the capacities 
of elderly people, discussed earlier, may also predispose the person seeking 
consent to assume that the elderly person has sensory impairment and to 
employ less effort in obtaining consent.
Physical impairment, such as paralysis after a cerebrovascular accident, 
may also inhibit the normal process of communication, thereby decreasing the 
effectiveness of the process. Physical impairment may also lead the consent- 
seeker to assume - perhaps incorrectly - that there is a corresponding mental 
deficiency, again creating problems in obtaining consent.
3.4.1.3 - Focus on deficits rather than capabilities
185Wilson, P.S., Fleming, D.M. and Donaldson, I., 'Prevalence of hearing loss ammong people 
aged 65 years and over: screening and hearing aid provision', British Toumal of General 
Practice, 1993; 43: 406-409.
186ibid., p. 407.
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A third problem with obtaining consent in elderly patients and potential 
research subjects is that there is a tendency to focus on the weaknesses in the 
elderly person's capacities, particularly if he or she is demented. It has been 
noted that the first question which tends to be asked when dealing with elderly 
people is whether they are competent, rather than aiming to maximise the 
decision-making capabilities of the elderly individual187,188. As compromised 
autonomy in the elderly is, in the main, neither a complete lack nor due to a 
single irreversible cause, involving the elderly in research can be made a more 
ethical process by adapting the structure of research projects, and the way in 
which consent from older participants is sought.
3.4.2 Problems with institutionalisation
Institutionalisation is also a problem for elderly individuals, including 
potential research subjects, particularly as it is far more common in this age 
group than in younger persons. Institutionalised elderly are more vulnerable 
and dependent than other elderly persons, and this poses problems for research 
on such individuals. The decreased autonomy associated with this 
phenomenon may be exacerbated by a number of other factors, of which there 
are at least eight. These are as follows.
Firstly, in common with other institutionalised persons, such as 
prisoners and long-term psychiatric patients, the elderly are likely to 
experience changes in their behaviour and personality, leading them to behave 
in an 'institutionalised' way. This may be exaggerated by the attitudes of staff 
who perceive the elderly person in a stereotypic way, and may be more marked 
in the elderly than younger individuals as they are less likely to be discharged.
Secondly, the elderly person is physically frail and vulnerable, and has 
much less hope of ever being discharged from the institution than younger
187Hope, T., 'Aging, research and families', T.Med.Eth., 1997; 23: 267-268.
188See also Olde Rikkert e t<3/(1997), op. cit., pp. 271-276.
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individuals. Thus, there may be less motivation to treat them as though they 
will return to pre-morbid functioning, and their autonomy underestimated as a 
consequence.
Thirdly, he or she is also likely to be financially constrained, making it 
difficult for him or her to make any change in his or her circumstances should 
they be less than satisfactory.
Fourthly, they may tend to be less assertive than younger individuals for 
social and cultural reasons, and may 'give up' more than younger persons who 
are institutionalised because it is considered more 'normal' (perhaps 
incorrectly) for older persons to be institutionalised.
Fifthly, the elderly person's family may contribute by pressuring them to 
take up residence in the institution, and may similarly pressure their relative to 
participate in research.
Sixthly, the health of the older individual tends to become worse once 
they are institutionalised, which further increases their frailty and dependence, 
and further compromises their ability to make decisions freely. Their cognitive 
capacities may tend to decrease through lack of stimulation, and this 
temporary, reversible state of affairs may persist if no effort is made to 
overcome it, thereby further compromising the autonomy of the individual.
Thus, it may be seen that the above factors are problematic in that they 
increase the dependency of the institutionalised individual, and exacerbate 
their lack of autonomy. They are dependent on the institution to provide them 
with shelter and care. This may make them prone to consenting to participation 
in research when they may not do so had they more alternatives open to them. 
They may feel that their dependence on the institution means that they must 
comply with requests such as those for participation in research.
Seventhly, the relationship between the older person and his or her 
doctor may be compromised by institutionalisation; the physician is often the 
person responsible for admitting an elderly person to high level care, such as a
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nursing home, and the resentment the older person may feel may decrease the 
quality of the relationship. Thus, if the physician responsible for obtaining 
consent for participation in research, the process of obtaining consent may be 
complicated by the decreased quality of the doctor-patient relationship. A 
poorer doctor-patient relationship may also expose the elderly person to risks 
from research if the person recruiting the elderly individual is n o t the doctor; 
the elderly person may be less likely (or able) to consult his or her doctor for 
advice, thereby increasing the potential risks.
Finally, another factor working against the elderly person in an 
institution is that their dependent state naturally predisposes them to feel 
obliged to participate in research, and may lead to them receiving an excessive 
number of requests to participate. Apart from the issues of compromised 
autonomy and its implications for research, multiple requests to participate 
may cause problems for research insofar as an elderly person may end up 
involved in multiple trials simultaneously, possibly without the knowledge of 
the different research teams189.
3.4.3 - Problems with community-based care of the elderly and the way in 
which this impacts on autonomy
Related to institutionalisation are other forms of care for elderly people, 
such as care of various kinds utilised in order to keep the elderly person in the 
community. Although attempts to keep elderly persons in their homes have the 
potential to increase the happiness and independence of such individuals, and 
would appear to contribute to their autonomy, the kinds of care which may be 
involved in community living may in fact compromise the autonomy of the 
elderly. And, obviously, decreased autonomy has implications for research 
involving the elderly. Thus, claiming that elderly persons living in the
189Royal College of Physicians (1990), Research Involving Patients, Royal College of Physicians, 
London, p. 24.
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community are sufficiently independent and autonomous to allow their 
participation in research may be oversimplifying the case.
3.4.3.1 - Family pressures and their impact on the elderly
An escalating need for care at home may create problems because it 
places increasing pressure on other family members.
In one sense, this is less likely to be an issue nowadays, given that the 
structure of families have changed, tending to be more fragmented, both 
structurally and geographically. Thus, it may be community services, rather 
than family, who provide home care for the elderly.
On the other hand, however, when family members are available to 
provide care for elderly relatives, the likelihood that they will be fewer in 
number means that an often unreasonably great burden is placed on these 
carers.
This situation may create tensions within the family that tend to impact 
negatively on the elderly individual. The older person may also be pressured to 
enter residential care, thereby weakening his or her autonomy. In addition, 
entry into a nursing home or hospital makes the elderly person both less 
autonomous yet more likely to be approached for participation in research.
3.4.3.2 - Community services and their significance for the elderly
If the family are unable to care for their elderly relative, care in the 
community tends then to come from community services. This also poses 
problems for the autonomy of the older person.
Many people, but particularly elderly people, may feel that it is more 
'natural' for the elderly to be cared for by their families, and when this cannot 
be achieved, they may be disinclined to accept help from other agencies. This 
may lead to a lack of adequate care and medical intervention, perhaps 
exacerbating physical problems and cognitive decline. A failure to accept care
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from community services, and the resulting lack of care, may lead the older 
person to be institutionalised earlier than they need have been.
If, on the other hand, help is accepted from community services, the 
older individual may feel guilt that they are being a 'burden' on society, 
particularly when stereotypes about the capabilities of the elderly prevail. 
Acceptance of care in this way may also lead the elderly to feel increasingly 
dependent, and to cease to function as a fully autonomous being unnecessarily.
A final problem with community care is that eventually it fails to be cost 
effective, and it may be necessary to move the elderly person to higher-level, 
institutional care, even though they may resist this. The combination of 
institutional care with pressure to be there may mean the elderly person reacts 
negatively and may become depressed or decline in other respects, thereby 
compromising their autonomy.
3.4.4 - Difficulties with relatives of elderly people
The care of elderly individuals in the community raised the issue of 
family involvement in such care and associated difficulties, and there are a 
number of other ways in which relatives can create problems for elderly people 
- including relationships between family members and conflict of interest. Both 
good and bad relationships between elderly persons and their families have 
implications for research insofar as both may affect the way in which the 
elderly person behaves - including how they behave in response to requests to 
participate in research. Disparity between the interests of the elderly person 
and those of his or her family may also create problems.
3.4.4.1 - Good pre-existing relationships within the family
The first issue is that if the relationship between the elderly person and 
their family has been good, hospitalisation is likely to result in stress for both
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parties. Such stress may compromise the elderly person's autonomy in a 
number of ways.
Firstly, the stress itself may directly decrease the individual's ability to 
make reasonable decisions; similarly, it may lead to related conditions such as 
depression, which also adversely affect autonomous decision-making. (This is 
likely to be exaggerated in elderly patients as they tend to be hospitalised for 
longer, thereby increasing the likelihood that stress and depression will 
complicate matters when consent for research is sought.) Thus, these kinds of 
factors are problematic for research on the elderly because they affect the 
individual's autonomy, thereby complicating the process of obtaining informed 
consent.
Secondly, in this situation, participation of the elderly person in research 
may also be complicated by the person's desire to be reunited with supportive 
family; for example, he or she may agree to participate in research in the hope 
that this will improve their chances of going home.
3.4.4.2 - Stressed relationships within the family
A second aspect of an otherwise good relationship between the elderly 
person and his or her family is that even if the relationship has always been 
good, ongoing illness or decreasing cognitive function may lead to family 
stress, anger and guilt which cannot be helped by outside intervention190. In 
this case, hospitalisation of the elderly person functions as a relief for family 
members, and three problems arise in this situation.
Firstly, the elderly individual may be pressured by family to remain in 
hospital, thereby increasing the likelihood that there will be research problems 
insofar as the longer an elderly person remains an in-patient, the more likely 
they are to be approached for recruitment to research. Longer periods of 
hospitalisation may also complicate research in that the elderly person is more
190ibid., p. 378.
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likely to develop problems which compromise their autonomy - such as 
thinking and behaving in an 'institutionalised' way, and by developing 
comorbidity.
Secondly, the family may also - deliberately or otherwise - misrepresent 
the extent of the elderly person's illness or disability in order to prolong the 
break from care they receive while the elderly person is in hospital. This 
misrepresentation is more of a problem for elderly patients than patients in 
other age groups because elderly persons do tend to be more likely to be 
unwell, with a greater number of diseases at work, than younger persons. Thus, 
a misrepresentative image of an elderly person's health or capabilities is more 
likely to be accepted as true; and the stereotypic perception of elderly people 
outlined in previous sections may also contribute further to this problem, 
particularly when the stereotypic perception increases the tendency to give 
more weighting to the opinions of the relatives.
Thirdly, stress and guilt on the part of family members may lead them to 
pressure elderly relatives into participating in research. This is because medical 
intervention - including research, particularly if the cause of the elderly 
person's problems are not understood or treatable - implies that there is a 
medical reason for the person's condition, which serves to alleviate feelings of 
stress and guilt.
3.4.4.3 - Poor pre-existing relationships within the family
I have discussed the two ways in which go o d  family relationships may 
impact on the elderly person. However, it may also be the case that 
relationships between older individuals and their families may have been poor, 
even prior to illness or dementia. This also may influence the way in which the 
elderly person behaves, leading to repercussions for research involving the 
elderly.
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One obvious way in which poor family relationships impact on the 
elderly is that hospitalisation provides welcome relief for both the elderly 
person and the relatives. The elderly person may be inclined to agree to 
participate in research in the hope that their stay will be prolonged, thereby 
avoiding reunion with his or her family. Conversely, the relatives may pressure 
the elderly person to participate in research in the hope that he or she will be 
hospitalised for longer.
Relatives may also hope that involvement in research will reveal some 
cause for the elderly person's behaviour which will absolve them of 
responsibility for the poor relationship; or that an underlying medical reason 
may be discovered which might again be contributing to the problems in the 
relationship.
Removal of the elderly person from the home environment may also 
create a new equilibrium into which the elderly person may not be readily 
accepted191; this kind of effect may be exacerbated if the elderly person's 
absence is prolonged by hospitalisation or participation in research.
Thus, as I have discussed, both good and bad relationships within the 
family of an elderly person may have consequences for the elderly individual's 
autonomy and attitude towards participation in research.
3A.4.4 - Conflict of interest within the family
A further way in which the family of an elderly patient or research 
subject may affect matters is when the in terests of the family conflict with those 
of the patient. As has been noted, it should not be the responsibility of the 
physician (or indeed researcher) to intervene in such problems192, but it is 
impossible to dissociate the role played by relatives, and the impact of the
191Oppenheimer (1991), op. cit., p. 380.
192ibid., p. 379.
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family, from the elderly person as a distinct entity in the clinical or research 
setting.
Traditionally, it is held that the doctor should pursue the course of action 
which is in his or her patient's best interests, even when this is in conflict with 
the best interests of relatives, for example. (This is relevant to research in that 
the attending doctor often plays a fundamental role in recruiting patients for 
research and forming the link between the research subject and the research 
project.) However, there are a number of reasons193 why this focus on the best 
interests of the patient alone may not be relevant.
One is that it is already the case that patient's best interests are 
sometimes overridden.
A second reason is that it does not seem reasonable to impose demands 
on relatives which would not be expected of other carers, such as health care 
workers.
Thirdly, the interests of the elderly person and his or her family are often 
not readily separable; an example might be an elderly person whose family can 
no longer supply adequate care, but who refuses to go into a nursing home 
because he or she wishes to leave money to his or her children. One might say 
that it is in the best interests of the offspring to keep the elderly person at home, 
but that the best interests of the elderly person would be served by putting him 
or her into a nursing home. However, it is arguable that it is not clear that the 
elderly person's best interests are so straightforward; it may be in his or her 
best interests to be kept at home, given the obvious importance the elderly 
person attaches to the act of leaving money to his or her children194.
Fourthly, the preference given to an individual's best interests is usually 
to protect that individual from harm from 'malign influence'195; however, it is 
arguable that this applies less to families, and certainly not in the majority of




situations in which one might wish to take into account the interests of the 
relatives.
3.5 - Defending research involving the elderly
3.5.1 The importance of research involving older individuals
The difficulty then, of course, is that all the difficulties discussed above 
contribute to compromised autonomy in the elderly, or other difficulties for 
consent, which should mean that the elderly individual cannot give informed 
consent. Yet informed consent is generally considered to be an essential 
element of research, without which the research cannot go ahead. It is arguable, 
however, that research in the elderly is still necessary, for four reasons.
3.5.1.1- Medical problems unique to the elderly population
Firstly, there are special medical problems unique to old individuals, and 
some medical problems are increasing in the elderly as fewer are dying early of 
ischaemic heart disease and cardiovascular disease.
It is arguable that medical problems which are common to both older 
individuals and younger groups should perhaps be researched using younger 
research subjects because it is less likely that they will have the kinds of factors 
leading to compromised autonomy that are seen in the elderly. (This is also the 
case when dealing with diseases common to both adults and children.)
However, research on the elderly might still be necessary to ensure that a 
given disease takes the same course in the elderly as in younger individuals 
when the disease is common to all groups (as well as for problems seen only in 
older age groups), given that conclusions reached in studies of young people 
cannot be extrapolated to elderly people196. Further, research may be necessary,
196Bell, J.A., May, F.E., Stewart, R.B., 'Clinical research in the elderly: ethical and 
methodological considerations', Drug Intell.Clin.Pharm., 1987; 21:1002-1007.
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not only on the elderly in preference to younger research subjects, but also on 
elderly subjects with compromised autonomy rather than unimpaired elderly - 
as in the case of dementia research, for example.
3.5.1.2 - Different biological responses in the elderly
Secondly, the elderly comprise only 14% of the population, yet consume 
nearly one third of all medications197, indicating the importance of research in 
this age group. They also have different drug metabolism; this is particularly 
marked if the individual is both elderly and ill198, and multidrug therapy is also 
more common, leading to an increased risk of adverse drug reactions199. The 
widespread use of medications in the elderly, as well as the different way in 
which they are handled by the bodies of the elderly, emphasise the importance 
of drug trials involving the elderly.
The elderly are not only more likely to have problems with medications 
they are given, but they are also more likely to be on the receiving end of 
substandard drug trials. This is because the drug industry is highly 
competitive, and vast sums of money are involved. However, the elderly are 
problematic for drug testing, having complicated physiology and existing 
comorbidity, and so tend not to be recruited because of this. As a result, the 
elderly tend to be excluded from trials200 when in fact they should be included.
3.5.1.3 - Social problems specific to older individuals
Thirdly, the ever-increasing proportion of elderly people in society raises 
many social issues for the elderly, such as problems with housing, community 
care, institutionalisation, and so forth. Research in areas such as these - less
197Avorn (1997), op. cit., p. 1033.
198Avorn, J., Gurwitz, J.H., 'Principles of pharmacology', in Cassel, C.K., Cohen, G., and Larsen, 
E. (eds) (1997), Geriatric Medicine, Springer, New York.
199Mannesse, C.K. et al, 'Adverse drug reactions in elderly patients as contributing factor for 
hospital admission: cross sectional study', BMT, 1997; 315:1057-8.
2°°Avorn (1997), op. cit., p. 1033.
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directly medical - are also important. Without research into the particular 
problems characteristic of old age, improvements in knowledge and care 
cannot come about; hence the importance of such research. This is important 
not only in order to maximise the happiness, health, and productivity of older 
individuals, but also to decrease problems and expenses for families and for 
society more generally.
3.5.1.4 - Social cost of elderly health
And fourthly, health care for the elderly already occupies a substantial 
proportion of the health care budget, owing to the comparatively extensive 
morbidity seen in this group. As the proportion of elderly people in society will 
continue to increase in coming years201, it is arguable that research into 
problems characteristic of this age group is necessary, both for their care and to 
prevent minimise the drain on resources which we are likely to see in the 
future.
3.5.2 Why research involving elderly with compromised autonomy may be 
defensible
Even if researchers are confronted with potential elderly research 
subjects with compromised autonomy, a number of factors may mean that 
some research can be considered more justifiable for research subjects with 
compromised autonomy.
3.5.2.1 - Benefits to the individual may increase acceptability of research
Firstly, research may be considered to be more ethical if there are direct 
benefits to the individual which are likely to result from the research,
201This is reflected by a number of statistics. People aged over 60 currently constitute a fifth of 
of the British population, but will be a third by 2030; in 1951, Brtain had 300 people aged over 
100, whereas by 2031, it is estimated that there will be 34 000 people over 100; and those aged 
over 80 represent the fastest-growing section of the population. Taken from Greengross, S. etal, 
'Aging: a subject that must be at the top of world agendas', BMT, 1997; 315:1029-30.
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particularly if these benefits are felt to outweigh the risks incurred and the 
resources utilised in the research. That is, a favourable cost-benefit analysis 
obviously is to be preferred, particularly when treatment or research is 
complicated by compromised autonomy on the part of the patient or research 
subject.
A related aspect is when no direct benefit is expected for the individual, 
but when it is anticipated that the research will yield benefit for the group 
overall. This may be considered defensible for a number of reasons: the 
individual may still advantage from the benefits conferred on the group as a 
whole; the elderly research subject with compromised autonomy is more likely 
to have given some kind of indication in advance of how they would feel about 
participating in research (compared with the case of children); and many 
factors contributing to compromised autonomy in the elderly may be 
comparatively minor and still permit the elderly person to be able to consent 
quite well and validly (again compared with children, in whom a restriction of 
autonomy is generally held to be more global).
3.5.2.2 - Types of procedures and research may make involvement of elderly more ethical
Secondly, the type o f procedure involved in the research is relevant. 
Research using safer and less invasive procedures such as urinalysis would 
appear to be more ethical when the research subject has compromised 
autonomy than invasive and high-risk procedures such as surgery.
Some elderly individuals may have different or unexpected responses; as 
an example, demented individuals may also have different responses to certain 
situations - for example, they may be more distressed undergoing a CT scan 
than cognitively intact individuals - which may affect adversely the extent to 
which research on such individuals can be considered ethical. Other procedures 
may, however, be more acceptable to the demented elderly person.
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Further, a number of practical measures may be taken to facilitate the 
elderly person's involvement in research, and to decrease the extent to which 
their autonomy is compromised. For example, many institutionalised elderly 
people experience a decrease in cognitive function related to their 
unstimulating environment. This may in part be reduced by providing a more 
stimulating environment, and the resulting increase in cognitive function may 
render the elderly person more able to consent to take part in research.
Similarly, altering the structure of a research project - for example, by 
'training' the elderly person in the early stages of the trial202 - may make it more 
ethical by increasing the understanding of the potential research subject, and 
therefore the validity of his or her consent.
In addition, not all types o f research are the same; many kinds of 
research which are potentially useful for the elderly - such as social policy 
research, research on care, and music therapy - obviously are much more 
acceptable for those with compromised autonomy, given their relatively non- 
invasive and non-intrusive nature.
3.5.2.3 - Justification of research on elderly with compromised autonomy based on levels of 
satisfaction involved
Thirdly, research on elderly with compromised autonomy may also be 
considered justifiable in that it may generate a sense of satisfaction  for a 
number of parties involved.
The staff caring for the patient (if the research subject is 
institutionalised) may derive satisfaction from feeling that the maximum is 
being done for the elderly person; and if a disease entity is detected or defined 
through involvement in research, the staff may be better equipped to deal with 
the patient. In addition, involvement of institutionalised elderly persons in
202Olde Rikkert, M.G.M., van den Bercken, J.H.L., ten Have, H.A.M.J. and Hoefnagels, W.H.L., 
'Experienced consent in geriatrics research: a new method to optimize the capacity to consent in 
frail elderly subjects', T.Med.Eth., 1997; 23: 271-276.
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research may be to their advantage in that health problems may be detected 
when otherwise the elderly person would not have had contact with medical 
services.
The family may also derive satisfaction from the fact that their elderly 
relative is involved in research, in that the person may derive direct or indirect 
benefit from the research; it also implies that the elderly person is receiving 
attention and care.
Finally, and most importantly, the elderly research subjects themselves 
may derive satisfaction from participating in a study; they may feel as though 
they are doing something positive, contributing both to their health, as well as 
to society and other people with similar problems. It is important to note that 
the kinds of problems which potentially can decrease the autonomy of the 
elderly may be much more subtle and varied than the usually more global 
decrease seen in many other groups (for example, those in a persistent 
vegetative state). Thus, while there are many potential problems which one 
needs to be aware of when dealing with the elderly - such as poverty, family 
tensions, social differences, physical frailty and illness and impaired cognitive 
function - there may be a sufficiently small number of factors compromising 
autonomy to make consent valid.
3.5.2.4 - Defending research on the elderly based on previously-expressed acceptance of 
research
Fourthly, research on an elderly person with compromised autonomy 
may be justifiable if the person has expressed previou sly  an acceptance of or 
wish to participate in research - a situation different from that of children as 
potential research subjects, who are unlikely ever to have expressed any view 
on this matter. The validity of a criterion such as this for involvement in 
research is heightened if the research in question involves: little or no risk; a 
high benefit-to-risk ratio; probable benefit to the individual; and little that
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could be considered invasive or intrusive (as in studies of the care of the 
elderly, epidemiology, and so forth). However, there remain problems with this 
criterion for inclusion of the elderly in research. These four problems are as 
follows.
The first problem with using previously-expressed acceptance of 
research as justification for research on an elderly person with compromised 
autonomy is that few people are likely to give explicit views on whether they 
would wish to be included in research were they unable to consent for 
themselves. This is in contrast with certain other clinical scenarios, such as 
being in a persistent vegetative state; this latter situation is usually more 
prominent in the minds of most people than research and, accordingly, they are 
more likely to have expressed views on the way in which they would want to 
be treated.
A second problem with using a previously-expressed acceptance of 
research as grounds for inclusion in a study is that an expression of support for 
research generally does not necessarily translate into a willingness to 
participate oneself. And even if there is evidence that the elderly individual had 
communicated a willingness to participate in research himself, there is no 
guarantee that such a view will always remain current; the individual may 
change his or her mind, without the knowledge of the family or friends who are 
likely to be questioned on the views of the non-autonomous elderly person.
The third difficulty is that even if the elderly person has previously 
indicated that they would be prepared to participate in research were they to 
become unable to consent for themselves, it may be the case that they have not 
understood the nature of research in general. And it is almost certain that it 
would be impossible for them to understand the specifics of a particular study 
in advance; it is also unlikely that an individual is able to predict in advance 
how he or she would feel about involvement in particular kinds of research.
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Finally, the situation may be complicated by the involvement of the 
elderly person's family, who may be unreliable in reporting the previously- 
expressed wishes of their relative. Family members may substitute their own 
views for those of the elderly person. Or they may misrepresent the views of 
the person through ignorance of the person's true views, through a desire to 
help their relative (either by involving them in research or preventing them 
from participating, depending on what they perceive to be in the best interests 
of their relative), or through other factors (such as an inability to cope with an 
unwell elderly person, and a subsequent desire to pinpoint a 'medical reason' to 
explain the situation).
Thus, it can be seen that there are a number of objections against using 
previously-expressed acceptance of research as a criterion for inclusion of 
elderly research subjects with compromised autonomy. These problems, as I 
have discussed, include the lack of likelihood that an opinion specific to 
research has been given in advance; a general support of research may not 
signify one's own participation; the person may change his or her mind; the 
person may not understand research generally, and is unlikely to have given 
views on specific kinds of research; and the elderly person's family may 
complicate matters by misrepresenting the views of the person.
However, a previously-expressed acceptance of research may still be 
useful, particularly for potential elderly research subjects with compromised 
autonomy. This is because compromised autonomy in the elderly is far less 
likely than other groups to be absolute (except in cases of advanced dementia, 
coma, and so forth) - as I have discussed - and although the elderly person may 
lack one or two of the criteria used to assess competence, it is not the case that 
this makes the elderly person unable to consent meaningfully.
It is likely that many elderly individuals with compromised autonomy 
may still retain many of the criteria we would consider necessary for 
competence and consent, and it is in this way that the use of other, minor
122
factors can be seen. For example, a previously-expressed acceptance of research 
by an elderly person with compromised autonomy may not be considered 
sufficient, on its own, to justify involving the person in research. However, a 
factor such as this may be useful when considered in conjunction with other 
criteria which indicate that involvement in research may be appropriate.
35.2.5 - Summary of factors which may render research on elderly with compromised 
autonomy acceptable
Thus, in summary, there are a number of factors which may make 
research on elderly individuals with compromised autonomy more acceptable. 
These include: benefits (direct and indirect) for the individual; a modification of 
research procedure and the kinds of research performed to make it less 
invasive and intrusive; satisfaction on the part of staff, family, and the elderly 
person himself; and a previously-expressed acceptance of, and willingness to 
participate in, research.
Although some of these factors would not be considered a satisfactory 
criterion for including an elderly person with decreased autonomy in research, 
they may serve as useful factors which can help an assessment of the suitability 
and ethics of the individual's involvement in a research project. As I have noted 
above, this is partly because the elderly with compromised autonomy are often 
borderline cases, rather than completely lacking in autonomy. For example, an 
elderly person who has a poor relationship with his or her family may consent 
to participate in research in the hope that this will increase the length of their 
stay in hospital, away from their family, yet be quite cognitively intact and 
healthy and not subject to compromised autonomy in any other way. In a case 
such as this, it may be seen that although it is important to be aware of factors 
such as poor family relationships, obviously the individual is essentially 
competent.
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It is in situations such as these where some of the factors outlined in this 
section may be useful - for example, a previously-expressed wish to participate 
in research may allow inclusion of the person in research insofar as it 
compensates for the fact that the elderly person appears to be consenting in 
order to stay in hospital, away from his or her family.
3.5.3 Research involving autonomous elderly
It is of course the case that a good number of elderly persons - 
particularly the 'young old' - are free from the kinds of factors which may 
adversely affect autonomous decision-making.
However, the existence of other elderly persons with a decreased 
capacity to consent to research may lead us to restrict autonomous elderly from 
participating. This may in part be due to the stereotypic perception that many 
more elderly people are impaired than is actually the case. Therefore, the 
capabilities of each individual elderly person to consent may be less likely to be 
adequately assessed. In addition, stereotypic perception creates the possibility 
that legislation may be implemented in order to protect the non-autonomous 
from exploitation in research, thereby preventing the autonomous elderly from 
participating in research.
However, it is obviously the case that this is undesirable. Elderly 
persons, as a group, stand to be disadvantaged if research is not carried out into 
problems affecting them, and it is clearly preferable that research subjects be 
able to consent when they can. Further, it would appear an unreasonable 
imposition on the liberty of the individual to prevent autonomous elderly 
persons participating in research on the basis of their age, when we extend no 
such prohibition to other autonomous groups. Autonomous elderly are just as 
likely to have altruism, curiosity and scientific enthusiasm as younger
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persons203, and it does not seem right to prevent them from participating in 
research when they are in fact autonomous.
3.5.4 - Economic and resource factors in favour of research involving the elderly
A further point in support of some research involving elderly subjects 
with compromised autonomy has its basis in economics and the problem of 
resource allocation. The health problems of the elderly already occupy a 
disproportionate amount of the health care budget, and as the proportion of the 
population who are elderly will continue to increase in coming years204, it is 
arguable that research on the health problems and care of the elderly is 
desirable in that it will help reduce the resources allocated to the health of this 
age group.
Research also increases the likelihood that the elderly will receive 
improved care and quality of life, and it is not clear that they should be denied 
the possibility of this on the grounds that resources would be better spent 
elsewhere. It is often contended that health care resources are better spent on 
younger patients. In one sense, this may be justifiable, in that younger patients 
tend to do better and any benefits they receive are likely to last longer owing to 
a longer lifespan. In addition, older individuals may exert considerable 
pressure - 'grey power' - leading to a potential for misallocation of resources in 
favour of the elderly. On the other hand, benefits should be assessed depending 
on existing disability205, not simply on the basis of age; elderly individuals who 
do not have existing comorbidity may easily do as well as younger persons.
In addition, it does not seem justified to deny the elderly access to 
research and care which may greatly improve their quality of life on the 
grounds that they have already had 'a good innings'. This is only valid if one 
assesses 'a good innings' simply on the number of years the individual has
203Oppenheimer (1991), op. cit., p. 375.
204Greengross (1997), op. cit., p. 1029.
205Mason and McCall Smith (1994), op. cit., p. 276.
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lived. In other senses, the elderly person may not have had such a good innings 
as many younger people. For example, life as a young person would have been 
a good deal more difficult for many of the elderly than it is for younger 
individuals today206. It is also worth noting that although the elderly have been 
alive for longer, they have not had access to sophisticated health care and 
technology for any longer than younger people, given that many treatments 
and techniques were developed later in the lives of the former.
A final point in favour of providing resources for research involving the 
elderly is that we are making a false distinction between the 'elderly' and 
ourselves - it has been noted207 that the elderly are ourselves, and to designate 
them as a separate group is simply freezing a thin slice in time, thereby creating 
a false impression that somehow the elderly are a distinct group.
Thus, it would seem that there are reasons for research on the elderly 
which render it both necessary, and justifiable in many respects.
3.6 - Conclusion
To summarise, it may be seen that the autonomy of elderly persons is 
affected in a number of ways.
These include: the terminology applied to elderly people; stereotypic 
perceptions of the elderly; endogenous and exogenous factors decreasing 
capacity for consent; the varying degrees of impairment which exist; 
institutionalisation; community care; and the relatives of elderly people.
However, research is still important in this group of people in order to 
optimise their management and to improve their quality of life.
The acceptability of research may be increased if: it benefits the 
individual; leads to satisfaction; there exists a previously expressed desire to 
participate; the methodology can be modified to optimise the capacities of the
206Oppenheimer (1991), op. cit., p. 382.
207Daniels, N., Am I my parents' keeper? An essay on justice between the young and the old, 
OUP, Oxford, quoted in Oppenheimer (1991), op. cit., p. 381.
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individual; to provide equitable distribution of resources; and to improve the 
health of the elderly.
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CHAPTER 4 - RESEARCH ON PSYCHIATRIC PATIENTS
4.1 - Introduction
In this chapter, I shall discuss a number of factors which relate to 
performing research on individuals with mental illness.
I shall discuss: the importance of research in this group; past exploitation 
of the mentally ill and the way in which this affects our attitude towards them 
now; the factors affecting autonomy in psychiatric patients, such as the 
continuum between normal and abnormal, stigma, impaired reasoning and 
communication, difficulty assessing levels of understanding, 
institutionalisation and involuntary treatment, and the use of psychotropic 
medications.
I shall also discuss the special cases of children and the elderly who are 
also mentally ill, as well as issues for the doctor involved in psychiatric 
research.
Finally, I shall outline ways in which ethical research in the psychiatric 
population may be brought about.
4.2 - Why research on psychiatric patients is necessary
Obviously, psychiatric patients may also suffer from various medical 
problems which are seen in other members of the population who do not suffer 
with mental illness, and it may be argued that for conditions such as these, it 
may be preferable to use people who do not suffer mental illness as research 
subjects.
However, as is the case with problems unique to children (such as 
congenital heart disease, Wilms' tumours, and retinoblastoma) or the elderly 
(for example, dementia and falls), psychiatric patients have particular problems 
which are unique to them as a group, and which make some research desirable 
and indeed necessary.
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This is important in that research increases knowledge of various mental 
illnesses, thereby augmenting understanding of the pathogenesis, symptoms, 
clinical course, treatments, and impact on the sufferer of such illnesses. This 
allows more effective diagnosis, a more realistic understanding of such 
illnesses, and better treatment of such conditions. This in turn ultimately 
improves the lives of those who suffer mental illness.
4.3 - Past exploitation of psychiatric patients and the implications of this for 
research
Part of the reluctance to involve psychiatric patients in research stems 
from the many abuses they have suffered over the years, both in a research 
context, and more generally in society.
4.3.1 - The mistreatment of minority groups in a research context
Until recent times, experimentation and research were carried out with 
comparatively little regulation to protect the research subjects. As a result, 
potential research subjects were often selected from minority groups who had 
no real protection, and little support.
For example, children, particularly orphans and 'foundlings', were often 
recruited because they were readily accessible in orphanages, had no family or 
friends of sufficient influence to protect them, and were considered 
dispensable208.
Another major group was of course the mentally ill, who have been 
treated as either unwell or criminal for much of history. This made them ideal 
candidates for research purposes, as they too often had little social support to 
protect them, often had impaired means of communicating any discomfort or
208Lederer, S.E. and Grodin, M.A., 'Historical Overview: Pediatric Experimentation', in Grodin, 
M.A. and Glantz, L.H. (eds) (1994), Children as Research Subjects, Oxford University Press, 
New York and Oxford, pp. 4-9.
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discontent, and were viewed as sub-standard members of society. And people 
who were both children and mentally compromised were doubly vulnerable.
4.3.2 - Exploitation and poor treatment in a research context of subjects who are 
mentally compromised
An example of exploited research subjects who were both mentally 
vulnerable and children occurred Willowbrook in the U.S., where mentally 
retarded children were deliberately infected with hepatitis, to study the disease; 
parents were given faster admission if they consented to the procedure209. Jonas 
Salk also trailed his vaccine on a child who was mentally retarded210.
Another example of the exploitation of the mentally compromised is the 
way in which the notion of mental illness has been misused in some countries, 
such as the USSR, as a means to control individuals on a personal and political 
level. This was made possible through social and political pressures, 
inadequate controls and checks on the clinical process, legislative problems and 
poor clinical standards211.
4.3.3 - Nazi Germany: an example of exploitation of psychiatric patients for 
research purposes
A notable, yet comparatively little-publicised, example of exploitation of 
psychiatric patients is the way in which psychiatric patients were treated in 
Nazi Germany. The Nazi state was perceived as being 'organic' (biologisch), 




211Fulford, K.W.M., Smirnov, A.Y., and Snow, E., 'Concepts of Disease and the Abuse of
Psychiatry in the USSR', British Tournal of Psychiatry 1993:162; 801-810.
212Proctor, R.N., 'Nazi Doctors, Racial Medicine, and Human Experimentation', in Annas, G.J. 
and Grodin, M.A. (eds), The Nazi Doctors and the Nuremberg Code - Human Rights in Human
Experimentation, Oxford University Press, New York and Oxford, pp. 19-20.
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This generated the idea of racial hygiene, and started a prolonged 
propaganda campaign that focussed on degrading the 'useless eaters' - namely, 
groups such as the homeless and psychiatric patients213. Under the guise of 
'mercy killings' - designed also in part to free up hospital beds for the war 
wounded - 70 000 people in mental homes were killed by Hitler in 1939, and 
during WWII, one quarter of psychiatric patients starved to death as they were 
too low on the ration list214. The apparatus used to gas Jewish people was 
available because it had been designed to kill the mentally ill215.
Psychiatrists were directly involved in this abuse of German psychiatric 
patients; leading psychiatrists and anthropologists translated Nazi ideological 
slogans into supposedly scientific categories as a basis for racial hygiene216.
Psychiatrists were also involved in experimentation on psychiatric 
patients under the Nazi regime. The notions of mental illness were greatly 
exploited for political and social ends; for example, a Nazi psychiatrist, Robert 
Ritter, studied Asozialen (antisocials and gypsies) and concluded they were of 
primitive intelligence217.
This demonstrates the way in which psychiatrists have exploited their 
role in the past, and the way in which the definition of 'mental illness' may be 
manipulated for political or other ends.
4.3.4 - Attempts to minimise the exploitation of the mentally ill for research 
purposes
However, there have been moves in recent years to decrease the 
probability of abuse or unfair treatment of psychiatric patients.
213Pross, C., 'Nazi Doctors, German Medicine, and Historical Truth' in Annas and Grodin 
(1992), op. cit., p. 33.
214Proctor, in Annas and Grodin (1992), op. cit., pp. 23-4.
215ibid, p. 25.
216Pross, in Annas and Grodin (1992), op. cit., p. 38.
217ibid, p. 37.
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For example, psychiatric patients can now no longer be detained against 
their will for an indeterminate length of time; there are strict requirements that 
a patient be seen by several doctors during the early stages of their admission, 
and their case is heard by a visiting magistrate at the earliest opportunity 
(usually within a week) who can overturn the decision to schedule a psychiatric 
patient218. Even if a patient needs to be put into seclusion, because he or she is 
at risk of harming him- or herself, or others, he or she needs to be reviewed on 
an hourly basis by a medical practitioner, with a view to ending the period of 
seclusion219.
In fact, past abuses may lead to problems now in that we may 
overcompensate when dealing with psychiatric patients. This approach may 
partly be because of a fear of letting some research subjects with compromised 
autonomy 'slip through the net', and be damaged by the research process 
because insufficient care was taken. However, it may be that this fear itself 
provides a certain degree of protection, in that it creates a heightened 
awareness of the possibility in the researcher, who will then be vigilant in their 
interactions with the individual. In addition, even if a psychiatric patient did 
occasionally have an adverse outcome, it does not seem reasonable to limit the 
exercise of autonomy for the majority of the mentally ill who do have a 
sufficient degree of autonomy. This would be a standard that we would not 
apply to the population more generally - for example, we do not alter our 
approach to research for autonomous adults on the off-chance that an adult 
who appears autonomous may not be sufficiently so - so it does not seem right 
to impose different standards on groups such as the mentally ill.
On the other hand, some writers have claimed that 'we should value 
liberty more highly than mental health, no matter how [it is] defined'220, but it
218Central Sydney Area Health Service, Royal Prince Alfred Hospital Camperdown, NSW, 
Australia.
219Northern Sydney Area Health Service, Manly Hospital, Manly, NSW, Australia.
^^zasz, T. (1972), Law, Liberty and Psychiatry, Harcourt Brace Jovanovich, New York, quoted 
in Downie, R.S. (ed) (1996), Medical Ethics, Dartmouth, Aldershot, p. 402.
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has been noted that attitudes such as this may be an overreaction to the fact that 
psychiatric patients have been ignored or poorly treated in the past, and that in 
putting liberty above all other considerations, we may be condemning them to 
another form of imprisonment221. This may lead people to erroneously accept 
the patient's preferences, no matter how they are arrived at, in an attem pt to 
preserve their autonomy and self-determination222. It has been noted that 
freedom is a fundamental value, but there are other values which need to be 
preserved (such as equity, justice, self-respect, and life itself), and that freedom 
itself is a hollow value if the individual lacks adequate understanding, an 
ability to reason, or a reasonable assessment of likely outcomes223.
It is arguable that for individuals with compromised autonomy, it is 
negligent and unfair to place too much responsibility on them - by making 
them consent for themselves, when they may lack the capacity for this - and 
that the researchers, and society more generally, should take some of the 
responsibility for this decision-making. Further, given the level of knowledge 
of the researchers, compared with that of research subjects with impaired 
autonomy, it may be that it is our duty to use this information, rather than 
expecting the research subject to deal with this by him- or herself.
4.4 - Autonomy and the psychiatric patient
The autonomy of psychiatric patients is affected by a number of factors, 
which I shall discuss. These include: the continuum that exists between normal 
and abnormal; stigma surrounding mental illness; impaired reasoning and 
communication; difficulties gauging the level of understanding when assessing 
psychiatric patients; external factors affecting a mentally ill person; the
^Chodoff, P., The Case for Involuntary Hospitalisation of the Mentally I1T, in Downie (1996), 
op. cit., pp.403,406.
^Brock, D.W. and Wartman, S.A., 'Sounding Board: When Competent Patients Make Irrational 
Choices', in Downie (ed) (1996), op. cit., p. 408.
^M acklin, R., 'Refusal of Psychiatric Treatment: Autonomy, Competence, and Paternalism', in 
Edwards, R.B. (ed) (1982), Psychiatry and Ethics - Insanity, Rational Autonomy, and Mental 
Health Care, Prometheus Books, p.332.
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possibility of involuntary treatment; institutionalisation; mental illness itself; 
and the existence of mentally ill individuals who are minimally affected. These 
impact on autonomy, and affect on psychiatric research in various ways.
4.4.1 - The continuum which exists between the mentally ill and 'normal1 
individuals
Many psychiatric conditions represent a continuum between normal and 
the markedly abnormal, and their diagnosis often depends on the subjective 
(and potentially fallible) judgement of psychiatrists224.
4.4.1.1 - The continuum of mental illness and the way in which this differs from other groups 
with compromised autonomy
While psychiatric illness can be said to represent a continuum, this 
differs from other groups who have compromised autonomy - such as children 
and the elderly - in certain ways. The notion of a continuum is somewhat true 
of children and the elderly, in that they represent the extremes of age in the 
human population, and also in the sense that those groups contain individuals 
with a wide range of capabilities and capacities.
However, the range of states covered by the blanket of mental illness is 
much broader, and the capacities and degrees of impairment even more varied; 
the notion of a continuum appears to be even more prominent with psychiatric 
conditions and the sufferers of such conditions.
Some psychiatric conditions are very close to 'normal' on the continuum, 
and as a result may be difficult to segregate these potential research subjects 
from 'normal' individuals. A good example of this is personality disorder, in 
which the boundary between 'normal' and 'abnormal' can be difficult to 
evaluate, as well as quite arbitrary.
^C hodoff, in Downie (ed) (1996), op. cit., p. 404.
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4.4.1.2 - The continuum of mental illness and the wav in which this differs from physical disease
It should also be pointed out that some physical illness can be a 
continuum as well - for example, hypertension is a range of blood pressures, 
the 'normal' cut-off becoming increasingly low as more is learned about the 
long-term effects of even mildly elevated blood pressure.
This may be distinct from the case of the mental health spectrum in that 
having some physical diseases, such as mildly elevated blood pressure when 
previously the same reading would have been considered normal, does not 
carry the same negative connotations, emotive power, and associated 
difficulties for the sufferer.
4.4.1.3 - Neurosis versus psychosis
One way in which the continuum of psychiatric illness is manifested is 
shown by the way in which the term 'mental illness' encompasses both neurotic 
and psychotic conditions. Psychosis and neurosis represent a vast clinical 
spectrum, from mild anxiety, to uncontrolled, violent psychotic episodes.
However, a failure to recognise the existence of this continuum may 
mean that even sufferers with mild disease, few symptoms, or treated disease 
may be subjected to the same kinds of prejudices as those with more severe 
symptoms, by being categorised as 'mentally ill'.
This may lead to problems when research involves psychiatric patients, 
as the whole group may mistakenly be thought to possess the same capabilities 
and capacity for consent. There may be a tendency to use the most severe end 
of the spectrum as representative of the capacities of psychiatric patients, partly 
because this subset of the psychiatrically ill is most visible, most problematic, 
has the biggest range of problems, is most likely to benefit from research into 
their behaviour, and is most vulnerable.
4.4.1.4 - Partially and completely treated mental illness
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Further, unlike groups that are classified on the basis of age, psychiatric 
patients may also be partially or completely treated, thereby further blurring 
the line between 'normal' and 'abnormal'.
Again, this causes problems when performing psychiatric research, 
because those potential research subjects with mental illness that is treated may 
be able to function at a normal or near-normal level, which would make 
informed, autonomous consent possible. On the other hand, those who are 
partially treated may be less likely to be able to consent for themselves, but it 
may be difficult to assess their degree of impairment.
A further complicating factor is that the extent to which a patient is 
treated may change over time. For example, a mentally ill person whose disease 
is well managed may give their consent to participate in a research project, but 
then may deteriorate during the project, making their on-going consent less 
clear. Conversely, a potential research subject with a psychiatric illness may be 
limited in their participation, or have a proxy consent on their behalf, but then 
improve subsequently to the level where they could realistically consent for 
themselves.
4.4.1.5 - Symptomatic and asymptomatic psychiatric disease
Patients may also be asymptomatic at various stages of their illness as 
part of the natural course of the disease, which can complicate assessment of 
their autonomy and their suitability to consent to participation in research.
Bipolar disorder, for example is characterised by episodes of both manic 
and depressive behaviour, interspersed with often quite long periods of normal 
behaviour. This, again, raises difficulties when recruiting psychiatric patients 
for research, as they are classified as having a psychiatric condition (with 
negative connotations and associated perception that they may be incompetent 
to consent to participation in research) even during their periods of normal
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behaviour. It may also be difficult to assess h ow  normal these patients are at a 
particular time, given the changeable nature of their disorder.
4.4.1.6 - Difficulties in diagnosing mental illness and implications for research
The fact that mental illness represents a continuum with normal 
(compared with many somatic diseases, where there is a particular, definable, 
physical abnormality) may lead to difficulties with diagnosis.
On one hand, some individuals with mental illness may be 
underdiagnosed, their behaviour being insufficiently obtrusive to lead to 
presentation, diagnosis and treatment. Examples might be people suffering 
from anxiety or obsessive-compulsive disorder. Others with some psychotic 
features may not be diagnosed because their symptoms are thought to be 
'eccentric behaviour' - that is, not sufficiently abnormal to be classified as 
formal mental illness. These people may be considered 'normal' and be thought 
fit to consent, when in fact they may be sufficiently impaired to compromise the 
consent process.
Conversely, some people may be diagnosed with mental illness when 
they are in fact comparatively normal - such as some people with borderline 
personality disorder - and this may have significant impact on the individual, 
in terms of impairing their autonomy, and exposing them to stigma, which is 
difficult to avoid. Thus, they may be considered to be incompetent to consent 
to, or refuse, participation in research.
In addition, once an individual has been labelled as having a psychiatric 
illness, it is very difficult to overcome such labelling, even if it is incorrect. It 
also legitimises enormous power over those people who have been labelled225.
4.4.2 - Stigmatisation and the fear of the mentally ill
^Edwards, R.B., 'Mental Health as Rational Autonomy', in Edwards (ed) (1982), op. cit., p. 68.
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Psychiatric patients are also different from other groups, such as children 
or the elderly, in that they are more markedly stigmatised on the basis of their 
condition (although children and older persons may face preconceptions about 
their capabilities).
4.4.2.1 - Stigmatisation as a way of reinforcing the difference between normal and abnormal
The existence of a continuum between normal and abnormal in mental 
illness, compared with most physical illness, may generate fear and negativity. 
This is partly because mental illness, with its negative connotations, comes 
uncomfortably close to the normal population. By stigmatising psychiatric 
conditions, the rest of the population may attempt to broaden the division 
between the mentally ill and 'normal' people as a way of 'protecting' 
themselves.
4.4.2.2 - The lack of clearly defined biological basis to mental illness and the way in which this 
may contribute to stigma
Mental illness may also be feared because it is not obviously biological, 
or at least purely biological, in its basis. For example, there are a number of 
conditions which have a recognised organic basis, and although they may lead 
to similar behavioural manifestations as some 'psychiatric illnesses', they are 
not classified as such. These include delirium, and aphasia and mental 
retardation.
It has been noted that such conditions are not classified as mental 
illnesses because they have a biological basis226. And although some mental 
illnesses may ultimately be found to have a corresponding biological basis, at 
present this is not well understood. It is clear that the terms used in psychiatry 
do not ascribe pathology - many terms were used prior to the knowledge of
^Boorse, C., 'What a Theory of Mental Health Should Be', in Edwards (ed) (1982), op. cit., p. 
34.
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any underlying organic process227. As a result, diagnosis of mental illness does 
not rely on finding an objective, physical state in a patient; it relies instead on 
more subjective interpretation of symptoms.
This may contribute to stigmatisation of the mentally ill, again in an 
attempt to differentiate them from 'normal' people. (Having said that, it is 
worth noting that both organic and mental illness share a socially constructed 
negative evaluation, however228.)
4.4.2.3 - Changes in definitions of mental illness and implications for stigmatisation
In addition, notions of mental illness, and the range of conditions which 
fall under the banner of psychiatry, have changed with time.
For example, more recent editions of the DSM no longer include 
excessive smoking or a predilection for too much caffeine as mental illnesses229, 
or homosexuality. Conversely, newer editions now include problems such as 
pre-menstrual syndrome, whereas older editions did not recognise this cluster 
of symptoms as a clinical entity.
The changing nature of mental illness may also generate fear in people, 
because it further blurs the division between 'normal' and 'abnormal'. This may 
exacerbate stigmatisation of psychiatric patients, again with a view to 
broadening the division between 'them and us'.
4.4.2.4 - Stigmatisation of the mentally ill and portrayal of mental illness in the media
Stigma towards the psychiatrically unwell is likely to have been 
exacerbated by the negative portrayal and perception of the mentally ill 
throughout many periods in history, as well as in literature, journalism, film
^Sedgwick, P., 'Illness - Mental or Otherwise', in Edwards (ed) (1982), op. cit., p. 52.
^Veatch, R.M., "The Medical Model: Its Nature and Problems', in Edwards (ed) (1982), op. cit., 
p. 91.
^Edwards (1982), op. cit., p. 74.
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and television. Such depictions of mental illness and its supposed treatment do 
little to eradicate the negative perception of mental illness.
A well-known example is Jack Nicholson's character in One Flew Over 
The Cuckoo's Nest. This has probably had such a significant impact on the 
public because it portrays an apparently misdiagnosed free spirit who, once 
inside a mental institution, cannot convince staff he is in fact not suffering from 
a mental illness.
In addition, the behaviour of the mentally ill is often shown as being 
very extreme and alien to usual behaviour, and treatment usually portrayed as 
barbaric. Examples include unmodified electro-convulsive therapy, which is no 
longer in use today, or frontal lobotomies; psychosurgery has not been 
performed in New South Wales for several decades. Representations such as 
these prey on the fears of many people.
4.4.2.5 - Implications of stigmatisation for the autonomy of the mentally ill
This stigmatisation disempowers the mentally ill, and may weaken their 
autonomy both at an endogenous and an exogenous level. At an internal (or 
'endogenous' level), it may lead the mentally ill person to feel rejected, 
worthless, and unable to cope, which may affect their ability to consent for 
themselves. On the other hand, stigmatisation may lead to adverse, external 
circumstances for the patient, such as poverty, lack of social support, decreased 
education and job possibilities, and disrupted interpersonal relationships. 
These may also affect the capacity for autonomous choice and consent-giving.
4.4.3 - Impaired reasoning and communication in psychiatric patients and the 
implication of this for research
Another main way in which autonomy is impaired relates to abnormal 
reasoning and communication. Psychiatric patients may have difficulties as 
research subjects because they may not reason in the same way as other
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individuals, particularly when acutely unwell, and as a consequence of this, 
they may not communicate in the usual way, which leads to a number of 
problems.
This may be seen to be different from the case of research on children or 
the elderly, in that although very young children and very demented elderly 
may not reason in the same way as most other people, in general, the basis of 
their reasoning has some features in common with others, and their 
communication to some extent conforms to the normal rules of social 
interaction.
This problem with reasoning and communication impacts negatively in a 
number of ways, including impaired interpersonal relationships. The 
relationship with health professionals may be adversely affected, leading to 
difficulties in managing the patient, suboptimal treatment, and problems 
obtaining consent for participation both in treatment and research.
In addition, other relationships, particularly intimate relationships with 
the patient's family and friends, may also be deranged, leading to isolation of 
the psychiatric patient, and a lack of support and trust, a phenomenon that is 
often seen among psychiatric patients. As a result, such patients may lack an 
ability to understand the implications of agreeing to participate in research, and 
may not have a sufficient support network to protect them against irrational 
decision.
4.4.4 - Difficulty assessing the level of understanding in psychiatric patients
Although psychiatric patients demonstrate certain behaviours which we 
associate with their condition, in general the impact of mental illness on the 
sufferer is much harder to assess than somatic illness and disease. Even if we 
have not had a particular illness with predominantly physical manifestations, 
our personal experience usually allows us to have some insight into the 
condition, and some appreciation of how it must feel for the patient. However,
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it is much harder for outsiders to gain insight into the nature of mental illness, 
and the way in which it feels for the sufferer.
It should be pointed out that we cannot truly know what it actually feels 
like to be another person; usually, however, we interpret their behaviour as a 
basis for our interaction with them. So to say that we cannot rely on the 
behaviour of psychiatric patients to gain insight into their feelings and wishes 
may be imposing restrictions on them that we would not usually apply to other 
individuals.
However, it may be argued that our interpretation of the behaviour of 
other people usually relies on the assumption that the other person is 'normal' 
and knows the 'rules' of interaction. This obviously applies on a day-to-day 
level, as well as for interactions with patients and unwell people. The 'patient 
role' is a well-known phenomenon, and in the experience of this author, 
patients who violate these rules - including psychiatric patients - are 'bad' or 
'difficult'.
4.4.5 - The impact of mental illness on external factors influencing autonomy
Problematic communication skills, coupled with the often negative 
perception of the psychiatrically unwell in our community, leads also to other 
difficulties such as unemployment. This in turn leads to problems with poverty, 
lack of housing, and decreased self-esteem. All these factors diminish the 
patient's sense of self and ability to cope. They also may function as exogenous 
factors which weaken the patient's autonomy, insofar as they may affect the 
individual's capacity to freely give consent to participate in research.
4.4.6 - Involuntary treatment of the mentally ill and implications for their 
autonomy
Psychiatric patients can also be treated against their will, which has 
obvious implications for autonomy.
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Obviously, anyone who is behaving in an impaired way who is thought 
to be incapable of making a rational decision, can in theory have their wishes 
overridden by appealing to the Guardianship Board. And it may be seen that 
the wishes of some elderly persons and of some children may be viewed as 
inappropriate because they do not have the characteristics of an autonomous 
being, and lack rational judgement.
However, this phenomenon seems to occur far more frequently in the 
psychiatric population, partly because the very nature of the individual's illness 
implies that they lack these features we associate with rational decision and 
autonomy. Subsequently, psychiatric patients are frequently treated against 
their will, which may further decrease already impaired autonomy by making 
the patient believe their wishes are unlikely to be regarded. The nature of the 
treatment (for example, sedatives and antipsychotics) also further impair 
decision-making and autonomous action.
4.4.7 - Institutionalisation of psychiatric patients and effects on autonomy
Psychiatric patients tend also to be hospitalised for long periods, which 
makes them prone to becoming institutionalised. This has implications for the 
autonomy of such patients, and, consequent to this, may impact on the ability 
of psychiatric patients to consent for themselves.
4.4.7.1 - Institutionalisation and why this is a significant problem for the mentally ill
The negative effect of institutionalisation on autonomy and consent may 
be even more marked in psychiatric patients than in other hospitalised groups, 
because the mentally ill tend to be hospitalised more frequently, for longer, and 
more often against their will than other members of society. They may be aware 
that they are often unable to function normally in the outside world, whereas a 
'normal1 person, even if hospitalised for a long period of time, usually would
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still believe that he or she had the capacity to function normally in the 
community.
4.4.7.2 - The effects of institutionalisation on mentally ill persons and implications for consent
These factors may affect the autonomy of the psychiatric patient, making 
him or her more likely to consent to participation in research against his or her 
will.
He or she may fear that refusal may lead to either prolongation of the 
hospital stay (if the patient is unhappy being hospitalised) or premature 
cessation of the hospitalisation (if the patient fears discharge from hospital).
There may be a perception in the mentally ill individual that he or she 
may have no medical or psychological option but to agree to participate; he or 
she may also fear transfer to another, more restrictive facility; and such patients 
may believe that they have no legal right to refuse to go along with that which 
they are asked to do230.
The psychiatric patient may also believe that refusal to participate in 
research may mean that they will receive sub-standard care, or face further 
discrimination from the hospital staff, when such staff may already be the 
patient's only form of social and emotional support.
4.4.8 - The use of psychotropic medications in the psychiatric population and 
implications for autonomous choice
The autonomy of psychiatric patients may also be affected because such 
patients are frequently prescribed various psychotropic medications, ranging 
from hypnotic sedatives and anxiolytics, to anti-psychotic medications, often in 
significant doses, and sometimes with the aim of sedating the patient to such an 
extent that he or she may sleep for twenty-four hours or more; this author was
230Breggin/ P.R., 'Coercion of Voluntary Patients in an Open Hospital', in Edwards (ed) (1982), 
op. cit., p. 240.
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once required to sedate a violent psychotic patient, restrained by six members 
of staff, using 80mg of diazepam and 40mg of haloperidol intravenously, 
against the patient's will, at the insistence of the staff in the psychiatric unit.
Smaller doses of psychotropic medications are also frequently used on a 
long-term basis, and while the usefulness and necessity of such medications 
cannot be denied, the potential negative impact on the psychiatric patient's 
autonomy is evident.
This is obviously distinct from other potential research groups, such as 
children or the elderly, in that medications are either infrequently used, or in 
fact designed to try to enhance the patient's mental function and potentiate 
characteristics we associate with autonomy. Although medications used for the 
treatment of mental illness may also be given with the aim of normalising the 
patient's behaviour, the side effects often compromise their capacity for 
autonomous choice.
Thus, the use of psychotropic medication in the psychiatric patient 
population may lead to problems with research, because these medications may 
affect the way in which the patient reasons and communicates, and the extent 
to which their decision to participate could be said to be voluntary.
4.4.9 - The effect of mental illness itself on autonomy
A final point is that freedom is not merely defined by a lack of external 
controls; it has been noted that internal, psychological factors can be just as 
damaging in 'throttling the spirit' as any external influence231. Thus, the direct 
influence of the mental illness itself may impair thought and behaviour just as 
forcibly as any other factor that impairs autonomy.
4.4.10 - The impact on the autonomous choice of minimally affected psychiatric 
patients
^ C hod off (1996), op. cit., p. 406.
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There are, of course, a significant number of psychiatric patients who are 
either partly or totally treated; who are asymptomatic at a given time; or who 
have forms of mental illness that do not significantly inhibit their functioning 
on a day-to-day level (such as comparatively mild anxiety and depression).
Such individuals may also be adversely affected if it is erroneously 
believed that the impaired members of the psychiatric population are 
representative of all mentally ill people - a misconception that may be enhanced 
by negative public perception, a tendency to focus on the floridly unwell 
mentally ill, and a desire to protect those individuals who are impaired.
Such beliefs may lead to even the comparatively well mentally ill having 
their freedom to choose inhibited by the attitudes of family, friends, the general 
public, the medical profession, research bodies, and legislative bodies. This 
discrimination may manifest itself in a number of ways, including: a reluctance 
to initiate certain studies; little effort to involve patients in existing trials; 
excessive focus on the deficits of patients; underestimation of their capacities; 
insufficient effort taken to elicit their suitability for consent; a tendency to 
assume incapacity when none may exist; and the implementation of legislation 
limiting the involvement of the mentally ill as a group in research, irrespective 
of individual capabilities.
4.5 - Children and psychiatric research
Children who suffer from mental illness pose particular problems when 
involved in psychiatric research. These include: added constraints on 
autonomy; underdiagnosis; lack of knowledge of how best to treat them; 
diagnostic challenges; disrupted family and interpersonal relationships; and 
misuse of psychiatric diagnoses to explain other problems. These points will be 
discussed individually.
4.5.1 - Multiple factors affecting autonomy
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The first, and most obvious, point is that children with mental illness 
face twice as many difficulties from the point of view of factors which inhibit 
autonomy, because they have the difficulties of being a child, as well as being a 
psychiatric patient.
4.5.2 - Underdiagnosis of mental illness in children
It was also not recognised for a long time that children were affected by 
mental illness. As a result, many children with psychiatric problems were either 
not diagnosed, or were not diagnosed for a long period of time. This meant that 
many adverse behavioural traits and dysfunctional ways of coping could 
become entrenched, and have a lifelong effect on the individual. In addition, 
those children who were diagnosed faced added stigma because it was thought 
to be so unusual to see mental illness in children.
Children can also pose diagnostic challenges, as they pass through stages 
of certain actions of beliefs which might be problematic were they to persist. 
However, many little phobias and anxieties are common and transient in 
children, and as a result it can be difficult to establish which require 
intervention and which are likely to resolve spontaneously. It can also be more 
difficult to assess which of these states are problematic and should be treated, 
because it can be harder to assess the impact - both immediate and more long­
term - on children than adults. This is because they can lack the means to 
communicate their distress in an effective way, and they do not have the same 
experience as adults which might be helpful to them in assessing factors which 
are likely to have a negative effect.
4.5.3 - Lack of knowledge of how to treat children with mental illness
There is also a lack of consensus on how to treat children who have 
mental illness, partly because it is a comparatively new field, and partly 
because research in children in general tends to be more limited than in the
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adult population. This means that research in such groups is even more 
important, because limited knowledge on how we should treat children with 
mental illness means they may receive substandard care.
4.5.4 - Disruption of relationships and support network
Although in general children have more support from family and other 
social contacts than other groups with compromised autonomy, such 
relationships may be disrupted in children who have a mental illness, which 
exposes them to the risks of being exploited and poorly treated. Because of the 
often negative connotations of being mentally unwell, parents may deny that 
there is a problem, which leads to underdiagnosis, mismanagement, lack on 
involvement in research, and perpetuation of poor treatment and limited 
understanding of children with mental illness.
However, the quality of interpersonal relationships may be improved by 
participation in research, by improving the family's understanding of mental 
illness and their contact with their child. The family and the patient may benefit 
directly from the treatment in the research project, and more indirectly from 
learning more about the condition232.
4.5.5 - Medicalisation of social problems
Finally, there can be a tendency to overmedicalise children's behaviour, 
perhaps because medical labelling adds a degree of legitimacy to certain 
behaviours, and because it takes blame away from others (for example, 
parents).
An example is ADHD (attention deficit hyperactivity disorder), with 
which a vast number of children are diagnosed. It is debatable whether the 
behaviour that the majority of these children exhibit is in fact normal and
^^ sh er, T.W. and Telesford, M., 'Involving Families to Improve Research', in Hoagwood, K., 
Jensen, P.S. and Fisher, C.B. (eds) (1996), Ethical Issues in Mental Health Research With 
Children and Adolescents, Lawrence Erlbaum Associates, New Jersey, p. 31.
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appropriate, although perhaps difficult to manage at times. This may be partly 
because we find it easier to 'blame' adults for their behaviour, whereas with 
children we find them less blameworthy, and tend to search for external causes 
and explanations for their behaviour.
4.5.6 - Conclusion: children and mental illness
Thus, it may be seen that there are a number of extra factors which 
contribute to compromised autonomy in children who are also mentally ill. It is 
important to recognise the existence of factors such as these, in order that 
understanding, proper research, and treatment can be optimised in these 
patients.
4.6 - The elderly and psychiatric research
The elderly also represent a special group on individuals when they 
suffer from mental illness. An awareness of the special factors affecting this 
group is important in dealing with them, particularly with a view to involving 
them in research.
4.6.1 - Multiple factors affecting elderly people with mental illness
The first main problem is that - as for children with mental illness - this 
group of research subjects have more potential factors which could affect their 
autonomy. Problems which are faced by elderly people generally are 
compounded by those factors which may affect the autonomy of psychiatric 
patients, thereby making this group particularly vulnerable.
4.6.2 - Underdiagnosis of mental illness in the elderly
Mental illness in the elderly can tend to be underdiagnosed. The elderly 
may: be less likely to seek medical treatment; have a greater suspicion and fear 
of mental illness than younger people; tend to present with less florid
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symptoms than younger people; and attribute their symptoms to 'just getting 
old'. The patient may be viewed as being merely old and crabby and eccentric, 
or their symptoms may be attributed to the life changes which are common in 
this age group, such as retirement, increased medical problems, and deaths of 
spouses and friends.
It may also be argued that mental illness may be overlooked in the 
elderly because the may have had mental illness for much of their adult lives. 
Thus, those who remain undiagnosed by old age may have milder symptoms, 
or have learned techniques to help cope with their mental illness. They may 
also have had their symptoms for such a long period of time that others fail to 
recognise them; instead, such symptoms may mistakenly be thought to just be 
part of the person's normal, albeit somewhat dysfunctional, state.
4.6.3 - Treatment difficulties in the elderly with mental illness
Treatment of mental illness in the elderly may also be more difficult than 
in other age groups. As I mentioned above, mental illness may have been 
present in elderly people for many years, making a change of habits difficult. 
Some forms of mental illness in the elderly, such as depression, tend to be more 
refractory, and resistant to treatments such as electro-convulsive therapy. The 
elderly may be more prone to side effects, such as postural hypotension in 
response to tricyclic antidepressant medications.
4.6.4 - Problems related to psychiatric illness may be compounded by age- 
related factors
Some of the problems seen in psychiatric patients may be compounded 
in the elderly with mental illness. For example, understanding and 
communication which is already compromised through mental illness may be 
worsened by dementia, strokes, blindness and deafness. Poverty and
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disempowerment may also be exacerbated, and the burden placed on families 
and the healthcare system is even greater.
4.6.5 - Conclusion: elderly and mental illness
Research is important to clarify problems such as these, and to optimise 
the treatment of the elderly with mental illness, but recognition of the way in 
which they impact on the autonomy of the individual, and, consequently, on 
the research process, is important.
4.7 - The doctor-patient relationship in psychiatric research
The doctor-patient relationship may be complicated by a number of 
factors when a clinician participates in research involving mentally ill patients. 
There are at least several such problems.
Firstly, there may be disruption of normal doctor-patient dynamics and 
roles. Secondly, there may be difficulties for the patient in recognising the 
distinction between the separate roles of doctor and researcher. Thirdly, there 
exists potential conflict of interest for the doctor at a number of levels, such as 
duty to safeguard the patient's best interests, pressure to perform research, and 
social conscience and need for preventative medicine. These will be discussed 
individually.
4.7.1 - Interaction between the doctor and the psychiatric patient
The doctor-patient relationship may be affected if the patient fails to act 
in the 'proper' way - that is, if they fail to act according to the 'rules' of the 
doctor-patient relationship. It is arguable that the doctor-patient relationship is 
very formalised, and this provides a security (for both parties) which can be 
threatened if the 'rules' are breached.
As a result, the quality of the relationship between doctor and 
psychiatric patient may be suboptimal, as many psychiatric patients fail to
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behave in the 'normal' and essentially predictable way that most other patients 
behave.
This may have an adverse effect clinically - particularly for psychiatric 
patients, whose therapy is based primarily on the establishment of good 
rapport between patient and clinician.
However, other aspects of the doctor-patient relationship may be 
affected, an example being difficulties obtaining consent to participate in 
research, and ensuring retention of patients in a study.
4.7.2 - Difficulties in recognising dual interests for the doctor
Another problem with performing research on mentally ill individuals is 
that - as in the case of children233 - they may have less perception of the vested 
interests of a doctor who has the dual role of clinician and researcher, if they 
are have very florid disease or are impaired through external factors, such as 
high doses of psychotropic medications.
4.7.3 - Conflict of interest for the doctor involved in research on mentally ill 
patients
4.7.3.1 - The duty to one's patient and the way in which this may be compromised when a 
clinician is involved with research on the mentally ill
One such way the doctor-patient relationship may also become 
complicated in a research context is because (as is the case with other groups of 
research subjects with whom a clinician has contact) the doctor has certain 
obligations to 'do his or her best' for a patient - that is to say, the well-being of 
the patient ought to be of paramount importance, and the actions of the doctor 
should be to maximise benefits to the patient.
233Weithorn/ L.A. and Scherer, D.G., 'Children's Involvement in Research Participation 
Decisions: Psychological Considerations', in Grodin and Glantz, (eds) (1994), op. cit., p. 151.
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However, the involvement of a clinician and his or her patients in 
research may lead to conflict in this respect, in that the patient may not be 
receiving the best intervention possible. Examples of this might be involvement 
in a randomised controlled trial, where different groups receive treatment of 
various kinds, or possibly placebo. The placebo is obviously ineffective, and 
denies some research subjects access to the treatment, which may be effective, 
ineffective, or less effective than the standard treatment for a particular 
condition. Thus, involvement of the doctor in a randomised controlled trial 
violates the Hippocratic tradition234.
This conflict for the doctor is even more pronounced when the potential 
research subjects are people with compromised autonomy, such as children, the 
elderly, and those with mental illness, as they may be less able to understand 
the nature of research and potential complications and disadvantages.
It is arguable that this is most problematic for psychiatric patients, 
insofar as children (and the elderly to a slightly lesser extent) usually have a 
number of other people who can provide support and advice; their emotional 
needs and protection can be provided by a relatively broad support network. 
The social support network of psychiatric patients in general is less adequate, 
however, and sometimes the doctor and other health staff are the patient's only 
advocates. This, combined with the decreased autonomy of some psychiatric 
patients, makes to involvement of the doctor in research potentially 
complicated.
Another problem might be when a patient refuses to participate in a 
study when the doctor believes it would be in the patient's best interests to do 
so. The doctor may feel that he or she has a moral, social and professional duty 
to do what it 'in the best interests' of the patient. Many patients often end up 
thanking the doctor for a particular course of action, even if they initially
234Schiiklenk, U. and Hogan, C., 'Patient Access to Experimental Drugs and AIDS Clinical Trial 
Designs: Ethical Issues', in Kuhse, H. and Singer, P. (eds) (2000), Bioethics - An Anthology, 
Blackwell, Oxford, p. 443.
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resisted such a course of action. Society usually expects doctors to take ultimate 
responsibility for the well-being of patients. And some patients may want or 
expect the doctor to be coercive235.
4.7.3.2 - Career pressure on doctors to become involved in research
The involvement of clinicians in research on the mentally ill also may be 
complicated by conflict of interest in a number of respects other than the duty 
to do the best for one's patients. One such problem is the increasing pressure on 
clinicians to participate in research.
Involvement in research is increasingly important for promotion for 
clinicians, and as a result, the doctor in question risks being over-zealous in 
recruiting patients for his or her study.
This is of particular relevance in psychiatric patients, insofar as they may 
be more prone to exploitation, often having fewer social supports and being 
more likely to be institutionalised, than other research groups.
4.7.3.3 - Social conscience and the way in which this may lead to conflict of interest for doctors
Another source of conflict for a doctor involved in research is social 
conscience. Social conscience may drive the doctor's participation in research, 
owing to the significant impact mental illness has on the lives of sufferers and 
their family and friends, and on society.
A doctor may also feel it is his or her duty to try to improve the quality 
of life for groups such as the mentally ill, by being involved in research to try to 
help them. Groups such as the mentally ill tend to be overlooked in terms of 
funding and research, compared with some other research groups, such as 
children with cancer; the latter seem to invoke greater sympathy and support.
^Breggin (1982), op. cit., p. 242.
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A concern for factors such as these may lead the researcher to press for 
participation in a study, even when it is not directly of benefit to the patient, or 
in his or her best interests, which is where the conflict lies.
4.7.3.4 - Preventative medicine and the implications of this for doctors conducting research 
involving the mentally ill
Similarly, a doctor may similarly wish to recruit patients to participate in 
research in the hope that the study may provide means for prevention of 
various illnesses and problems.
This is particularly relevant for psychiatric illness, as it has such a broad 
and significant impact on the patient and his or her life. The financial cost to the 
community of mental illness is enormous, due to factors such as sick leave, 
long-term care as an in-patient/ long-term institutionalisation, and the 
decreased ability of the patient to work and contribute to society in the usual 
way.
Again, a focus on the social cost of mental illness, and a desire to 
minimise this through research may complicate the doctor-patient relationship 
as the patient's interests may not be consistent with this course of action.
4.7.3.5 - Potential areas of conflict of interest which may be less an issue when dealing with 
psychiatric patients
Some potential areas of conflict for a doctor involved in research tend to 
be less an issue when dealing with psychiatric research. These include: an 
increase in the amount of funding available, which is generally less marked in 
psychiatric research, compared with other ares such as HIV/AIDS and cancer; 
and the expansion of clinical research as a profession, which tends to be seen 
more often in areas such as clinical pharmacology236, rather than in psychiatry.
236Beecher, H.K., 'Ethics and Clinical Research', in Kuhse and Singer (2000), op. cit., p. 422.
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4.7.3.6 - Problems with the role of the doctor as a researcher
Finally, involvement of doctors in clinical research, particularly 
psychiatric research, may also be problematic in that they may exercise their 
'therapeutic zeal' and be prone to offer advice or to make clinical 
interpretations of the data with which they are presented237, rather than simply 
collecting information. This is particularly the case in psychiatric research, as 
the tool used to elicit data for the research study is the same as the therapeutic 
tool (i.e., discussion, interaction with the patient, questioning, and 
interpretation).
In addition, research of the sort performed in psychiatry differs from 
other kinds of medical research in that there are fewer objective markers that 
can be utilised; thus, findings may be less objective, and more dependent on the 
interpretation of the clinician. This can complicate the role of the clinician in 
research because the boundary between treatment and research can become 
blurred; and the objectivity of research findings is much less marked than in 
many other kinds of research, as it is clinician interpretation which is 
fundamental in gathering research findings.
4.8 - Ways in which ethical research involving psychiatric patients may be 
brought about
It may be seen from the preceding sections that there are a number of 
factors that adversely affect the research process when it involves mentally ill 
individuals. However, given the importance of at least some kinds of research, 
it may be more appropriate to consider how the autonomy of mentally ill 
individuals might be optimised, in order to allow appropriate research, in a 
safe, controlled environment that is acceptable both to researcher and patient.
^Attkinsson, C.C., Rodenblatt, A., and Hoagwood, K., 'Research Ethics and Human Subjects 
Protection in Child Mental Health Services Research and Community Studies', in Hoagwood, 
K., Jensen, P.S., and Fisher, C.B. (eds) (1996), Ethical Issues in Mental Health Research With 
Children and Adolescents, Lawrence Erlbaum Associates, New Jersey, p. 51.
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4.8.1 - Emphasising the capacities the psychiatric patient does possess
Firstly, it is important to focus not on what the mentally ill person cannot 
do, but what he or she can do. That is, it is important to develop an awareness 
of the factors that are related to autonomy, the way in which these factors 
manifest themselves behaviourally, and how to assess whether they are present 
in a give individual.
These factors include the factors I described in the preceding sections, 
namely: the ability to reason and communicate; one's sense of self; the extent of 
a support network; exogenous adverse circumstances, such as poverty and lack 
of family and friends; the degree of institutionalisation present in a given 
patient; the severity of his or her mental illness and the autonomy factors likely 
to be most affected by the symptoms associated with the condition; and the 
effectiveness of therapy.
4.8.2 - The necessity of avoiding imposing unreasonably strict criteria when 
assessing psychiatric patients with a view to involving them in research
It is important also to avoid the temptation to be unreasonably strict in 
one's assessment of the capacities of a mentally ill individual in considering 
them for research.
As discussed earlier, an awareness of the poor treatment historically of 
research subjects and of different minority groups (such as children, the elderly, 
and psychiatric patients) has led to an enhanced awareness of the risk of 
exploitation of these groups. This may give rise to a tendency to lean to the 
other extreme - that is, to limit unnecessarily the involvement of some 
individuals in research.
It is worth noting that the Nuremberg Code - which represents a turning 
point in the way in which research subjects and their rights were viewed - was 
formulated in response to the treatment of prisoners by the Nazis. The majority
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of these individuals were 'competent but confined'238 - that is, the fundamental, 
internal factors that contribute to autonomy, such as reason, were intact, but 
their ability to exercise their autonomy was restrained by external factors.
However, many potential research subjects, particularly in the current 
scientific climate, are not externally confined or restrained, but may have some 
'internal' restraints on their autonomy, such as memory or reasoning problems, 
difficulty communicating, limited comprehension, or an inability to appreciate 
the possible consequences of their actions. Application of codes such as the 
Nuremberg Code to individuals such as these may be inappropriate, given the 
type of research subject for whom it was originally formulated, and the fact that 
it was probably not envisaged that the Code would be used for non-competent 
people239. Despite this, such codes have become fundamental to the notion of 
research.
4.8.3 - Modification of the research methodology to increase the acceptability 
for psychiatric research subjects
The actual methodology of the research project may need modification, 
however, when dealing with patients or individuals with compromised 
autonomy. For example, the way in which information is conveyed to the 
patient in gaining consent may need to be modified, perhaps with alternative, 
more suitable language being used, and by communicating information at 
times that suits the patient (for example, when least sedated by psychotropic 
medications, or when symptoms best controlled).
Psychiatric patients may also be distressed by things that are less a 
problem for normal people, and such things may need to be modified to make 
the research process more acceptable to them.
^Grodin, M.A., 'Historical Origins of the Nuremberg Code', in Annas and Grodin (1992), op. 
cit., p. 138.
^ ib id , p. 139.
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They may be more fearful of confined spaces (either due to their 
underlying illness, such as anxiety or claustrophobia, or through negative 
associations they have developed through their treatment, such as being 
restrained or confined). This may mean that imaging techniques - such as PET 
scanning240 and MRI, which are fairly commonly used in psychiatric research - 
may be unacceptable to these individuals.
Similarly, such patients may be more fearful of receiving injections or 
psychotropic medications, due to their treatment in the past. Or they may resist 
even the interview process involved in research, as for them, communication 
such as that is comparable to their treatment, which may have negative 
connotations for them.
It is also important to have sufficient flexibility in the research structure 
to accommodate patients who are comparatively well and autonomous, such as 
those who are currently asymptomatic, or who have well-controlled symptoms, 
or illnesses that have less impact on autonomy, such as some milder forms of 
the neuroses.
4.9 - Conclusion
To summarise, I have discussed ways in which poor treatment of 
psychiatric patients in the past has led to a reluctance to involve them in 
research.
The autonomy of psychiatric patients may also be affected by: an 
assumption that all psychiatric patients have similar capabilities; stigma; 
communication difficulties; involuntary hospitalisation and treatment; and 
psychotropic medications.
Children and the elderly with mental illness have the problems of being 
mentally ill compounded by other, age-related factors and represent an 
especially vulnerable group.
240For example, see Hoagwood, Jensen and Fisher (1996), op. cit., p. 148.
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The doctor-patient relationship may also be disrupted by abnormal 
communication, and by conflict of interest.
However, research remains important in psychiatric patients to decrease 
suffering and to increase their quality of life. Research can be made more 
acceptable by: recognising the factors outlined above; emphasising the 
capabilities the patient does have; and modifying the methodology of the 
project to increase acceptability for the patient and for ethical considerations.
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CONCLUSION
In chapter 1, I discussed ethical concerns which relate to research in 
general.
A focus on such concerns relate to increasing public awareness of 
research and its implications, an increased awareness of the rights of the 
individual, an increased capacity for funding and intervention, the increasing 
role of clinicians in research, and historical precedent of poor treatment of 
research subjects in the past.
A central premise of ethical research is informed consent. The notion of 
consent raises a number of issues. These include: difficulties in establishing 
what constitutes informed consent; 'patient' and 'professional' standards of 
information disclosure; problems with communication and misunderstanding; 
and risk assessment.
Experimentation and research both raise issues. Experimentation, 
although more a d  hoc, allows the possibility of flexibility to accommodate the 
needs of individuals. Research, though more directed and less risky, does not 
allow the same degree of flexibility as experimentation.
Research may be clinical or non-therapeutic. Clinical research may lead 
to problems because it involves clinicians, who may experience conflict of 
interest, and because it also tends to involve ill people, who may be prone to 
exploitation.
Non-therapeutic research also raises issues. These include problems with 
risk-benefit analysis, whether patient consent is sufficient to compensate for the 
risk involved, the problems with involving ill people in non-therapeutic 
research, and motivation to participate in research.
An awareness of these issues helps permit more ethical research 
practices.
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In chapter 2 ,1 discussed the ethical problems of performing research on 
children. It may be seen that research involving children is necessary, at least to 
a certain extent, in order to optimise their wellbeing and safety.
The role of parental consent is often pivotal in such research, and can be 
seen to derive from a historical backdrop on which children were viewed more 
as property of their parents, than individuals in their own right. Increasingly, 
however, a more moderate role for parents is being advocated, with increasing 
weight and responsibility being given to children.
Difficulties with parental consent may arise when it is seen as a 
substitute for the child's own judgement, or to be in the best interests of the 
child. Other problems include lack of parental understanding, difficulties in 
assessing the amount of information to give to parents, and risks to the child 
secondary to parental consent.
Arguments in favour of parental consent include providing a means for 
the child to access certain benefits, the development of pro-social traits in the 
child, and preservation of family relationships. It may also be difficult to find a 
good reason to override parents' wishes, if there is no particular harm done to 
a child through such a decision.
The autonomy of the child raises certain issues. Firstly, it is partly 
dependent on age, so older children may be fully autonomous. Evidence 
suggests that the majority of children and adolescents have good powers of 
reasoning and often make similar judgements to adults. This suggests that a 
continuum of capabilities should be reflected by a continuum of consent.
Adolescents represent a special case, as although they reason in ways 
similar to adults, they have some special concerns and values which are age- 
specific and which need to be borne in mind when assessing a teenager's 
capacity to consent. There are a number of reasons why it may be appropriate 
to accept adolescent choices, but these may need to be overridden to ensure the 
safety of the adolescent at times.
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Psychological and social research may pose particular problems. The 
abundance of comparatively well children available for this kind of research 
may lead to undue risk-taking when involving them in research. The subjective 
element of assessment may affect outcomes and cause problems within family 
relationships. Longer studies such as these may have difficulties recruiting and 
retaining subjects. Such studies are often also essentially non-therapeutic, and 
may raise problems because children are exposed to risks for comparatively 
little benefit.
The role of the doctor in research on children raises a number of issues. 
These include the conflict between research obligations and the duty to care for 
one's patient. The relationship of the doctor and the parents may be affected, 
with feelings of mutual obligation. Parents may also pressure the doctor to 
allow them access to high-risk or alternative trial therapies, especially if the 
condition is life-threatening. Limited understanding on the part of the parents 
may also complicate the research process and the involvement of the doctor.
Understanding the issues relating to research involving children may 
help minimise problems and maximise the involvement and well-being of this 
subgroup of the population.
In chapter 3, I discussed research on the elderly, and some of the 
problems which may be encountered when performing research on such a 
group.
I showed that the autonomy of elderly people could be compromised in 
a number of ways. The first such factor is ambiguity in the terminology applied 
to elderly people, which often leads to all elderly people being grouped 
together and thought to have similar capabilities, when in fact this is not the 
case. Secondly, stereotypic perceptions also work against those elderly people 
who are competent. Thirdly, a range of factors - both internal and external - 
may also affect autonomy, including physical and cognitive impairment,
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poverty, reliance on family for support, institutionalisation, and relationships 
with relatives. It is important to note, however, that there is a significant range 
of capabilities in this age group.
Despite these problems with autonomy and consent-giving, research in 
the elderly is important to maximise the health and well-being of the people in 
this age group, as they can have special problems which do not exist in other 
age groups.
The acceptability of research on this age group may be increased by: the 
benefit to the research subject individually, and the group as a whole; alteration 
of the research methodology to increase involvement of and acceptability for 
elderly people; the satisfaction derived; previously-expressed acceptance of 
research; economic benefit to the community and older people generally, 
through improvements in health and lifestyle; and the existence of many 
elderly people who are autonomous.
In chapter 4, I discussed to problems encountered when involving 
patients with mental illness in research.
It may be seen that past exploitation of psychiatric patients has led to a 
reluctance to involve them in research.
This is compounded by the fact that the autonomy of the mentally ill 
may be compromised in a number of ways. These include: the continuum that 
exists between 'normal' and 'abnormal'; stigmatisation of the mentally ill; 
communication difficulties and abnormal interpersonal relationships; and the 
effects of hospitalisation, involuntary treatment, and psychotropic medications.
Children and the elderly with mental illness face added problems 
because they have all the problems associated with mental illness, as well as 
age-related constraints on autonomy (discussed in chapters two and three).
The doctor-patient relationship may also be affected because there is 
abnormal interaction between the doctor and the patient, the psychiatric patient
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may have difficulty comprehending the dual roles of the doctor in this context, 
and there exists conflict of interest for the doctor on a number of levels.
Despite these factors, however, research involving the mentally ill is 
important to optimise their treatment, and to improve their quality of life. 
Research in the psychiatric population may be made more acceptable by being 
aware of the factors operating in this kind of context, by emphasising the 
capacities that such patients do have, and by modifying the methodology to 
optimise consent and acceptability for the patient.
So it is to be hoped that an awareness of the kinds of factors which serve 
to diminish the autonomy in groups who have compromised autonomy, may 
help to develop an awareness of the factors operating in such individuals, and 
to allow us to develop more ethical ways of conducting research, so that groups 
such as children, the elderly, and the mentally ill, may benefit from research 
and lead happier and healthier existences.
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